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1. Abstract 
In the present work the concept of decarboxylative couplings and the strategy to use 
carboxylates as directing groups for C−H functionalizations have been decisively improved in 
three ways. These concepts emphasize the multifaceted nature of aromatic carboxylic acids as 
expedient starting materials in homogeneous catalysis to construct highly desirable molecular 
scaffolds in a straightforward fashion. 
In the first project, the restriction of decarboxylative biaryl synthesis to exclusively couple 
aryl halides with ortho-substituted benzoic acids has been overcome by a holistic optimization 
of a Cu/Pd bimetallic catalyst system (Scheme 1). Long ago postulated, this is now the proof 
that decarboxylative cross-couplings are not intrinsically limited to different decarboxylation 
propensities of benzoic acids or hampered by excess halides, accessing for the first time the 
entire spectrum of aromatic carboxylic acids as starting materials for the decarboxylative 
biaryl synthesis. 
 
Scheme 1: Decarboxylative cross-coupling of non-ortho-substituted benzoates with aryl 
chlorides. 
The second project uses the carboxyl moiety as directing group for the ortho-arylation with 
aryl bromides and -chlorides catalyzed by comparatively inexpensive ruthenium. The 
carboxylic acid group remains untouched after the ortho-functionalization giving the 
possibility to a wealth of further diversifications via decarboxylative ipso-substitutions. 
Within the same project, a Cu/Ru bimetallic catalyst system was found to be able to switch 
the decarboxylative biaryl coupling from the ipso- to the ortho-position, complementing the 
Cu/Pd system developed in the first project (Scheme 2). 
 
Scheme 2: Carboxylate directed ortho-arylation with aryl bromides and -chlorides. 
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In a third project, a redox neutral C−C bond formation revealed the full synthetic potential 
of the carboxyl group. The CO2H moiety acts as a classical directing group for the C−H 
hydroarylation of internal alkynes to form highly desirable 2-vinyl benzoic acids (Scheme 
3A). With propargylic alcohols the hydroarylation is followed by an in situ esterification, 
showing that after easing the C−H cleavage, the directing group can be transformed into 
another functional group, thus, acting as a transformable directing group (Scheme 3B). Most 
importantly, a new fascinating reaction mode is activated by embedding the decarboxylation 
within the C−H functionalization event. This mode of action is capable to solve 
regioselectivity issues that inherently occur when dealing with carboxylates as directing 
groups. A so-called deciduous directing group is cast off simultaneously within the C−H 
functionalization event, resulting in an inherently monoselective pathway (Scheme 3C). 
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Scheme 3: Multipurpose directing ability of a carboxylic acid group. 
These methods were developed with the permanent goal of ensuring high sustainability. 
They do require neither pre-functionalized starting materials nor additional oxidants and 
provide access to a number of chemically relevant molecules from abundant, inexpensive and 
toxicologically innocuous educts. 
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2. Structure of the thesis 
The present thesis is written in a cumulative form. The regioselective catalytic 
transformation of aromatic carboxylic acids covers the main part of this work. Based on the 
doctoral regulation of a cumulative dissertation, this work contains 5 original and published 
manuscripts. Sources cited in the present work as well as the citations within the depicted 
original publications are part of the corresponding projects. A detailed statement of 
contributions of each author is listed in front of the depicted publications. 
The introduction emphasizes the importance and characteristics of aromatic carboxylic 
acids as well as their application in regioselective transformations, ranging from classical to 
modern synthetic approaches. Herein, the tremendous progress experienced in this field over 
the past decade exemplifies the multifaceted nature of aromatic carboxylic acids as a 
privileged starting material for a plethora of catalytic diversifications constituting an 
advantageous alternative to preformed carbon nucleophiles. Moreover, a new reaction concept 
in carboxylate-directed C−H functionalizations - carboxylates as deciduous directing groups - 
is presented as a key technology for the catalytic regioselective construction of complex 
molecules from readily available precursors. 
Subsequently, the section “research objectives” is supposed to pinpoint the remaining 
central challenges in catalytic transformations of benzoic acids as well as the conceptual 
strategies that have been applied to face them. The “result and discussion” chapter consists of 
each elaborated project. They are briefly introduced and contain a depicted reprint of each 
respective original and published work. 
In the experimental section, all analytical and preparative instruments as well as the 
standard parallel reaction set-up are specified. All procedures for the synthesis of the used 
starting material as well as all isolated compounds are given. This part consists mainly of the 
supporting information of each published work. 
References and a brief CV are given in the end of this document. 
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3. Introduction 
The development of sustainable methods for the concise construction of complex organic 
compounds from simple molecules is a major objective in modern synthetic chemistry.[1–4] 
Based on the founding works of Ullmann[5] and Goldberg[6] in the early 20th century, the 
synthesis of new C−C or C−heteroatom bonds mostly rely on transition metal-catalyzed cross-
couplings of preformed organometallic reagents, such as organoboronates, Grignard reagents 
or organotin compounds, with carbon electrophiles (Scheme 4, left top).[7–11] Back then, these 
discoveries were at the forefront of the advancement of research and their significance was 
certified with the Nobel Prize in Chemistry in 2010 for “for palladium-catalyzed cross 
couplings in organic synthesis” awarded to Negishi, Suzuki and Heck.[12] Although highly 
effective, these reactions have innate disadvantages such as laborious preparation of sensitive 
organometallic reagents and the production of copious amounts of waste, which are reputed to 
be ecologically as well as toxicologically alarming. Due to the increasing level of 
environmental awareness over the past decades, the need for sustainable approaches to replace 
these traditional coupling reactions gained increased attention.[13–19] 
 
Scheme 4: Approaches for C−C or C−heteroatom bond formations. 
A major improvement regarding waste and toxicity reduction is witnessed by Sonogashira-
Hagihara or Tsuji-Trost type reactions (Scheme 4, right top).[20–22] Carbon nucleophiles are 
generated from innately reactive compounds, such as C−H acidic compounds or allylic 
scaffolds bearing leaving groups, avoiding pre-synthesis of organometallic reagents and 
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accruing metal salts as waste. These systems have been applied in numerous, highly valuable 
transformations. However, these reactions are limited to the intrinsic reactivity of either 
coupling partner and are therefore limited in scope and functional group tolerance. In the 
meantime, two major strategies have been established that diminish the major drawbacks of 
traditional cross-coupling reactions to a certain extend (Scheme 4, bottom). Firstly, the 
decarboxylative cross-coupling as one of the alternative strategies is particularly worth 
mentioning. Carboxylic acids or carboxylate salts are readily available in great structural 
diversity, are toxicologically harmless and can be easily handled under ambient conditions. 
Therefore, no laborious preparation compared to classical carbon nucleophiles are required, 
which additionally guarantees a certain quality of the starting material. Moreover, innocuous 
CO2 is released in the course of the reaction instead of stoichiometric amounts of often toxic 
metal salts. Decarboxylative couplings of aromatic carboxylates allow the ipso-substitution 
with various carbon residues such as aryl, vinyl, allyl or heteroaryl groups, with alkoxy, 
amino, halo and other functionalities.[23–30] The second strategy, which avoids preformed 
organometallic coupling partners, is C−H activation (Scheme 4, right bottom). C−H bonds, 
which are chemically inert under traditional cross-coupling conditions, are used as anchor 
points for the generation of carbon nucleophiles and the bond formation occurs with relatively 
high atom economy.[31–44] The C−H bond cleavage is triggered either by its intrinsic reactivity 
(e.g. acidic C−H bonds), or is aided by strong coordinating moieties that bring the metal into 
their proximity. The nature of the directing group is decisive to keep the high atom economy 
for which C−H activation reactions are designed. However, in most cases particularly 
efficient directing groups need to be pre-installed and removed a posteriori, thus deteriorating 
the atom efficiency. In this context, aromatic carboxylic acids are ideal substrates as the 
relatively small carboxylate group has shown the ability to trigger ortho-C−H 
functionalizations and can be removed with particular ease, maintaining high levels of atom 
efficiency.[45–50] 
The following work consists in the development of reactions which apply the strategies of 
decarboxylative cross-couplings and carboxylate-directed C−H functionalizations. Moreover, 
it includes examples in which both approaches are merged into one to overcome selectivity 
issues, which is a major limitation in C−H activation reactions. It gives an overview of the full 
synthetic potential of aromatic carboxylic acids in modern catalytic cross-coupling chemistry 
to achieve inexpensive, waste-minimized, and regioselective formation of new, chemically 
relevant scaffolds. 
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3.1. Aromatic carboxylic acids 
3.1.1. Occurrence, application and characteristics of aromatic carboxylic acids 
Implementing aromatic carboxylic acids as versatile building blocks in organic synthesis is 
highly desirable because these acids are among the most privileged naturally occurring 
structural motives.[51–54] The so-called benzoic acid is the simplest example of aromatic 
carboxylic acids. It contains a carboxyl group directly bound to a benzene ring and is a 
colorless crystalline solid (m.p.: 122 °C) with faint, pleasant odor.[55] It naturally occurs in 
numerous berries, such as cranberries, bilberries and cowberries, is also a component in honey 
and it is formed in yogurt and curdled milk as a result of microbial decomposition of hippuric 
acid.[56–61] Benzoic acid was first described by Nostradamus in 1556 and obtained by 
sublimation from gum benzoin, a resin from several trees of the genus Styrax. Despite that, 
the right elemental composition was first reported almost 300 years later by Wöhler and 
Liebig in 1832.[62] With a pKa-value of 4.20, benzoic acid is slightly more acidic than acetic 
acid (pKa = 4.76), but less acidic than formic acid (pKa = 3.77). Thus it is present in its 
deprotonated form under physiological conditions.[63] The acidity of a benzoic acid derivative 
can vary substantially depending on the electronic properties of a substituent. The Hammett 
equation is a powerful tool to predict the acidity of benzoic acids carrying para- and meta 
substituents.[64–67]  
 
Scheme 5: Selected examples for benzoic acid-based pharmacophores and functional 
materials. 
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The pharmacological activity of carboxylic acid-based compounds is usually enhanced as a 
result of electrostatic interactions caused by the inherent polarity of the carboxyl group. This 
aspect is often critical for sufficient binding on a specific target.[68] In fact, benzoic acid itself 
already has antifungal properties and is therefore often used as a food preservative in 
beverages as a sodium salt (Scheme 5).[57,69–71] In general, aromatic carboxylic acids are 
particularly popular among chemists as they show great versatility serving as potential biocide 
as well as drug candidates, functional materials, food additives and recently as organic 
photocatalysts (Scheme 5).[68–91] Derivatives of benzoic acids are known to be biologically 
active and were used in ancient times for medicinal purposes.[92–94] Even in the era of 
Hippocrates (400 B.C.), people were advised to chew on the bark of white willow (Salix alba) 
to treat fever and inflammations. The extract of the willow bark contains a cocktail of 
compounds, some of which are still used today to cure low back pains and osteoarthritis.[95–97] 
One of these components is salicylic acid, which was first discovered by Piria in 1838 as an 
oxidation product of salicin.[98] One year later Löwig and Weidmann, extracted salicylic acid 
directly from meadowsweet.[99] Albeit its antipyretic and anti-inflammatory effect, salicylic 
acid as active ingredient became soon unpopular in pharmaceutical chemistry because of the 
numerous documented adverse reactions by oral intake ranging from strong gastric irritation 
to hearing loss.[100–103] Despite this medical impairments, it is still a commonly used additive 
in creams and solutions to treat acne.[71,102] In mid to late 19th century, acetylsalicylic acid 
(better known as Aspirin©) became an increasingly famous, less irritating surrogate of 
salicylic acid. Initially commercialized by Bayer, it is now one of the most consumed 
pharmaceuticals worldwide.[104,105] compared to their pharmaceutical application, the 
utilization of aromatic carboxylic acids in functional materials is less common. Nevertheless, 
due to the electron withdrawing effect of the carboxyl group and extended delocalized π-
system, aromatic carboxylic acid derivatives are merging as electron acceptors in sensitizers 
for organic light emitting diodes (OLEDs) and dye-sensitized solar cells (DSSCs).[89,90,106–109] 
Moreover, the carboxyl moiety shows particular convenience in serving as anchor point for 
the straightforward fixation of the dye to a TiO2 semiconducting surface.[110–113] Beyond that, 
the so-called xanthane dyes, such as eosin Y, rhodamine, fluoresceine and rose bengal, which 
contain a benzoic acid moiety, are commonly used as fluorescent target agents or laser dyes as 
well as organic photocatalysts.[91,114–119] The latter is recently emerging as a powerful 
application to substitute expensive transition metal catalysts for cross-coupling chemistry.[120] 
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3.1.2. Synthesis of aromatic carboxylic acids 
The wide spectrum of applications for aromatic carboxylic acids inspired chemists to 
provide straightforward approaches for the synthesis of benzoic acid and its derivatives. 
Traditionally, (hetero-)aromatic carboxylic acids are synthesized via oxidation of the 
corresponding alcohols or aldehydes. However, the necessary strong oxidants, such as 
potassium permanganate, potassium dichromate or Jones reagent (a solution of CrO3 in 
H2SO4) are ecologically questionable.[121–125] An alternative approach utilized within the 
industry is to convert toluene or p-xylene into benzoic acid or p-phthalic acid, respectively, by 
the oxidation of the benzylic position with molecular oxygen in the presence of cobalt, 
manganese or vanadium catalysts (Amoco process, Scheme 6A).[121–123,126–130] 
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Ar-CO2H
 
Scheme 6: Traditional and industrial syntheses for aromatic carboxylic acids. 
α-Acidic carbonyl compounds, e.g. ketones, react with halides under basic conditions to 
the corresponding carboxylic acids and chloro-, bromo-, or iodoform, depending on the used 
halide (haloform reaction, Scheme 6B).[131–133] Under both acidic or basic conditions, nitriles 
as well as esters, amides, anhydrides and acid chlorides, can be hydrolyzed to provide 
carboxylic acids from various starting materials (Scheme 6C and E).[121,122] The Cannizzaro 
reaction offers the possibility to convert two equivalents of aldehydes into one equivalent of 
the corresponding acid and alcohol, respectively (Scheme 6D).[134–136] However, due to strong 
basic conditions, scope and functional group tolerance are very limited. Aromatic carboxylic 
acids can also be prepared by the direct implementation of CO2 into a carbon nucleophile. 
Grignard reagents offer the opportunity to formally transform a C−X bond into a C−CO2H 
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bond (Scheme 6G).[121,122,137] However, multiple steps and stoichiometric metal waste are 
major drawbacks of this approach. A more elegant carboxylation reaction was discovered by 
Hermann Kolbe in 1860 and later on improved by Rudolf Schmitt, commonly known as 
Kolbe-Schmitt reaction (Scheme 6F).[138–141] Sodium phenolate is treated with CO2 (4.4 bar) 
at 135 °C and after hydrolysis exclusively yields the ortho-hydroxy benzoic acid; also known 
as salicylic acid.[142] By increasing the temperature to 185 °C in combination with NaH as 
base, the reaction requires only 1 atm of CO2.[143] To date, the exact mechanism remains 
unclear, however, the high regioselectivity for the ortho-substitution is presumed to be a 
result of an in situ formed complex between the sodium phenolate and carbon dioxide 
(Scheme 7, Ia) or of an intermediary formed carbonate (Scheme 7, Ib).[105,142] It is worth 
mentioning, that the corresponding potassium phenolates react to the para-hydroxy benzoic 
acids, which is expected for a SEAr-type reaction. The potassium cation is too large and 
therefore not capable to form the corresponding chelate assisted intermediate II depicted in 
Scheme 7.[144] 
 
Scheme 7: The Kolbe-Schmitt reaction. 
This reaction is generally applicable to various phenols including the ones with polycyclic 
and even heterocyclic aromatic cores (usually available in considerable structural diversity via 
Hantzsch condensation),[121,124] and is (to this day) the industrially preferred approach to 
synthesize salicylic acid.[105,142] More modern approaches for the direct implementation of 
CO2 into an aromatic Csp2−H or Csp2−Halogen bond that allow more moderate reaction 
temperatures, broader scope, and higher selectivity, rely on transition metal catalysts such as 
Rh, Ni, Pd, or strong, Al-, Fe-, Cu- and Au-based Lewis acids.[145–156] Albeit aliphatic 
carboxylic acids constitute another highly important class of compounds, their preparation as 
well as their diversification go beyond the scope of this work and are therefore not included in 
this thesis. 
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3.2. Classical diversification of aromatic carboxylic acids 
Traditional diversifications of aromatic carboxylic acids are mostly governed by 
transformations of the reactive CO2H group. Due to the strong polarity of the carbonyl bond 
and the relatively high acidity of the hydroxyl group, nucleophilic additions/substitutions as 
well as acid/base reactions are very commonly used synthetic tools to derivatize benzoic acids 
in a rather straightforward fashion (Scheme 8, top).[124,137]  
P
C
l 5 R-OH
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Pb and LiCl
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Scheme 8: Overview of classical diversifications of benzoic acids. 
As depicted in Scheme 8 the carboxyl group offers numerous possibilities for 
transformations.[131,137] Apart from more conventional reactions, such as esterification, 
reduction or conversion into more reactive species, e.g. acid chlorides or anhydrates, 
carboxylic acids can be used as starting materials for other valuable synthons in organic 
chemistry.[121,122,127] With the Hunsdieker reaction, halo arenes can be formed in a rather 
efficient radical pathway, in which the halide is installed selectively into the ipso-position.[157] 
Chlorobenzene on the other hand can also be accessed via the Kochi reaction.[157] However, 
due to the stoichiometric amounts of toxic Pb(OAc)4 used as an oxidant the synthetic utility of 
this reaction is somewhat restricted. Likewise, the direct amidation of acids can be achieved if 
the acid is activated in situ via an active ester with, for instance, dicyclohexylcarbodiimide 
(DCC). Very often, other additional reagents such as 1−hydroxybenzotriazole (HOBt), are 
needed for an efficient amidation. Due to the poor atom economical balance, this reaction is 
highly undesirable, yet it represents one of the most established method for peptide coupling 
in laboratory to date.[158] Another rather rudimentary way to form amides directly, yet with 
very restricted functional group tolerance, is the vigorous thermal treatment of the acid and 
amine precursors. The anodic oxidation of benzoic acid via Kolbe electrolysis in presence of 
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nitriles is one way to prepare imides. However, depending on the nitrile used, the reaction can 
also lead to the formation of anthranilic acid derivatives. [159–163] Interestingly, in aqueous 
solution Fichter and Uhl observed that, upon electrochemical oxidation, benzoic acid forms a 
mixture of hydroxybenzoic acid, hydroquinone and catechol.[164] Another important reaction 
that will be explicitly discussed within the next chapters, is the metal promoted extrusion of 
CO2 to form the corresponding arenes.[28,30] 
The aromatic core on the other hand is traditionally functionalized via electrophilic 
aromatic substitutions (SEAr) (Scheme 8, top).[137,157]. A wealth of electrophilic functional 
groups can be installed this way. As a result of the negative mesomeric effect of the carboxyl 
moiety, the electrophile is usually directed into the meta-position. However, harsh reaction 
conditions and often poor selectivity with respect to mono- vs disubstitutions regularly occur. 
3.3. Transition metal-catalyzed diversifications of aromatic carboxylic 
acids 
Reactions of benzoic acids in the presence of a transition metal catalyst further display how 
versatile these substrates are. Transformations of the reactive CO2H groups can be performed 
much more gently if catalyzed by metals. For that matter, functional group tolerance as well 
as chemo-, regio-, and enantioselectivity can be highly improved. Furthermore, new synthetic 
pathways can be accessed, leading to a greater variety of compounds, which were before 
either inaccessible or only achievable after a laborious multi-step preparation. Another 
important feature that occurs when metals are involved in the transformation of carboxylic 
acids is the ability of the CO2H group to act as a chelating directing group to facilitate C−H 
bond cleavage reactions in a specified position. An introduced electrophile is then installed 
into the proximal ortho-position, this way overriding the innate meta-directing effect of the 
carboxyl moiety.[165] Finally, the metal-catalyzed extrusion of CO2 to give aryl−metal species 
to replace pre-synthesized organometallic compounds further emphasizes how attractive 
carboxylic acids are in contemporary chemistry. 
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Scheme 9: Multifaceted nature of aromatic carboxylic acids in transition metal catalysis. 
Scheme 9 gives an overview on the application of aromatic carboxylic acids in highly 
topical areas of homogeneous catalysis. This work will mainly focus on the use of the 
carboxyl moiety as leaving group for decarboxylative cross-couplings (chapter 3.3.1.) and as 
directing group for the C−H functionalization of the aromatic core (chapter 3.3.2.-3.3.3.). 
Herein, the different modes of action of the CO2H group will be elucidated in detail. The 
combination of carboxylates as directing groups and as leaving groups will be particularly 
stressed as a new approach for regioselective C−H functionalizations (chapter 3.3.3.). It 
should be mentioned, that there are also numerous reports on metal-catalyzed addition 
reactions of the CO2H group onto unsaturated compounds such as alkenes or alkynes. 
Likewise, transition metal-catalyzed transformations of acyl−metal species derived from 
activated carboxylates are described in many literature precedents. However, for the sake of 
clarity, and since these types of reaction do not play a detrimental role in the present work, 
both will be omitted. 
3.3.1. Carboxylates as leaving groups for catalytic ipso-substitutions (decarboxylative 
cross-couplings) 
Over the past decades carboxylic acids (and their salts) have been intensively studied as a 
replacement of expensive organometallic reagents in cross-coupling reactions. Carboxylic 
acids are inexpensive, readily available in great structural diversity, toxicologically unharmful 
and are easy to store and handle. However, forming carbon nucleophiles from 
metal−carboxylates via CO2 extrusion is usually energetically disfavored, which makes the 
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development of catalytic processes highly challenging. Nevertheless, owing to holistic 
adjustments and tuning of catalyst systems, the chemical community was able to develop 
numerous efficient reactions to form new C−C and C−heteroatom bonds at the former 
C−CO2H position, producing CO2 as waste instead of stoichiometric metal salts (Scheme 
10).[23,26–29,47,166–192] 
"X
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Scheme 10: Overview on decarboxylative cross-coupling reactions of aromatic carboxylic 
acids. 
The simplest decarboxylative cross-coupling reaction is the protodecarboxylation. This 
reaction is particularly useful as it gives the opportunity to a traceless removal of the CO2H 
functionality once it is not required anymore in a molecular scaffold, e.g. for late stage 
derivatization to enhance the bibliography of biologically active compounds or of Hantzsch 
esters and analogs.[193–197] As early as 1930 Shepard et al. described that halogenated 
derivatives of furancarboxylic acid are more likely to decarboxylate in the presence of 
stoichiometric amounts of copper than without a metal presence.[198] Nilsson, Cohen, 
Sheppard and others extended this reaction type to substituted benzoic acids by combining 
stoichiometric amounts of copper, bipyridine ligands and nitrogen containing aromatic 
solvents.[199–205] However, these protocols were efficiently applicable only to “activated” 
benzoic acids, namely the ones carrying electron-withdrawing ortho substituents or few 
heterocyclic aromatic carboxylates. The decarboxylation of non-activated aromatic carboxylic 
acids was instead found to be rather difficult. In 2007, Gooßen et al. performed intense 
studies to identify more active decarboxylation catalysts in order to access entire assortment 
of benzoic acids. Finally, the same group was able to find a suitable copper-based catalyst 
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system capable of catalytically defunctionalizing non-ortho-substituted benzoic acids to give 
the corresponding arenes at reasonably temperatures (170 °C).[206] Particularly efficient was 
the implementation of phenanthroline-based ligands for copper, and a specific, carefully 
deoxygenated solvent mixture composed of NMP and quinoline (Scheme 11). 
CO2H
FG
Cu2O/ligand (10 mol%)
NMP/quinoline (3:1), 
170 °C, 12-24 h
H
FG + CO2
up to 90% yield
N N
RR
R' R' R = R' = H
or
R = H, R' = Ph
ligand:
 
Scheme 11: First truly catalytic protodecarboxylation of unactivated benzoic acids. 
Later, long reaction times could be avoided by performing the reaction under microwave 
irradiation.[207] With a silver(I)-catalyzed protocol, numerous activated benzoic acids were 
efficiently decarboxylated at temperatures around 80−120 °C, which was 50 °C below 
previously reported copper-based methods. Moreover, very electron-rich or halide containing 
benzoic acids, were accessed for the first time, complementing the copper catalyst 
system.[208,209] Other metals, such as rhodium, nickel or palladium, were found to mediate the 
CO2 extrusion to form aryl−metal species, which were in situ trapped by protons.[210] 
Nevertheless, these protocols were still restricted to activated (hetero-)aromatic acids or 
required reactions performed in gas phase at very high temperatures.[211] More recently, the 
group of Greaney described a silver-catalyzed radical protodecarboxylation process, which is 
applicable to both activated and non-activated aromatic acids.[212] Yet, over-stoichiometric 
amounts of K2S2O8 as oxidant are needed. One year later the group of Nolan reported a 
gold(I)-catalyzed CO2 extrusion/protodemetallation sequence, in which non-activated meta-
 and para-benzoic acids were efficiently converted into the corresponding arenes.[213] 
Adamantylcarboxylic acids as the right proton source was crucial to achieve protodeauration 
of the usually stable aryl−gold species.[174,214] 
The reason for a reluctant decarboxylation of benzoic acids without activating ortho 
substituents lies within the electronic properties of the substituents. DFT calculations on the 
copper(I)-catalyzed decarboxylation showed that the decarboxylation is mostly governed by 
short-range electron-withdrawing inductive effects conducted via the σ-backbone, thus most 
vehemently affected by ortho substituents.[206] Moreover, other calculations showed that steric 
repulsion facilitates the CO2 extrusion as well.[215] Contrary to this, long-range mesomeric 
effects transmitted via the π-system do not significantly reduce the free reaction energy.[206] 
Introduction 
 
 15 
Βased on experimental and computational results a catalytic cycle was proposed (Scheme 
12):[201,206,207,209,216] 
 
Scheme 12: Proposed mechanism for the protodecarboxylation catalyzed by a 
copper−phenanthroline system. 
The copper−phenanthroline−carboxyl complex (I) undergoes decarboxylation via insertion 
of the metal into the aryl−CO2 bond (transition state II). CO2 extrusion gives the aryl−copper 
species III which is protodemetallated by the newly introduced substrate to form again the 
intermediate I along with the arene. 
Arguably, a more valuable transformation in the context of decarboxylative couplings is 
the ipso-implementation of other synthons apart from protons. The carboxyl group of 
activated benzoic acids can be cleaved to form C−halides and pseudo halides, C−N, C−O, 
C−S, C−P etc. bonds.[47,173,175,177–179,182,184–189] Most of these transformations are catalyzed by 
copper, silver or palladium combined with stoichiometric amounts of oxidants. 
Decarboxylative cross-couplings strategies to form new C−C bonds are particularly 
interesting because they offer the opportunity for great “synth-tactical” variety for the concise, 
stepwise construction of organic scaffolds starting from readily available building blocks.[217] 
The group of Gooßen and many others developed efficient methods for the ipso-
allylation, -vinylation, -alkylation and -arylation of aromatic carboxylic acids.[168] The latter is 
particularly important because of the ubiquity of biaryls in pharmaceuticals and functional 
materials.[218,219] The synthesis of this structural motif via transition metal-catalyzed 
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decarboxylative cross-couplings constitutes a major part of this work and will be therefore 
elucidated in detail. 
3.3.1.1. Biaryl synthesis via decarboxylative oxidative cross-couplings 
The groups of Crabtree,[191] Maiti,[172] Larrosa,[220] Glorius,[221,222] and others[27,170,186] 
reported that under oxidative conditions the aryl−metal species, which is formed by 
decarboxylation, can be trapped by simple arenes and heteroarenes to form biaryl scaffolds in 
a rather straightforward fashion. However, these reactions are either restricted to 
(hetero)arenes bearing C−H acidic positions or require comparatively harsh reaction 
conditions with over-stoichiometric amounts of silver or copper salts as oxidants. Moreover, 
most aromatic acids need to be activated for decarboxylation by σ-electron-withdrawing 
substituents in the ortho-position (Scheme 13A). 
 
Scheme 13: Decarboxylative biaryl synthesis under oxidative conditions. 
The versatility of functional groups is rather narrow and the cross-coupling occurs very 
seldom intermolecularly (Scheme 13B). Oxidative decarboxylative biaryl syntheses can also 
be conducted between a C−CO2H moiety and an organometallic reagent (Scheme 13C). Yet 
examples for these types of cross-coupling are rare. The group of Liu reported a 
decarboxylative Suzuki reaction between highly activated aromatic carboxylic acids and aryl 
boronic esters.[223] Nevertheless, this reaction is triggered by relatively high loadings of 
Pd(TFA)2 and over-stoichiometric amounts of expensive silver oxidants. A major challenge 
was to tune the decarboxylation rate with the transmetallation step. As a result, the choice of 
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the right organoboron compound was crucial to achieve an efficient coupling with specific 
benzoic acids. In this context, trialkoxyarylsilanes were also found to be suitable aryl sources 
for the synthesis of biaryls.[224] This decarboxylative Hiyama coupling is catalyzed by a 
trimetallic palladium/silver/copper-system, with Pd being the cross-coupling catalyst, silver as 
the oxidant, and finally copper with a trifold role: as oxidant, as fluoride-source for the silane 
activation, and as decarboxylation catalyst. Under oxidative conditions the coupling between 
two aromatic carboxylic acids is possible via double-decarboxylation (Scheme 13D). The 
Caryl−Caryl bond is formed at the respective former C−CO2H bond. Homocouplings as well as 
heterocouplings are reported in literature.[225–230] In all cases, the efficient conjunction was 
only achieved with activated (hetero-)aromatic acids and the chemoselectivity for 
electronically similar acids is rather poor with respect to homo- vs heterocoupling.[27] 
3.3.1.2. Biaryl synthesis via decarboxylative redox-neutral cross-couplings 
In contrast, redox-neutral decarboxylative biaryl syntheses have emerged as a particularly 
preferred reaction strategy because it obviates stoichiometric amounts of oxidants, thus 
minimizing waste. In this case, in situ formed aryl−metal species generated via 
decarboxylation are trapped by aryl electrophiles.  
 
Scheme 14: Bimetallic catalytic decarboxylative biaryl synthesis. 
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All monometallic catalyst systems reported in literature are restricted to highly activated 
(hetero-)aromatic acids. Instead, bimetallic catalyst systems, in which a cross-coupling 
catalyst is combined with a decarboxylation catalyst, are particularly effective (Scheme 14). 
The concept of a bimetallic system offers the unique possibility for an extremely accurate 
tuning of each catalyst to achieve maximum performance. To date, combinations of Pd as the 
cross-coupling catalyst with copper or silver as the decarboxylation catalyst are the only 
reported bimetallic systems to achieve efficient catalytic redox-neutral decarboxylative biaryl 
couplings. It is highly challenging to achieve perfect synergistic performance of both metals 
with regard to the two parallel occurring catalytic cycles (exemplified in Scheme 14), which 
coincide at the transmetallation step.  
 
Scheme 15: Timeline of significant advancements of bimetallic decarboxylative biaryl 
synthesis. 
Scheme 15 depicts the evolution of redox-neutral catalytic decarboxylative biaryl 
syntheses over time. The seminal protocol was reported by Gooßen in 2006.[231] For the first 
time catalytic decarboxylation was used in cross-coupling catalysis, showing that in fact 
carbon nucleophiles can be catalytically generated in situ and further trapped by electrophiles 
other than just protons. However, it was mandatory to fine-tune the bimetallic catalyst system 
for each substrate in order to compensate different decarboxylation propensities of aromatic 
acids, which considerably alter decarboxylation rates. Moreover, this protocol was limited to 
ortho-nitrobenzoic acids and aryl bromides as the electrophilic coupling partner. A second 
generation Pd/Cu-bimetallic system extended the scope to the reputedly more challenging aryl 
chlorides as electrophile source (Scheme 15, 2008 bottom).[232] It was crucial to identify a 
suitable ligand environment on the palladium, without hampering the decarboxylation cycle. 
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Unfortunately, this protocol was again mainly restricted to ortho-nitro benzoic acids. Still, 
accessing inexpensive and ubiquitous aryl chlorides improved the synthetic utility of 
decarboxylative cross-couplings and gaining attention as a serious alternative to traditional 
transformations. In 2007, Gooßen and Thiel explored experimental and computational 
insights on copper-catalyzed protodecarboxylations, which finally proved to be the key to 
efficient catalytic transformation of benzoic acids regardless of their substitution patterns 
(Scheme 15). These findings include that the decarboxylation is hampered by additional 
halide salts, particularly for non-ortho-substituted benzoic acids. In the course of a cross-
coupling reaction with aryl halides, these anions are increasingly released, forming relatively 
stable copper halide salts. As a consequence, the formation of the required copper carboxylate 
via salt metathesis (Scheme 14) is unfavored. As a matter of fact, non-ortho-substituted 
benzoic acids are efficiently converted solely in the presence of aryl triflates as aryl 
electrophiles (Scheme 15, 2008 top).[233] Hence, weakly coordinating 
trifluoromethylsulfonate anions do not compete against the formation of the copper 
carboxylate, which is required to close the decarboxylative catalytic cycle. However, two 
major drawbacks are the relatively high reaction temperatures (170 °C) and that the reaction is 
restricted to expensive aryl triflates. With marginal adjustments, this protocol was later 
extended to more robust and less expensive aryl tosylates.[234] Instead, reputedly less active 
aryl mesylates required a tailored imidazolyl phosphine ligand on the palladium to ensure an 
efficient activation and were not suited as coupling partner for non-ortho-substituted benzoic 
acids.[235] For all, high reaction temperatures remained disadvantageous. Shortly thereafter, 
silver was found to be an efficient decarboxylation catalyst, which is able to truncate the 
aryl−CO2H bond at considerably lower temperatures compared to copper-based systems 
(Scheme 15, 2009). Nevertheless, decarboxylative cross-couplings with aryl halides catalytic 
in silver remained elusive because stable silver halides are formed during the reaction 
impeding catalytic turnovers.[181,191,236] This was solved again by implementing aryl 
electrophiles bearing leaving groups, such as triflates or tosylates, which generate poorly 
coordinating anions at the transmetallation step (Scheme 15, 2010).[237] In order to shed light 
on the mechanism of bimetallic catalyst system and to find a recipe to overcome the 
remaining challenges of efficiently converting non-ortho-substituted benzoic acids with aryl 
halides and lowering the high reaction temperatures, Gooßen and van Wüllen examined the 
entire Pd/Cu bimetallic catalytic cycle thoroughly (Scheme 15, 2014).[238] They compared the 
calculated energy barriers for the reaction of ortho-fluoro benzoic acid and para-fluoro 
benzoic acid. In accordance to previously reported calculations on the copper-catalyzed 
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decarboxylation only, the CO2 extrusion is energetically disfavored for both ortho- and para-
fluoro benzoic acid, but not necessarily the highest in energy for each case in the entire 
reaction profile. As a matter of fact, when considering the hole bimetallic cycle the highest 
energy barrier for para-fluoro benzoic acid was identified as the transmetallation step and not 
the decarboxylation. Interestingly, the salt metathesis is, unexpectedly, for both cases equally 
difficult. This step partially dictates the reaction only because its energy is added to the 
decarboxylation, which is easier for ortho-substituted than for non-ortho-substituted 
benzoates. Concluding, the results show that depending on the substrate, the rate-determinig 
step lies either at the decarboxylation or at the transmetallation and not, as assumed before, 
only at the CO2 extrusion and preceding salt metathesis. Preliminary attempts to facilitate the 
transmetallation by specifically customized bridging P,N-ligands led to a system, which is 
able to mediate the reaction at only 100 °C.[239] This demonstrates that holistically optimizing 
all steps, it should in theory allow to efficiently couple non-activated benzoic acids even in 
the presence of excess halides at mitigated temperatures. A success would be highly 
rewarding by showing that the full range of carboxylic acids, as source of carbon 
nucleophiles, can fully compete in terms of efficiency with organometallic reagents, which 
are traditionally used in transition metal-catalyzed biaryl synthesis. 
3.3.2. Carboxylates as directing group for ortho-C−H activations 
Over the past decades, a tremendous progress in directed C−H activations was achieved. 
This concept has established itself as an efficient tool to create complex molecules in a 
straightforward fashion and can be regarded as a fundamental synthetic strategy.[240–243] The 
numerous reported protocols range from the transformation of Csp3−H to Csp−H bonds with 
pre-functionalized (C−X or heteroatom−X) as well as with non-pre-functionalized (C−H or 
heteroatom−H) coupling partners, to form new C−C or C−heteroatom bonds, just formally 
releasing H2, H2O, or HX.[31,45,244–249] Arenes are functionalized more efficiently by applying 
catalyst systems, which are directed by strong chelating directing groups (usually Lewis basic 
moieties). Moreover, more extended, strong directing groups can be used to regiospecifically 
and chemoselectively access all positions on the arene.[250,251] However, protocols in which 
the sole purpose of the directing group is to bring a catalyst into proximity of a C−H bond 
without being required as a functional group in the final product, become as convenient as or 
even less convenient than traditional cross-couplings.[153] Frequently, their removal is only 
possible via laborious multi-step procedures and in certain circumstances the directing group 
even needs to be introduced in an extra step prior to functionalization. For these reasons, it is 
Introduction 
 
 21 
a major task in modern-day chemistry to seek for more expedient directing groups to enhance 
synthetic freedom and step economy in modern transformations.[252,253]  
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Scheme 16: Overview of carboxylate-directed ortho-C−H functionalization of benzoic acids. 
In this context, carboxylates fulfill all requirements for an ideal directing group.[254] They 
are convenient, non-toxic, and commercially available in substantial structural diversity. If the 
carboxylate group is not required in the final product, it can be truncated and/or replaced by a 
plethora of functional groups via decarboxylative cross-couplings, as shown in chapter 3.3.1. 
Another argument in favor of carboxylates as starting materials in directed C−H 
functionalizations is their broad application as potential pharmaceuticals and other functional 
materials. As a consequence, methods for their step- and waste-minimized atom economic 
diversification are highly sought-after. Scheme 16 gives an overview on carboxylate-directed 
functionalizations of the aromatic core of benzoic acid derivatives, ranging from C−C to 
C−heteroatom bond formation under oxidative as well as redox-neutral conditions, catalyzed 
by a number of transition metals. The following chapters will put a strong focus on the state-
of-the-art synthesis of biaryls and vinylarenes via carboxylate-directed C−H activation. The 
other transformations depicted in Scheme 16 move beyond the scope of this work and will 
therefore not be discussed. Nonetheless, these reactions are outstandingly important and 
represent useful synthetic tools for the diversification of aromatic carboxylic acids and for the 
synthesis of complex, otherwise inaccessible building blocks. 
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3.3.2.1. Carboxylate-directed arylation of aromatic carboxylic acids 
C−H arylations are evolving into a greener strategy for the synthesis of biaryls compared to 
traditional cross-couplings. These systems are particularly effective when aided by Lewis 
basic directing groups, such as pyridine, pyrimidine, imidazole, and others which guarantee 
efficient binding of the metal and ease the C−H cleavage process. However, these effective 
directing groups are rarely needed after the C−H functionalization event and are mostly 
difficult to remove. In contrast, carboxylates proved to be highly attractive synthons, because 
of their multipurpose potential. A poor σ-donating tendency and an intrinsic reactive character 
leading to undesired side reactions, however, create synthetic challenges. Hence, C−H 
arylations mediated by carboxylates as directing groups are difficult, making expedient 
methods quite rare. Nonetheless, the groups of Yu, Larrosa, Daugulis, Gooßen, and others, 
were able to develop protocols for the ortho-C−H arylation of benzoic acids (Scheme 17).[255–
264]
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Scheme 17: Overview on carboxylate-directed C−H arylations known in literature. 
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Pioneering work was achieved by Daugulis and Yu, who disclosed a Pd(OAc)2-catalyzed 
ortho-arylation of benzoic acids with aryl halides and aryl boron reagents, 
respectively.[255,256,265] Daugulis presented two methods, of which one is applied for aryl 
iodides, and the second for aryl chlorides as electrophilic coupling partner. For the coupling 
of aryl iodides, stoichiometric amounts of a silver salt as halophile are needed to achieve 
sufficient turnover by preventing the formation of catalytically inactive palladium iodide. 
Aryl chlorides on the other hand present a different challenge. Here, the oxidative insertion of 
Pd into the reluctantly reactive aryl-chloride bond is facilitated by electron-rich yet bulky 
phosphine ligands. The scope is strongly restricted to electron-rich benzoic acids and to non-
ortho-substituted aryl electrophiles. Moreover, in order to avoid that both ortho-positions next 
to the carboxylate group are functionalized, the benzoic acids need at least to be substituted at 
the meta-position. Double-functionalization is often observed for weakly coordinating 
directing groups, of which carboxylates are inherently included. In contrast, related reactions 
with strong chelating directing groups usually lead to a selective functionalization at one 
ortho-C−H bond. The group of Yu discovered that under oxidative conditions aryl boronates 
are also suitable coupling partners for the arylation of benzoic acids.[256,265] An interesting 
alternative to Daugulis’ protocol for the coupling of aryl iodides was described by Larrosa et 
al.[257] There, a combination of a more convenient tetramethylammonium salt with potassium 
acetate replaced silver as scavenger for halides. This way, intermediary formed PdI2-species 
are converted in situ to the active Pd(OAc)2 catalyst. Pd(OAc)2 combined with a 
monoprotected amino acid ligand in HFIP as the solvent boosts the reaction to unlock the 
coupling of benzoic acids with iodoarenes even at room temperature.[260] Kinetic studies 
revealed that the amino acid ligand accelerates the reaction rate to ensure higher catalyst 
longevity. Further improvements include reactions in aqueous solvents either in only water 
with aryliodonium salts as aryl source or when surfactants are added in a combination with 
iodoarenes as the electrophile.[259,264] All ortho-arylations of benzoic acids, which are 
catalyzed by expensive palladium precursors, are efficient only with highly activated but 
expensive aryl sources, such as iodoarenes, aryliodonium salts and aryl boronates. Moreover, 
most methods require the presence of stoichiometric amounts of expensive silver salts as 
halide scavengers or oxidants. 
Additionally, biaryls can be formed by carboxylate-directed dehydrogenative couplings, as 
disclosed by the groups of Lan, You and Li.[261,263] With Rh(III) and overstoichiometric 
amounts of silver-based oxidants, simple heteroaromatic compounds are coupled with benzoic 
acids at their most acidic C−H position. On the other hand, Rh(I) couples two benzoic acids to 
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form diaryl diacids. The reaction is performed in water with air and MnO2 as oxidants. 
Unfortunately, homocoupling is always preferred over heterocoupling, deteriorating the 
synthetic utility of this protocol. 
In order to replace expensive aryl iodides or aryl boronates as the aryl source, Gooßen et 
al. developed a method that allows implementing aryl diazonium salts as more convenient 
surrogates for aryl halides.[262] Aryl diazonium salts are often precursors to synthesize 
iodoarenes via Sandmeyer halogenation, which is also an industrially preferred process. Thus, 
Gooßen’s method formally obviates one additional step compared to the arylation with 
iodoarenes. Moreover, in the course of the cross-coupling reaction, only gaseous N2 is 
released, reducing the amount of heavy waste. The reaction is catalyzed by Ir(III) and 
performed at remarkably low reaction temperatures (60 °C). Control experiments revealed 
that the silver salt is likely to play a twofold role in the catalytic cycle. One role is as halide 
scavenger, to promote dissociation of the Ir-precursor facilitating the formation of the active 
catalyst species. As a second role, silver is believed to be involved as oxidant in one-electron-
transfer steps, for the stepwise oxidation to an Ir(V) intermediate, which should then readily 
undergo reductive elimination to give the biaryl carboxylate. 
3.3.2.2. Carboxylate-directed alkenylation/alkynylation of aromatic carboxylic acids 
To introduce C=C double bonds into the ortho-position of a carboxylate has been a highly 
topical area over the past decade. All transformations can be summarized into two main 
strategies: First, Redox neutral reactions allow introducing an alkyne or alkene onto the 
aromatic ring with minimum waste. These reactions are extremely rare. In fact, only one 
example of a transformation, that can be categorized as such, was reported earlier to this 
work. Second, oxidative Fujiwara-Moritani-type alkenylations, instead, have the advantage to 
obviate any pre-functionalization of either coupling partner. However, stoichiometric amounts 
of oxidants are required for a catalytic transformation. The versatility of these strategies is 
displayed in Scheme 18. 
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Scheme 18: Transition metal-catalyzed reactions of benzoic acids with alkynes and alkenes. 
Pioneering work on this field was demonstrated by the group of Miura. In the late 90s they 
disclosed that in a palladium-catalyzed Fujiwara-Moritani type oxidative coupling of benzoic 
acids with styrenes or acrylates, a mixture of products formed arising from different 
demetallative elimination mechanisms (Scheme 18, products of pathway B, C and D).[266] 
With acrylates, intramolecular hydroacetoxylation of the vinylarene, which is formed after 
reductive elimination, is preferred over β−hydride elimination. Products arising from the 
β−hydride elimination are observed when styrenes are used as coupling partners. The choice 
of which specific β−hydride is eliminated to finally give the 5- or the 6-membered ring, 
respectively, is apparently controlled by steric factors. As a consequence of poor 
chemoselectivity, this protocol lacks synthetic utility. Nevertheless, this is an early example 
of a direct ortho-olefination of benzoic acids in catalytic Fujiwara-Moritani reactions and 
inspired many groups to further improve this reaction mode.[267–270] Before that, a comparable 
reaction was only possible via the palladium-catalyzed coupling of preformed toxic 
arylthallium reagents with olefins to give the corresponding isocoumarins.[271] Over the last 
decade many groups focused their research on accessing this class of compounds via 
ortho-C−H functionalization of benzoic acids. The hydroarylation of internal alkynes with 
concomitant intramolecular reductive C−O bond formation crystallized as a preferred strategy 
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and was first published by Miura and Satoh in 2007 (Scheme 18D).[272,273] Rhodium and 
iridium were found to be particularly efficient catalysts allowing the reaction for a number of 
internal alkynes even in water and with reduced reaction times by microwave irradiation.[274–
277]
 More recently, ruthenium was used as a cheaper surrogate of Rh, Ir and Pd for the 
ortho-C−H olefination of benzoic acids.[278–280] It is worth mentioning that the tendency of the 
acid group to undergo Ru-catalyzed acetoxylation across the C,C triple-bond yielding 
enolesters makes the combination of alkynes with acids and ruthenium as catalyst to aim at a 
competing ortho-functionalization particularly challenging.[281–283] Nevertheless, the group of 
Ackermann were the first to disclose a ruthenium-catalyzed protocol in which diaryl as well 
as dialkyl alkynes were efficiently coupled to yield substituted isocumarins.[278] In order to 
achieve efficient turnover, it was essential to add stoichiometric amounts of copper acetate to 
the reaction medium. Another drawback is that unsymmetrically substituted alkyl,aryl alkynes 
reacted sluggishly and with poor regioselectivity. In the same year, the group of Jeganmohan 
reported that the amount of copper can be reduced to 20 mol% when the reaction is performed 
under aerobic conditions. Moreover, the regioselectivity of the reaction with unsymmetrical 
alkynes was completely controlled when aided by a silver salt.[279] Finally, with a designed 
ruthenium catalyst bearing mesitylene carboxylate as ligands, the group of Ackermann was 
able to replace the copper salt as terminal oxidant entirely by O2, formally producing 
environmentally innocuous water as waste.[284] The strong tendency of the carboxylate group 
to undergo intramolecular acetoxylation onto an alkene, impedes the ortho-C−H 
alkenylations/alkynylations without cyclization immensely (Scheme 18E). Only a handful of 
aromatic acids, mostly heterocyclic, are reported not to undergo cyclization. These reactions 
are catalyzed by rhodium combined with stoichiometric silver salts as oxidants and use 
Michael-acceptors, such as acrylates, as coupling partners.[285,286] In all cases, the scope is 
restricted to ortho-substituted benzoic acids to avoid double-functionalization. Very recently, 
Shishido disclosed an entirely waste-free C−C bond formation via carboxylate-directed ortho-
hydroarylation of internal alkynes followed by intramolecular hydroacetoxylation (Scheme 
18F). The reaction is aided by only catalytic amounts of base, is catalyzed heterogeneously by 
ruthenium coated on a ZrO2 surface, and represents the first example of an oxidant-free 
carboxylic acid directed functionalization with internal alkynes.[282] 
Another mentionable redox neutral carboxylate-directed alkenylation to form 
3−alkylidenephthalides from benzoic acids (product of Scheme 18, pathway A’), was 
reported by Gooßen and coworkers. The corresponding product is formed via a rhodium-
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catalyzed acylation[287] with anhydrides followed by cyclizing acylalization and consecutive 
elimination.[288] 
Literature clearly shows that waste-free and oxidant−free carboxylate-directed C−C bond 
formations are highly needed. However, one major challenge is to overcome the poor 
selectivity towards mono- vs difunctionalization on both ortho-positions, to allow accessing 
also simple, unfunctionalized aromatic carboxylic acids. 
3.3.3. Merging C−H activation with decarboxylation 
The major advantage of carboxylates as directing groups is that, after the C−H activation, 
the CO2H moiety constitutes a predetermined breaking point either for defunctionalization by 
protodecarboxylation or for functionalization by decarboxylative cross-couplings. This 
characteristic allows the potential regio- and chemoselective installation of a wealth of 
functional groups, accessing diversely multi-decorated arenes. As a matter of fact, this 
approach was successfully applied by chemists in a number of cases under different strategies 
(Scheme 19). 
 
Scheme 19: Different approaches for merging both C−H activation and decarboxylation for 
the regioselective multi-functionalization of benzoic acids. 
The strategy depicted in Scheme 19C is the most commonly used approach for the 
decoration of benzoic acid via subsequent C−H and C−CO2H bond cleavage events. In 
contrast, the strategy depicted in Scheme 19A represents a special feature of CO2. It is 
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transiently introduced prior to the C−H activation and removed from the aromatic skeleton 
after functionalization. These two strategies will be outlined in detail in the following two 
subchapters. The third strategy, depicted in Scheme 19B, was developed within this work and 
will be explained in detail in the “results and discussion” section. Nevertheless, the 
subchapter in this section aims at giving the conceptual background and to show the potential 
utility of carboxylates as deciduous directing groups. 
3.3.3.1. Carboxylates as traceless directing group 
The concept of a traceless directing group established itself as a powerful tool to formally 
invert the intrinsic reactivity of a substrate towards a nucleophile or an electrophile by 
overriding inherent electronic effects.[253] In this context, carboxylates are privileged synthons 
because they can be installed and removed with particular ease to form an new organic 
framework, releasing gaseous CO2. Miura was the first to show that the carboxylic acid 
functionality can trigger the C2-selective alkenylations of indoles with acrylic acids. In a 
control experiment in which the carboxylate directing group is omitted, the acrylate reacts 
selectively at the preferred C3-position (Scheme 20).[289] The carboxylic acid thus affects the 
inherent reactivity of indoles.[290] 
 
Scheme 20: Effect of the carboxylate directing group on the regioselectivity of the vinylation. 
The groups of Larrosa, Li, Chang, Su, Gooßen and others, which are particularly active on 
the field of carboxylate-directed C−H functionalizations, disclosed examples for the 
subsequent, and in some cases concomitant, protodecarboxylation of benzoic acids, which 
takes place after the C−H activation event (Scheme 21, left).[48,291] Moreover, Miura and 
others showed examples of ortho-functionalization with subsequent ipso-functionalization 
without the need for an interposed isolation (Scheme 21, right).[272,292,293] 
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Scheme 21: Examples for carboxylate-directed ortho-C−H functionalizations of benzoic acids 
combined with decarboxylative couplings. 
In most cases, the CO2H group is replaced by a proton consecutive to the C−H 
functionalization step. An early example was reported by Miura and Satoh, in which in a 
Fujiwara-Moritani type reaction the carboxylate group guides the terminal alkene into the 
ortho-position before being removed by the excess silver, present as oxidant and 
decarboxylative mediator.[285] However, the CO2 extrusion is so slow that the second ortho-
position needs to be blocked to avoid double alkenylation. This is also an issue in nearly all 
tandem ortho-functionalization / ipso-defunctionalizations of benzoic acids. Nevertheless, the 
potential of this reaction sequence unfolds when benzoic acids bearing electron donating 
ortho substituents are coupled with electrophiles. The group of Larrosa disclosed the ortho-
arylation of 2-substituted benzoic acids and aryl iodides with concomitant Ag-mediated 
decarboxylation.[294,295] The formed meta-substituted arenes, which are difficult to obtain by 
the use of conventional synthetic approaches, are generated in good to excellent yields 
regardless of their electronic properties. This strategy was later extended to the cross-
dehydrogenative coupling with simple heteroarenes.[296,297] Gooßen et al. showed that the 
iridium-catalyzed ortho-arylation of aromatic carboxylates with arene diazonium salts can be 
combined with a subsequent copper mediated protodecarboxylation in one pot.[262] Other 
functionalities such as amides or sulfonamides were also found to be accessible coupling 
products which survive the subsequent protodecarboxylation step.[287,298,299] 
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Examples for the tandem ortho-functionalization / ipso-functionalization are very rare. An 
excess of protons available in the reaction medium needs to be avoided in order to prevent 
fast protodecarboxylation. This is a difficult task, taking in consideration that the starting 
material itself can act as a proton source. Moreover, the literature exclusively contains 
intramolecular examples of this reaction mode as, intermolecularly, chemoselectivity as well 
as the regioselectivity are rather hard to control. As a matter of fact, in the iridium-catalyzed 
oxidative hydroarylation of benzoic acids with alkynes, the product formed is strongly 
dependent on the ortho substituent present on the aromatic acid (Scheme 22).[272,274,292]  
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Scheme 22: Iridium-catalyzed oxidative coupling of benzoic acids with alkynes reported by 
Miura and Satoh.[272] 
The reaction is presumed to occur via initial carboxylate-directed ortho-C−H metallation to 
give intermediate I (Scheme 22). The following alkyne insertion gives the seven-membered 
metallacycle II (Scheme 22). The concomitant decarboxylation gives intermediate III, which 
can undergo two competing pathways. The first pathway is another prompt alkyne insertion, 
which gives the corresponding naphthalene after reductive C−C bond formation, deriving 
from a tandem ortho-functionalization / ipso-functionalization sequence (Scheme 22, product 
A). However, this is only possible when no functional groups are adjacent to the carboxylate 
directing group. The second competing reaction is the protodemetallation to give intermediate 
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IV. The steric pressure induced by a substituent at the ortho-position triggers a second C−H 
activation step, which is directed meta to the former C−CO2H group and leads to the five-
membered metallacycle V. An additional alkyne insertion followed by reductive elimination 
gives the product B depicted in Scheme 22, which results from a tandem ortho-
functionalization / ipso-defunctionalization process. More recently, Miura and Satoh reported 
the tandem ortho-functionalization / ipso-functionalization of diphenylmine−2−carboxylic 
acid with internal alkynes (Scheme 23).[293] They proposed a reaction mechanism that starts 
with the ortho-C−H metallation at the benzoic acid residue to give intermediate I in Scheme 
23. The alkyne insertion into the aryl−metal bond forms the seven membered rhodacycle II. 
Protodemetallation of the Rh−alkenyl bond with concomitant decarboxylation give rise to the 
aryl−rhodium intermediate III. This then undergoes intramolecular oxidative arylation, finally 
yielding the alkenylated carbazole (Scheme 23A). The resulting Rh(I)-species is then re-
oxidized by copper to give the active catalyst species Rh(III). 
 
Scheme 23: Tandem ortho-hydroarylation / decarboxylative intramolecular ipso-arylation 
reported by Miura and Satoh. 
Interestingly, other directing groups such as 2−(diisopropylsilyl)−pyridines and 
−pyrimidines, 2−pyridyloxy groups and substituted triazenes are also able to mediate tandem 
ortho-functionalization / ipso-functionalization (Scheme 24).[300–306] However, these groups 
need to be installed onto the aromatic backbone before they react with the corresponding 
coupling partners. Moreover, their molecular weight is much higher than simple CO2 
decreasing the total atom economy. 
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Scheme 24: Tandem ortho-functionalization / ipso-functionalization with other directing 
groups. 
3.3.3.2. Carboxylates as transient directing group 
The strategy of transient directing groups has recently emerged as a powerful tool to avoid 
permanent covalently bonded directing groups, which in most cases need to be installed and 
later on removed under conditions that are frequently not compatible with labile yet important 
functionalities.[307,308] Transient directing groups are usually formed by condensing carbonyl 
groups with amines to give reversibly linked imines or enamines. The Schiff-base is a strong 
directing group, which is then able to guide the metal to the adjacent C−H position.[309–311] 
Another example of transient directing groups is given by the reversible transesterification of 
phenols with phosphinites (Scheme 25A).[312,313]  
 
Scheme 25: Two different strategies to apply transient directing groups. 
Transient directing groups can also be introduced into simple arenes as shown by the 
cooperative catalysis of norbornene and palladium, the so-called Catellani reaction.[314–316] 
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Norbornene can also be regarded as a transient mediator since in this case the substrate does 
not have a predetermined anchor point such as carbonyl group on which the transient group is 
condensed (Scheme 25B). With extended directing groups it is also possible to directly install 
functional groups in the meta-position.[317–319] In the context of carboxylate-directed C−H 
functionalization reactions, the group of Larrosa combined a Kolbe-Schmitt reaction with 
CO2H directed C−H functionalization. CO2 is added to the aromatic backbone, triggers the 
C−H cleavage process, and is then again removed after the functionalization event is fully 
completed.[320] This is the first example of CO2 as a transient mediator / directing group and in 
this way the usual selectivity of the reaction of phenols with electrophiles to give ortho- and 
para- instead of meta-substituted products has been overridden (Scheme 26). 
 
Scheme 26: Larrosa’s strategy to use CO2 as transient directing group to access meta-
substituted phenols. 
The reaction is performed in a three-step one-pot sequence. It tolerates phenols bearing a 
wealth of functional groups including electron withdrawing and donating moieties, which are 
coupled with various aryl iodides as well as heteroaryl iodides. Later, the same group reported 
a related transformation, in which salicylaldehydes are converted into meta-arylated 
phenols.[321] Instead of introducing CO2, the aldehyde is first oxidized to the corresponding 
salicylic acid, which then guides the transition metal-catalyzed ortho-arylation. Subsequent 
protodecarboxylation gives the final product. 
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3.3.3.3. Carboxylates as deciduous directing group 
The deciduous reaction mode of carboxylates as directing group has been developed within 
the present doctoral work, and will be therefore explained in detail in the “results and 
discussion” sections 5.3-5.4. This part is meant to give a short conceptual overview on this 
reaction mode. 
Apart from the generally challenging activation of inertial C−H bonds, the major issue of 
carboxylate-directed C−H cleavages is the poor selectivity toward mono- vs 
difunctionalization (Scheme 27, turquoise pathway).  
 
Scheme 27: Reaction modes of a carboxylate-directed C−H functionalization combined with 
decarboxylation. 
This results from the weak σ-donating ability of the carboxy group, which destabilizes the 
metallacycle formed after the C−H cleavage, making it a reversible event (Scheme 27,I).[252] 
In the presence of a coupling partner on the other hand, the metallacycle shows high reactivity 
resulting in an irreversible insertion of a functional group. Once one functionalization is 
completed, the carboxylate group can then direct another reversible C−H cleavage event 
(Scheme 27,II), leading to usually unwanted doubly functionalized carboxylates. The C−H 
activation process stops only at this point, more precisely, when no other adjacent C−H bonds 
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are present (Scheme 27,III). However, carboxyl groups constitute a predetermined breaking 
point, which in theory could be cleaved via decarboxylation after each completed C−H 
functionalization step (Scheme 27, red pathway). Hence, the extrusion of the DG causes this 
step to become irreversible as the metal cannot be guided to the next proximal C−H position 
anymore. However, the decarboxylation rate needs to be fast in order to cleave the directing 
group before a second C−H activation can take place. This is a very challenging task and can 
be achieved only when aided by strong decarboxylation catalysts. One rare example was 
reported by Gooßen et al. for the decarboxylative C−H etherification.[46] The insertion of an 
alkoxy group further facilitates the decarboxylation, occurring in perfect synchrony to the 
C−H functionalization. Theoretically, the C−H cleavage of the second ortho-position can also 
be avoided by a decarboxylation occurring concertedly with inserting a functional group into 
the aryl−metal bond of the preceding five membered metallacycle (Scheme 27, intermediate 
in dotted line). This pathway was already proposed by Miura and others for the iridium-
catalyzed naphthalene formation (Scheme 22). However, in his case the vinyl metal species 
immediately undergoes cyclization steps before either reductive elimination or protonolysis 
can take place. Forcing the intermediate in the dotted line depicted in Scheme 27 to undergo 
direct decarboxylation and protonolysis would obviate the formation of doubly functionalized 
arenes without the assistance of an additional decarboxylation mediator. We refer to this 
possible reaction mode as deciduous, because the carboxylate group is shed from the 
intermediate after it fulfilled its task. This sequence can be compared to a leaf of a tree in fall, 
which is cast off because it has served its purpose and is no longer required. 
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4. Research objectives 
The aim of this research was to rationally develop expedient methods for a concise and 
especially regioselective assembly of synthetic relevant products from readily available 
aromatic carboxylic acids. C−H activation and decarboxylative cross-couplings were the two 
main strategies applied to ensure that our objectives of high atom efficiency and a minimum 
amount of waste are achieved. The major challenge was to overcome the abovementioned 
intrinsic limitations of these concepts, which are encountered when dealing with aromatic 
carboxylic acids as starting materials in homogeneous catalysis. These framework conditions 
define the following specified objectives: 
• The first goal was to unlock the last missing piece in the context of decarboxylative 
biaryl couplings. The efficient redox neutral biaryl formation starting from aryl chlorides 
and benzoates, without activating ortho substituents, should be achieved for the first time 
by holistic optimization of a bimetallic catalyst system. It is a particularly challenging 
target because both aryl chlorides and non-activated benzoic acids are reluctantly reactive 
in cross-coupling reactions and because decarboxylative couplings are reputedly 
additionally hampered by the presence of excess halides. 
• The second goal was the redox neutral ortho-arylation of benzoic acids with aryl 
chlorides and bromides catalyzed by ruthenium. Such a protocol would shift the biaryl 
coupling from the ipso- to the ortho-position highlighting the perfect orthogonality to 
decarboxylative couplings. It is therefore important that the carboxylate group remains 
untouched after the reaction to give the potential opportunity for a stepwise synthesis of 
multi-functionalized arenes via a conceivable subsequent ipso-substitution. 
• The second goal was to circumvent the weak coordinating ability of carboxylic acids and 
diminish the issues that come with it in a straightforward fashion. Our vision was to 
embed the decarboxylation within the C−H functionalization to unlock the deciduous 
reaction mode of the carboxylate group. That means that the usually observed, but 
unwanted, double-functionalization on both ortho-positions will be avoided by 
concertedly extruding CO2 during one C−H functionalization event. Additionally, this 
reaction mode would override natural regioselectivity driven by intrinsic electronic 
properties commanded by already installed substituents. 
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5. Results and discussion 
The following chapters comprise a short overview of the aims and challenges of each 
project. Due to the cumulative form, every section contains a depicted copy of the 
corresponding original publication in which all citations and experimental data are included, 
respectively. Moreover, strongly related work, which has been published by other groups 
simultaneously to or after the own projects, are shown for comparison and as support for 
conducted preliminary mechanistic experiments. 
5.1. Catalytic Decarboxylative Cross-Coupling of Aryl Chlorides and 
Benzoates without Activating ortho Substituents 
In continuation with the development of decarboxylative cross-couplings for the synthesis 
of biaryls, this project targeted at the elaboration of an extremely potent Cu/Pd bimetallic 
catalyst system that would allow the efficient coupling of aryl chlorides with non-activated 
benzoates (Scheme 28). To date, such a transformation was not possible with state-of-the-art 
catalyst systems yet highly desirable, because it would represent a serious alternative to 
traditional cross-couplings. 
 
Scheme 28: Decarboxylative biaryl synthesis from aryl chlorides and benzoates without 
activating ortho substituents. 
Highly active protodecarboxylation catalysts developed by Gooßen et al. proved that the 
energy required to decarboxylate benzoic acids without activating ortho substituents can be 
surmounted at acceptably low temperatures. However, in a cross-coupling reaction with aryl 
halides, the halide salts formed after the transmetallation step would hamper the 
decarboxylation because of the difficult preceding salt metathesis, formally impeding the 
benzoate to enter the catalytic cycle (Scheme 29). 
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Scheme 29: General decarboxylative cross-coupling reaction for the biaryl synthesis and 
proposed reaction mechanism for a bimetallic catalyst system. 
Based on the postulated mechanism displayed in Scheme 29 it was tentatively assumed 
that efficient turnover can only be achieved when the salt metathesis between halide salts and 
benzoates is aided by coordinating ortho substituents. This hypothesis is supported by 
comparative protodecarboxylation experiments of o−nitrobenzoic acid and p−nitrobenzoic 
acids, in which the reaction is shut down by added halide salts, in the case of p−nitrobenzoic 
acid exclusively (Scheme 30).[322] 
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O2N +
[Cu], ligand H
O2N + CO2NMP/quinoline, 170 °C, 6 h
KBr
= ortho-NO2 : 100% without KBr; 95% with KBr
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Scheme 30: Influence of halides and substitution patterns on protodecarboxylations. 
Another result which supports the theory of a disfavored anion exchange is the efficient 
coupling of non-ortho-substituted benzoic acids with aryl electrophiles bearing non-
coordinating leaving groups such as triflates or tosylates, for which the salt metathesis is 
reputedly unproblematic.[233–235,237] Yet, these aryl sources are expensive and only available in 
limited functional diversity. A connatural reaction with substantially lower-priced and more 
diverse aryl halides is therefore a main target in the context of decarboxylative biaryl 
synthesis. 
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Extensive mechanistic investigations confirmed the disfavored salt metathesis. However, 
in strong contrast to experimental results, the substitution patterns were found to be 
surprisingly uninvolved in this step and the energy barriers are for both ortho- and para-
substituted benzoic acids almost identical.[238] The difference in reactivity lies within the rate 
determining energy span which is only revealed when taking in consideration the entire 
catalytic cycle and not each single step alone. The energy span for ortho-substituted benzoic 
acid is between the starting materials and the decarboxylation transition state, whereas for 
non-ortho-substituted benzoic acids the rate determining energy span lies between the starting 
materials and the transmetallation transition state. This energy span is found to be 
4−8 kcal mol-1 higher than in the ortho case, just enough to enable decarboxylative couplings 
at manageable temperatures. Nevertheless, the energy barriers for the transmetallation and 
decarboxylation are so similar for both substitution patterns that the actual rate determining 
step of a decarboxylative cross-coupling is probably depending on each individual substrate, 
but not as originally assumed on intrinsic decarboxylation propensities. The halide effect 
observed is probably due to the higher stability of copper or silver halides shifting the 
equilibrium so that less copper or silver carboxylate is present, decreasing the entire 
decarboxylation rate by additionally increasing its energy span. These computational studies 
indicate that an efficient decarboxylative arylation of benzoates without activating ortho 
substituents with inexpensive aryl chlorides can only be achieved by thoroughly optimizing 
each elementary catalytic step that is involved. The objective of this project was to develop an 
efficient catalyst system, which would confirm the postulated feasibility of this 
transformation. 
Thus, we started our investigation by optimizing the decarboxylation catalyst. It was soon 
demonstrated that the CO2 extrusion of non-ortho-substituted benzoic acids can even be done 
in the presence of excess halides (Table 1). 
Table 1: Optimization of the decarboxylation catalyst in the presence of excess halides. 
 
# [M] ligand additive solvent T/°C yield/% 
1 Cu2O phen - NMP/quin=3/1 190 99 
2 " " KCl " " 14 
3 " Me4phen " " " 99 
4 Ag2CO3 - " " " - 
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Reaction conditions: 3−nitro−benzoic acid (0.5 mmol), Cu2O (5 mol %), ligand (10 mol %), additive (0.5 mmol), 
3 mL of solvent, 190 °C, 16 h. quin = quinoline; NMP = N−methyl−2−pyrrolidone. Yields determined by GC 
analysis using n-tetradecane as the internal standard. 
The cross-coupling was examined by thoroughly optimizing the palladium co-catalyst 
system in the presence of the copper co-catalyst system. State-of-the-art palladium cross-
coupling catalyst systems were found inefficient, leading to higher levels of unwanted 
protodecarboxylated product instead of the desired biaryl. Further extensive optimization 
revealed that combining cationic palladium species with bulky phosphines, such as XPhos 
which reputedly activate aryl chlorides, gave the best results. With the best conditions in 
hands, benzoates, regardless of their substitution patterns, were smoothly coupled with 
numerous readily available aryl chlorides. 
We realized that it was difficult to steer the reaction in favor of the desired biaryl product 
when electron-rich aryl chlorides were implemented. Instead, protodecarboxylation was found 
to be the predominant pathway, leading to a more selective formation of the corresponding 
decarboxylated arene. The observation that the oxidative addition negatively affects the 
selectivity between cross-coupling and protonolysis can be rationalized by the energy span 
model.[323] By assuming that 1) for non-ortho-substituted benzoic acids the transmetallation 
transition state is the highest in energy but 2) is not effected by the nature of the Pd-bound 
aryl group, and 3) that the protodecarboxylation always proceeds with the same rate, a 
preceding oxidative addition of electron-rich substrates, which occurs with lower rate 
compared to electron poor electrophiles, would further enhance the rate-determining energy 
span. As a consequence, the protodecarboxylation outbalances the transmetallation, leading to 
simple arenes instead of the desired biaryls. 
Despite this limitation it should be mentioned, that this method is applicable to the full 
range of benzoic acids and it considerably surpasses previously reported protocols for the 
coupling of activated benzoic acids with aryl chlorides (Table 2). The reason for the high 
performance of this catalyst system is probably a result of a thorough optimization of each 
elementary catalytic step. Whereas in previously reported protocols the focus was to optimize 
the decarboxylation alone, which was thought to be the only possible rate limiting step. 
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Table 2: Direct comparison of this method with two other previously reported protocols for 
the exemplary coupling of ortho-, meta- or para-nitrobenzoic acid with para-tolyl 
chloride. 
 
# 5.1.-1 
yield of biaryl 5.1.-3 for each method 
CuI/Me4Phen 
(MeCN)4Pd(OTf)2/XPhos 
(this method) 
CuI/Phen 
PdI2/JohnPhos[232] 
CuI/Phen 
Pd(acac)2/JohnPhos[324] 
1 2−NO2 80% 71% 57% 
2 3−NO2 61% - - 
3 4−NO2 51% - - 
Me4Phen = 3,4,7,8-tetramethyl-1,10-phenanthroline; XPhos = 2-dicyclohexylphosphino-2’,4’,6’-
triisopropylbiphenyl; Phen = 1,10-phenanthroline; JohnPhos = (2-biphenyl)di-tert-butylphosphine. 
To summarize, the customized Cu/Pd bimetallic catalyst system depicted Scheme 31 in 
was found to enable the decarboxylative cross-coupling of non-ortho-substituted benzoates 
with aryl chlorides, proving that the limitations are not intrinsic. This system is highly 
performing and can be regarded as a true alternative to traditional cross-coupling reactions for 
the redox neutral synthesis of biaryls. 
 
Scheme 31: Reaction conditions elaborated during this project. 
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5.2. ortho-C-H Arylation of Benzoic Acids with Aryl Bromides and 
Chlorides Catalyzed by Ruthenium 
For this project we envisioned to switch the arylation of benzoic acids from the ipso- to the 
ortho-position with retention of the carboxylate group for potential orthogonal 
decarboxylative cross-couplings. As shown in chapter 3.3.2.1., carboxylate-directed C−H 
arylations are catalyzed by expensive Pd-, Rh- or Ir-catalysts and rely mostly on costly aryl 
iodides or aryl boronates as the aryl source. Moreover, oxidative protocols require 
stoichiometric amounts of silver-based oxidants. We therefore aimed at the challenging redox 
neutral transformation of aryl bromides and aryl chlorides, the most inexpensive and most 
available of the aryl electrophiles. This transformation should be mediated by a more 
affordable ruthenium catalyst, outperforming known protocols and able to compete with 
traditional biaryl syntheses via cross-coupling of preformed organometallic reagents (Scheme 
32). 
CO2H
+
X CO2HH
X = Br, Cl
FG'
FG'
[Ru] decarboxylative 
couplings
-CO2
FG
FG
 
Scheme 32: Ruthenium-catalyzed ortho-C−H arylation of benzoic acids with aryl bromides 
and aryl chlorides. 
The decisive breakthrough was to implement a ligand, which is capable of facilitating the 
oxidative insertion of the ruthenium into the aryl halogen bond. Electron-rich phosphines and, 
in rare cases, amino acids were already found beneficial in analogous C−H arylations of 
arenes bearing strong directing groups.[326–329] Intensive optimizations revealed that in fact the 
ligands play a detrimental role. 
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Scheme 33: Optimized conditions for the ruthenium-catalyzed ortho-C−H arylation of 
benzoic acids with both aryl bromides (method A) and aryl chlorides (method B). 
Bromoarenes are efficiently coupled when the ruthenium catalyst is potentiated by small 
electron-rich alkyl phosphines. Among them, triethyl phosphine particularly outperformed 
other ligands and can conveniently be applied in its HBF4 salt (Scheme 33, method A). 
Instead, aryl chlorides are preferentially converted when the non-proteinogenic amino acid 
DL−pipecolinic acid was used as ligand at slightly elevated reaction temperatures (Scheme 
33, method B). Control experiments revealed that the optimal conditions for aryl chlorides are 
not efficient for aryl bromides, suggesting that different reaction pathways might be involved 
in this case. In contrast, the reaction conditions elaborated for bromoarenes are applicable to 
aryl chlorides. However, comparable yields can only be achieved after substantially longer 
reaction times of 48 h instead of 18 h. These two methods showed broad applicability and 
comparable yields for both aryl bromides and aryl chlorides. As expected, double-arylation on 
both sides of the carboxylate group could only be avoided when one ortho-position is blocked 
either by an ortho- or sterically by a meta substituent. Interestingly, a competitive experiment 
in which an acetamido group is additionally present in the benzoic acid revealed that the 
ortho-C−H metallation is selectively guided by the carboxylate rather than by the amide group 
(Scheme 34). This feature is particularly remarkable because the C−H directing ability of the 
amide groups reputedly exceeds that of carboxylic acids and could give the possibility for 
orthogonal transformations via amide directed C−H functionalizations and even further via 
decarboxylative ipso-functionalizations. 
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Scheme 34: Selective ortho-C−H arylation in the presence of two competing directing groups 
and potential further regioselective transformations. 
To show the versatility of this reaction concept, the elaborated biaryl synthesis was 
combined with a concomitant protodecarboxylation and in another with a subsequent 
decarboxylative ipso-arylation (Scheme 35). 
CO2H
+ Ph
Br
H[Ru/Cu],
base
-CO2
H
Ph
R
R
R = Me, 54%
R = F, 71%
1) method A
2) [Pd/Cu],
Ph-Br
-CO2
Ph
PhR
R = F, 55%
 
Scheme 35: Tandem ortho-arylation / ipso-defunctionalization (left); tandem ortho-arylation / 
ipso-arylation (right). 
To our delight, only by adding catalytic amounts of copper as one of the reaction 
ingredients and increasing the temperature to 190 °C, the corresponding decarboxylated 
biaryls were formed in good yields without any additional steps or ligands (Scheme 35, left). 
This route can therefore be regarded as complementary to a decarboxylative cross-coupling of 
aryl halides with benzoates without activating ortho substituents because it yields the same 
products, but circumvents low decarboxylation propensities of non-ortho-substituted benzoic 
acids. On the other hand, the combination of ortho-arylation with decarboxylative cross-
couplings was only possible in a two-step, one-pot procedure (Scheme 35, right). 
Nevertheless, this is the first example for the synthesis of a terphenyl via an intermolecular 
tandem ortho-arylation / ipso-arylation. 
The method developed within this project highlights the multifaceted potential of aromatic 
carboxylic acids in catalytic regioselective transformations. With the implementation of 
inexpensive aryl bromides and chlorides and a cost-effective ruthenium catalyst, this reaction 
can be regarded as a serious alternative to traditional transition metal-catalyzed biaryl 
syntheses. 
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Independently to this project, the groups of Weix, Ackermann and Larrosa reported almost 
simultaneously alternative but related protocols. This emphasizes how topical the research 
area in carboxylate-directed ruthenium-catalyzed C−H functionalizations is (Table 3).[327] 
Table 3: Alternative protocols for the carboxylate-directed ortho-C−H arylation catalyzed by 
ruthenium. 
group Weix[331] Ackermann[332] Larrosa[333] 
conditions 
[(p−cym)RuCl2]2, PCy3, 
K2CO3, NMP, 100 °C, 
24 h 
[(p−cym)Ru(MesCO2)2], PCy3, 
K2CO3, NMP, 120 °C, 16 h 
[Ru(tBuCN)6](BF4)2], 
KOC(CF3)3, K2CO3, tBuCN, 
140 °C, 16 h 
aryl-source Ar−I, Ar−Br, Ar−OTf Ar−Br Ar−I, Ar−Br, Ar−OTf 
Weix: scope consists of 36 examples, up to 99% yield; Ackermann: scope consists of 30 examples, up to 93% 
yield; Larrosa: scope consists of 90 examples, up to 99% yield. 
The reaction conditions, scope, and yields reported by Weix and Ackermann are somewhat 
similar to the one reported in this work. Additionally, Weix’s method can be applied to the 
arylation of heteroaromatic carboxylates. Ackermann’s protocol is not restricted to ortho-
arylations. Instead, implementing bromoalkenes or bromoalkynes leads to the formation of 
vinyl- as well as alkynyl arene carboxylic acids.[334] The group of Larrosa disclosed reaction 
conditions which rely on a cationic Ru(II)-species instead of adding electron-rich ligands. 
They presented an impressive scope of 90 isolated products and highlighted the robustness of 
his protocol by upscaling the reaction to 50 mmol, maintaining excellent yields even with 
very low 0.5 mol% catalyst loadings. It is important to mention that in contrast to our 
protocol, all these methods are, although important and versatile, inefficient for the coupling 
of aryl chlorides. 
5.3. Regioselective C–H Hydroarylation of Internal Alkynes with 
Arenecarboxylates: Carboxylates as Deciduous Directing Groups 
The ambitious objective of this project was the development of a catalytic carboxylate 
directed C−H functionalization, which fully exploits the benefits of aromatic carboxylic acids 
as starting materials in homogeneous catalysis. By marginal deviation of reaction conditions, 
the carboxylate should reveal its manifold nature serving as classical (Scheme 36, left), 
transformable (Scheme 36, right), and cleavable directing group (Scheme 36, bottom). 
Especially in the latter case, we aimed at an inherently selective pathway, which would 
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circumvent often observed yet unwanted unselective double functionalization. The 
carboxylate directing group is supposed to be discarded within the catalytic cycle during one 
functionalization event. Since the directing group is used only as long it is required to guide 
one single functionalization before being cast off to prevent a second C−H cleavage, this 
reaction mode can be figuratively compared to a deciduous tree in autumn, which sheds his 
leafs after they fulfilled their purpose. Hence, we define this reaction pathway as deciduous. 
O
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R
R
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(het)
R
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Scheme 36: Multipurpose directing ability of a carboxylic acid group. 
As shown in section 3.3.2.2., alkynes proved to be efficient coupling partners in 
carboxylate directed oxidative C−C bond formations. These reactions occur via intermediary 
formed vinyl-metal species, which at this stage immediately undergo uncontrollable oxidative 
cyclization steps before a possible protonolysis can take place. In contrast, a redox neutral 
alkenylation via hydroarylation of alkynes obviates the presence of oxidants, hampering 
oxidative reaction channels, thus, keeping the reactive carboxylate group after the reaction 
untouched. Another challenge enters into force when the tendency of alkynes to react with the 
nucleophilic carboxylate to form enol esters, rather than with the C−H moiety, is enhanced by 
electron-deficient transition metal catalysts or ruthenium(II)-species. This innate reactivity 
emphasizes the arduous task associated with elaborating selective C−H hydroarylations of 
alkynes in the presence of a reactive carboxylate. 
Scheme 37 shows the reaction conditions which were developed within this project. 
Screening experiments revealed that ruthenium is the only metal capable to catalyze this 
transformation and that the reaction outcome strongly depends on the nature and the amount 
of base. Interestingly, guanidine carbonate, a base which has never been used in analogous 
transformation, was found to be crucial to achieve desired high yields and high levels of 
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regioselectivity. This base is ideally administered substoichiometrically in order to avoid the 
absence of protons, thus, guaranteeing a prompt product forming protonolysis. However, the 
reaction outcome is mostly manipulated by the solvent system. In a tert-amyl alcohol/water 
mixture, the carboxylate acts as a classical directing group (Scheme 37A). The reaction is as 
expected not inherently monoselective. The second ortho position thus needs to be blocked in 
order to avoid double functionalization. The reaction shows high functional group tolerance. 
Symmetrical diaryl alkynes as well as unsymmetrically substituted alkyl,aryl alkynes are 
well-tolerated. The latter react with impressive regioselectivity for the alkyl branched product. 
CO2H
+
(het)Ar R
[(p-cym)RuCl2]2 (4 mol%),
guanidine carbonate (0.2 eq.),
2-picoline (0.2 eq.), AcOH (1 eq.)
toluene, 120 °C, 24 h
[(p-cym)RuI2]2 (2 mol%),
guanidine carbonate (0.5 eq.),
tAmOH:H2O (10:1), 100 °C, 12-24 h
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AcOH (1 eq.)
tAmOH, 100 °C, 12-24 h
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Scheme 37: Carboxylate directed C−H hydroarylation of benzoic acids with internal alkynes 
with the CO2H moiety operating as A classical, B transformable, and C deciduous 
directing group. 
Under more acidic conditions and with propargylic alcohols as coupling partner, benzoic 
acids as well as acrylic acids react to form γ-alkylidene-δ-lactones via a tandem ortho-C−H 
vinylation/esterification process (Scheme 37B). The carboxylate group acts as a 
transformable directing group, complementing the numerous oxidative C−H 
vinylation/lactonizations which usually lead to isocoumarins. Yields and functional group 
tolerance for this case are also very high. Moreover, the in situ esterification deactivates the 
directing ability of the carboxyl group so that double functionalization is completely omitted. 
In the less polar solvent toluene the reaction leads to the exclusive formation of the 
decarboxylated product (Scheme 37C). The reaction is limited to symmetrical diaryl alkynes. 
However, the key finding is that double-functionalized products were never observed under 
these conditions which led us to the assumption of a concerted C−H 
vinylation/decarboxylation instead of a sequential process. In our case, the C−CO2H bond is 
truncated within the catalytic cycle, which makes a double functionalization impossible; a 
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pathway that we define as deciduous. A para- or ortho-substituted benzoic acid thus leads 
exclusively to a meta-monofunctionalized arene, whereas a meta-substituted benzoic acid 
leads to a para-functionalized product. Hence, the formal meta- or para-functionalization of 
arenes, which are by far the most challenging positions to manipulate selectively via direct 
C−H activation methods or electrophilic substitutions, becomes accessible.[335] 
The postulated deciduous pathway was further supported by a control experiment in which 
the products of the non-decarboxylative hydroarylation were submitted to the decarboxylative 
hydroarylation conditions (Scheme 38). In this case, the starting materials were recovered 
quantitatively. 
 
Scheme 38: Protodecarboxylation control experiment under decarboxylative hydroarylation 
conditions. 
Based on preliminary mechanistic investigations and previously reported related 
processes,[274,275,284] we proposed a tentative catalytic cycle for the deciduous reaction mode, 
which is depicted in Scheme 39. The first step consists of a carboxylate-directed C−H 
activation via a concerted metallation deprotonation (CMD) mechanism to form the 
ruthenacycle I. In the next step the alkyne inserts into the aryl-ruthenium bond, generating the 
seven-membered intermediate II. Intermediate IV is formed after a direct decarboxylation, 
preferentially in less polar solvent via transition state III. Protonolysis of the five-membered 
ruthenacycle IV regenerates the active catalyst species along with the mono-vinylated arene 
product. 
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Scheme 39: Proposed mechanism for the deciduous reaction mode. 
In conclusion, this project highlights the multifaceted nature of a carboxylate opening up a 
versatile, waste-free synthesis of 2-vinylbenzoic acids or lactones from abundant precursors. 
Additionally, the discovery of the carboxylic acid moiety to act as a deciduous directing 
group is presented as an highly powerful reaction mode to guarantee regioselective mono-
functionalizations. It bypasses the issues of a weak directing group and overrules innate 
regioselectivity which are unavoidably caused by intrinsic electronic properties. 
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Independently to this work, the groups of Ackermann and Zhao together with Hartwig 
disclosed decarboxylative ortho-C−H hydroarylation processes leading to the same products 
as those arising from a deciduous reaction pathway.[337,338] The conditions reported by 
Ackermann et al. comprise a customized (p-cym)Ru(MesCO2)2-catalyst in toluene at 100 °C 
and remarkably obviates any additional base. However, the benzoic acids chosen for the 
decarboxylative hydroarylation bear σ-electron withdrawing ortho substituents and have thus 
strong tendency to decarboxylate. Zhao and Hartwig report a catalyst system comprising a 
(p-cym)Ru(OAc)2 catalyst in a sophisticated mixture of solvents (dioxane/mesitylene/n-
heptane (2:2:1)). These conditions allow the decarboxylative hydroarylation of numerous 
ortho-, meta-, and para-substituted benzoic acids at already 80 °C. Additionally, 
implementing 20 mol% Cu(OAc)2 unsymmetrically substituted alkyl,aryl alkynes were also 
reacted to the corresponding vinylarenes with rather poor regioselectivity for the alkyl 
branched product. In this case, the reaction is more likely to occur via a sequential 
hydroarylation/decarboxylation process mediated by the presence of copper. It is important to 
mention that none of the reported protocols, including our work, allow the hydroarylation of 
terminal alkynes. In the case of phenyl acetylene we observed that the starting materials are 
recovered entirely unreacted after the reaction. 
Our initial preliminary mechanistic experiments and the hypothesis of a deciduous reaction 
mode were later confirmed by DFT-studies calculated by the group of Prof. Xin Hong.[339] 
Their investigations additionally showed that the deciduous pathway is considerably 
dependent on the ring size of intermediate II depicted in Scheme 39. The seven-membered 
ring seems to have the right geometry to allow a prompt decarboxylation directly from the 
intermediary metallacycle. The decarboxylation from a five- or eight-membered ring (n = 0 or 
n = 2, respectively) entails an energy barrier almost twice as high as the corresponding seven-
membered metallacycle (Scheme 40A). 
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Scheme 40: Calculated Gibbs free energies for decarboxylation barriers in a deciduous 
reaction mode depending on the intermediate structure (A). Calculated energy 
barriers for competing protonolysis and β-H elimination pathways (B). 
On the other hand, the vinyl functionality does not seem to play a detrimental role. The 
decarboxylation barrier of the saturated seven-membered metallacycle (n = 1), which would 
derive from an alkene insertion rather than alkyne insertion, is only 2 kcal mol-1 higher and 
should therefore be in theory also feasible. A successful reaction would be highly desirable 
because alkyl arenes are otherwise difficult to obtain. However, Xin Hong and coworkers 
have calculated, that after the decarboxylation a β-hydride elimination is preferred over 
protodemetallation, yielding again the corresponding vinylarenes (Scheme 40B). 
Interestingly, very recently the group of Baidya reported the decarboxylative hydroarylation 
of maleimides using carboxylate as deciduous directing group.[340] In this particular case, 
protodemetallation is preferred over β-hydride elimination leading to the alkylated arene 
instead of the Heck-product (Scheme 41). The authors do not comment on the reason for this 
selectivity. After the alkene insertion, the carbonyl group on the maleimide probably interacts 
with the ruthenium center hampering the conformation strictly required for successful β-
hydride elimination. 
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Scheme 41: Ruthenium-catalyzed C−H hydroarylation of maleimides using carboxylates as 
deciduous directing groups. 
The group of Xin Hong further calculated the solvent effect. We observed a strong impact 
on the reaction outcome depending on the nature of the solvent. In our case the polar protic 
solvent tert-amyl alcohol steers the reaction towards the non-decarboxylative pathway, 
whereas the aprotic and less polar solvent toluene favors the deciduous pathway. These trends 
were confirmed by the theoretical study (Scheme 42). 
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Scheme 42: Gibbs free energies calculated under the influence of the solvent. 
In toluene, the energy barrier for the deciduous pathway is 13.8 kcal mol-1. On the other 
hand, the energy barrier for the stepwise protonolysis in the same solvent is 4.4 kcal mol-1 
higher in energy, showing that in toluene this competing pathway is improbable. Instead, in 
the polar protic solvent methanol the non-decarboxylative reaction is favored, showing an 
energy barrier of only 11.3 kcal mol-1, which is 8.4 kcal mol-1 lower than the competing 
deciduous pathway. 
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5.4.  Doubly Regioselective C–H Hydroarylation of Unsymmetrical Alkynes 
Using Carboxylates as Deciduous Directing Groups 
In continuation with regioselective carboxylate-directed C−H functionalizations and our 
findings on the new reaction mode of the carboxylate moiety to act as a deciduous directing 
group, we aimed toward a more potent catalyst system, which would allow the 
decarboxylative C−H hydroarylation of all sorts of internal alkynes. 
CO2H
+
R'
R
H H
H
H
R
R'
+ CO2
high regio- and 
chemoselectivity
[Ru]
base
FG
FG
 
Scheme 43: Envisioned carboxylate directed decarboxylative C−H hydroarylation of 
unsymmetrical alkynes using carboxylates as deciduous directing groups. 
Especially unsymmetrically substituted alkyl,aryl alkynes were found to be reluctantly 
reactive in previous reports and required the presence of copper promoting the 
decarboxylation in order to avoid double functionalization. That means that in this case the 
reaction occurs via a sequential vinylation/decarboxylation process rather than a deciduous 
reaction mode. We were therefore eager to find a catalyst system based on one single metal 
capable of activating the deciduous character of the carboxylate directing group. 
Due to the numerous parameters that had to be taken into account, this reaction was 
particularly challenging to optimize. The major task was to avoid double functionalization by 
activating the deciduous pathway. Moreover, the reaction had to take place regioselectively in 
favor of the alkyl-branched formal ortho-vinylation and with high levels of E/Z 
stereoselectivity as well. The ruthenium-precursor [(hexamethylbenzene)RuCl2]2 was found 
to be more efficient in terms of conversion and selectivity instead of the state-of-the-art 
catalyst [(p-cym)RuCl2]2. The greater selectivity performance of this catalyst is probably due 
to the more bulky hexamethylbenzene ligand, which forces the alkyne insertion to occur in a 
specified trajectory. Moreover, the steric pressure induced by the ligand could ease the 
decarboxylation step by expelling the carboxyl group. To ensure a prompt protonolysis, the 
right proton source (mesitylene carboxylic acid) was particularly decisive. This additive is 
required to steer the reaction in favor of the deciduous pathway and diminishes competing 
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non-decarboxylative routes. Additionally, in order to achieve high conversions, the reaction 
medium needed to be buffered by a base system consisting of catalytic amounts of potassium 
carbonate and guanidine carbonate. Under conventional heating (120 °C) the reaction time is 
16 h. However, the desired transformation can be conducted under microwave irradiation 
within 5 minutes only, which is particularly desirable for drug discovery. With both reaction 
conditions (Scheme 44) the corresponding vinyl-arenes were formed in high to quantitative 
yields, with exclusive formation of the E-isomer and with impressive regioselectivities in 
favor of the alkyl-branched product (up to 99:1). 
 
Scheme 44: Doubly regioselective C−H hydroarylation of unsymmetrical alkynes using 
carboxylates as deciduous directing group. 
To summarize, a second-generation catalyst elaborated within this project allows for the 
first time the doubly regioselective decarboxylative mono-hydroarylation of unsymmetrical 
alkynes. The protocol requires only low loadings of inexpensive and easy-to-handle 
[(C6Me6)RuCl2]2 and no additional decarboxylation catalyst. With the new system, the 
extrusion of CO2 occurs along with the C−C bond formation even for alkyl aryl alkynes, so 
that double functionalization, a side reaction widely encountered in ortho-C−H activation, is 
fully suppressed. The new protocol is generally applicable to both electron-rich and -deficient 
(hetero-)arylcarboxylic acids bearing a broad range of substituents, in combination with 
diversely functionalized alkynes. In most cases, high yields and remarkable regioselectivities 
were achieved even for products that were inaccessible with the first-generation catalysts. The 
diaryl alkene products are key functionalities in functional materials, pharmaceuticals and 
natural products and the provided reaction variant under microwave irradiation offers the 
opportunity of a fast and cost-efficient drug discovery. 
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The results of this project have been published in Organic Letters. The original publication 
has been adapted for this work and enclosed with permission of the publisher: "Reprinted 
(adapted) with permission from A. Biafora, B. A. Khan, J. Bahri, J. M. Hewer, L. J. Goossen, 
Org. Lett. 2017, 19, 1232−1235: „Doubly Regioselective C−H Hydroarylation of 
Unsymmetrical Alkynes Using Carboxylates as Deciduous Directing Groups”.[342] Copyright 
2017 American Chemical Society." An additional license is not provided by this journal and 
is not required. 
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Due to the great response of the concept of carboxylates as deciduous directing group, we 
were asked to write an Account article in occasion of the special issue “Thieme Chemistry 
Journals Awardees – Where Are They Now?”. In here, we define the possible reaction modes 
of the carboxylate as directing group and specify in particular the concept of the deciduous 
reaction mode. 
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Results and discussion 
 
 79 
The article has been published in Synlett. The original publication has been adapted for this 
work and enclosed with permission of the publisher: "Reprinted (adapted) with permission 
from A. Biafora, L. J. Goossen, Synlett. 2017, 28, A−F:„Thieme Chemistry Journals 
Awardees – Where Are They Now? New Reaction Mode in Carboxylate-Directed C–H 
Functionalizations: Carboxylates as Deciduous Directing Groups”.[341] Copyright 2017 
Georg Thieme Verlag Stuttgart • New York." 
THIEME LICENSE 
TERMS AND CONDITIONS 
 
This Agreement between Agostino Biafora ("You") and Thieme ("Thieme") consists of your 
order details and the terms and conditions provided by Thieme and Copyright Clearance 
Center. 
License number Reference confirmation email for license number 
License date Aug, 03 2017 
Licensed Content Publisher Thieme 
Licensed Content Publication Synlett 
Licensed Content Title Thieme Chemistry Journals Awardees – Where Are They Now? New Reaction 
Mode in Carboxylate-Directed C–H Functionalizations: Carboxylates as 
Deciduous Directing Groups 
Licensed Content Author Agostino Biafora, Lukas J. Gooßen 
Licensed Content Date Jun 8, 2017 
Licensed Content Issue EFirst 
Type of Use Dissertation/Thesis 
Requestor type author of the original Thieme publication 
Format print and electronic 
Portion full article/document 
Results and discussion 
 
 80
Results and discussion 
 
 81 
Results and discussion 
 
 82
Results and discussion 
 
 83 
Results and discussion 
 
 84
Results and discussion 
 
 85 
 
Conclusion and outlook 
 
 86
6. Conclusion and outlook 
This work demonstrates new sustainable methods for the regioselective functionalization 
of aromatic carboxylic acids for the straightforward synthesis of chemically relevant 
scaffolds. 
Decarboxylative cross-couplings and C−H activation were the two concepts applied to 
reveal the full synthetic potential of benzoic acid derivatives as starting materials in 
homogeneous catalysis. Both aspects were merged into the novel concept of deciduous 
directing groups, improving significantly the expediency of the carboxyl group as a synthetic 
target. The tremendous catalytic performance of the developed methods certifies that 
decarboxylative cross-couplings and carboxylate directed C−H functionalizations can fully 
compete with traditional cross-coupling reactions, and that aromatic carboxylic acids can be 
regarded as a worthwhile and beneficial alternative to preformed organometallic starting 
materials. Scheme 45 summarizes all methods for the diversification of aromatic carboxylic 
acids that were developed within this doctoral work. 
 
Scheme 45: Overview on the cross-coupling reactions of benzoic acid derivatives developed 
within this work. 
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Based on theoretical insights on the bimetallic decarboxylative cross-coupling catalysis, 
we developed a new generation of Cu/Pd-catalyst with enhanced catalytic performance 
(Scheme 45A). This system allows for the first time the decarboxylative biaryl synthesis 
starting from aryl chlorides and benzoates without activating ortho substituents. As postulated 
at an early stage, this reaction is the experimental proof that decarboxylative cross-couplings 
are not intrinsically limited. Further studies should aim at reducing the admittedly high 
reaction temperature, which is still required for this process. One very promising strategy 
could involve the implementation of P,N-ligands capable of aiding the reputedly energetically 
disfavored transmetallation-step by bridging and pre-organizing the two catalysts involved. 
In a second project, an inexpensive ruthenium-catalyst was used for the ortho-arylation 
under retention of the carboxylic acid moiety (Scheme 45C). Aryl bromides were used as 
coupling partners when the Ru-precursor is aided by a small electron-rich phosphine ligand. 
More remarkably, with DL-pipecolinic acid as ligand the more challenging aryl chlorides 
were also efficiently coupled. Within the same project a Cu/Ru bimetallic catalyst system was 
found to shift the decarboxylative arylation from the ipso to the ortho position by using the 
carboxyl group as a traceless directing group and complementing the Cu/Pd catalyst system 
developed in the first project (Scheme 45B). Additionally, in a sequential ortho-arylation / 
ipso-arylation process, we demonstrated for the first time that merging C−H activation and 
decarboxylative couplings can be an expedient approach for the regioselective synthesis of 
multi-decorated arenes. 
In a third project, under redox neutral conditions, internal alkynes were used as coupling 
partners for the ortho-vinylation via C−H hydroarylation. In this case the carboxyl group 
revealed even more reaction modes. As a classical directing group, the carboxylate moiety 
was used to trigger the efficient ortho-vinylation yielding the 2-vinyl benzoic acids with high 
functional group tolerance and regioselectivities (Scheme 45D). Despite the importance of 
this protocol, the scope is restricted to ortho-substituted benzoic acids in order to avoid 
double functionalization. However, when the carboxy group is used as a transformable 
directing group in a tandem ortho-vinylation/esterification process, the directing ability is 
immediately deactivated after the reaction yielding the γ-alkylidene-δ-lactones exclusively 
(Scheme 45E). Another and within this doctoral work newly developed reaction concept is 
the deciduous reaction mode of the carboxyl moiety (Scheme 45F). The ortho-vinylation and 
decarboxylation occur in one step leading to an inherently monoselective pathway. Double 
functionalization is impossible because the directing group is shed within the catalytic cycle 
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after it fulfilled its purpose and is then no longer there to trigger a second C−H activation 
event. The first generation catalyst system was restricted to diphenylacetylene only. Finally, 
the second generation catalyst system, which was developed within the fourth project of this 
doctoral work, was applicable for the coupling of unsymmetrically substituted internal 
alkynes, yielding the corresponding vinylarenes in high yields and impressive regio- and 
stereoselectivities, optionally within just five minutes reaction times (Scheme 45G). 
The newly discovered deciduous reaction mode of the carboxyl group has tremendous 
synthetic potential. It is capable of overriding electronic effects of an already existing 
substitution pattern on the arene, formally guiding a coupling partner regiospecifically in a 
position which is usually inaccessible by conventional electrophilic substitutions of simple 
arenes. This new concept can be viewed as the gateway to advanced synthetic 
transformations, extending and diversifying the portfolio of carboxylate directed C−H 
functionalizations. 
 
Scheme 46: Potential future applications of the deciduous reaction mode. 
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Scheme 46 displays potential transformations enabled by the deciduous reaction mode. 
Part A shows that pursuing the strategy of hydroarylation reactions is worthwhile to install 
numerous coupling partners, including iso(thio)cyanates, allenes, ketenes, and simple alkenes 
regioselectively into the former ortho-position of a benzoic acid. It is a straightforward 
approach to synthesize (thio)amides, ketones, as well as alkylated and alkenylated aromates. 
Moreover, a possible electrophile introduced in the catalytic cycle at the decisive moment 
could allow the inherently regioselective multi-functionalization of benzoic acids in one 
single process. Unfortunately, we were not able to trap the intermediary metallacycle by any 
coupling partners other than just protons, to date. Such a reaction would be complementary to 
the Catellani reaction, but would obviate the addition of transient mediators such as 
norbornene. Part B in Scheme 46 shows that with the deciduous reaction mode the carboxyl 
group itself can migrate along the aromatic skeleton formally transforming an ortho-
substituted benzoic acid into a meta- or para-substituted one. More abundant meta-substituted 
benzoic acids can be transformed this way into para-substituted benzoic acids which are not 
easily accessible via conventional electrophilic substitutions. Further studies should aim 
exactly at these improvements in order to fully establish carboxylic acids not only as 
surrogates for organometallic reagents but as a more potent and versatile starting material for 
the synthesis of complex and otherwise inaccessible yet important building blocks. 
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7. Experimental Section 
7.1. General annotations 
7.1.1. Chemicals and solvents 
Commercially available chemicals and solvents with a purity of ≥95% were used directly 
or otherwise first purified by standard techniques.[343] Air and moisture sensitive compounds 
were handled and stored under nitrogen or argon atmosphere using standard Schlenk 
techniques. Liquid substances including reaction media were saturated with argon to exclude 
atmospheric oxygen. Toluene, 1,4−dioxane and mesitylene were dried over 
sodium/benzophenone. NMP and DMF were dried via azeotrope distillation with toluene. All 
solvents were stored over molecular sieves (3 Å), which were heated before in a microwave 
oven (2x2 min, 600 W) and cooled under vacuum (10−3 mbar) to room temperature. The 
benzoates were dried under vacuum (10−3 mbar) at room temperature for 1 h before using. All 
other organic salts were dried overnight under vacuum (10−3 mbar) at 60 °C. Inorganic salts 
were dried overnight under vacuum (10−3 mbar) at 160 °C. 
7.1.2. Parallel reaction set-up 
If not stated otherwise, a set of 10 parallel reactions were carried out in oven-dried 
20 mL headspace-vials for gas chromatography. All solid compounds were weighted under 
air, the reaction vessel were equipped with a 20 mm Teflon-coated stirring bar and closed 
with a vacuum-tight aluminum crimp-cap with Teflon-coated butyl rubber septa. Parallel 
vacuum/nitrogen flushing cycles of the reaction vessels (3 times) were carried out using a 
vacuum distributor, which was connected to the Schlenk line. Each distributor had 10 
vacuum-tight Teflon-tubing equipped with adapter for mounting Luer-Lock syringe needles. 
Extremely air and moisture sensitive compounds were weighted in the glovebox with nitrogen 
as inert gas. Liquid reaction components were injected via syringe through the Teflon-coated 
butyl rubber septum. The vials were placed in cylindrical holes (7 cm deep with a diameter of 
2.27 cm), which were drilled in a cylindrical aluminum block (height 8 cm, diameter 15 cm) 
with one additional hole for the temperature sensor. 
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After the reaction, the aluminum block was allowed to cool down to room temperature. 
The reaction vessels were carefully vented through the septum with a hollow needle. A 
suitable internal standard was added to the reaction mixture and diluted with a suitable 
organic solvent and water after which the reaction vial was shaken and the cap carefully 
opened. The reaction was either analyzed directly via 1H− or 19F−NMR or via gas 
chromatography by filtering 1.5 mL of the organic phase in a 2 mL GC-vial through a glass 
pipette containing a pad of 0.3 mL anhydrous magnesium sulfate. 
7.1.3. Analytical methods 
Mass spectra were recorded on a Varian GC-MS Saturn 2100 T or on an Agilent GC-MS 
5973N System. Ionization was performed via electron impact ionization (EI). High resolution 
mass analyses were performed with a Waters GTC Premier. 
Thin layer chromatography was performed using silica gel TLC-plates Polygram SIL 
G/UV254 from Macherey-Nagel. The Substances were detected either by quenching at 
254 nm or by fluorescence at 366 nm. 
Separation of substance mixtures were performed via column chromatography with a 
Combi Flash Companion-Chromatography-System from Isco-Systems. Readily packed 
RediSep and Grace Reveleris silica gel cartridges or Telos cartridges with basic aluminum 
oxide (0.063–0.200 mm, activity level I) were used as stationary phase. 
Gas chromatographic analyses were performed on a Hewlett Packard 6890 equipped with 
HP−5-columns with 5% phenyl-methyl-siloxane (30 m × 320 µm × 1.0 µm) from Agilent, 
Macherey-Nagel and Perkin Elmer. Injector temperature was set at 220 °C and the detector 
temperature was set at 330 °C. The standard measurement started with 2 min at 60 °C, 
followed by a linear temperature increase up to 300 °C with a rate of 30 °C/min after which 
the oven temperature was kept at 300 °C for additional 3 min. 
Mass spectra were recorded on a Varian GC-MS Saturn 2100 T or on an Agilent GC-MS 
5973N System. Ionization was performed via electron impact ionization (EI). High resolution 
mass analyses were performed with a Waters GTC Premier. 
Infrared spectroscopy was performed on a Perkin Elmer Spectrum 100 FT-IR spectrometer 
with Universal ATR Sampling Accessory. 
ESI-MS data were generated via electrospray ionization (ESI) from an acetonitrile solution 
with a concentration of approximately 0.1 mm and, if required, acidified with 5 µL of formic 
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acid. The solutions were infused continuously into the ESI chamber with a syringe pump at a 
flow rate of 2 µL/min. We used nitrogen as nebulizer gas at a pressure of 7 to 8 psi and as a 
drying gas with a temperature of 200 °C and a flow rate of 1 to 2 L/min. The electrospray 
needle was held at 4.5 kV. The mass spectra were recorded using a Paul-type ion trap mass 
spectrometer (AmaZon ETD, Bruker Daltonics). The ion source was operated in the positive 
and negative electrospray ionization mode. The scan speed was 32500 m/z per second with a 
resolution of 0.3 FWHM, the scan range was at least from 50 to 1500 m/z. The Instrument 
was controlled by BrukerTrapControl 7.2 software, data analysis was done with 
BrukerDataAnalysis 4.2 software. 
NMR spectra were recorded on a Bruker AMX 400 system using chloroform−d, 
methanol−d4 and dimethylsulfoxide−d6 as solvents, with proton, carbon, fluor and phosphor 
resonances at 400 MHz, 101 MHz, 376 MHz and 162 MHz, respectively. Some 
measurements were performed on a Bruker FT-NMR DPX 200 und Avance 600 and are 
marked as such. Processing the raw-data was done with ACD-Labs 12 software. The 
multiplicity of the signals is abbreviated with s = singlet, d = doublet, dd = doublet of a 
doublet, dt = doublet of a triplet, t = triplet, etc. All coupling constants are given in Hertz. 
Elemental analyses were performed on a Hanau Elemental Analyzer vario Micro cube. All 
melting points were determined with a Mettler FP61. 
7.2. Catalytic Decarboxylative Cross-Coupling of Aryl Chlorides and 
Benzoates without Activating ortho Substituents 
7.2.1. General Methods 
Chemicals and solvents were either purchased (puriss p.A.) from commercial supplier or 
purified by standard techniques.[343] All reactions, if not stated otherwise, were performed in 
oven-dried glassware under a nitrogen atmosphere containing a Teflon-coated stirring bar and 
dry septum. Reaction media were saturated with argon to exclude atmospheric oxygen. All 
reactions were monitored by GC using n-tetradecane as internal standard. Response factors of 
the products with regard to n-tetradecane were obtained experimentally by analyzing known 
quantities of the substances. The palladium catalysts (MeCN)4Pd(OTf)2, (MeCN)2Pd(OTs)2, 
(MeCN)4Pd(OMs)2 and ligand 4,7-dimethoxyl-1,10-phenanthroline were prepared according 
to the literature procedures and identified by comparison of their spectra with those of 
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authentic samples.[344][345] The aromatic carboxylates were prepared from the corresponding 
aromatic carboxylic acids following the procedures below and were directly used. 
A 250 mL, two-necked, round-bottomed flask was charged with the carboxylic acid 
(20.0 mmol) and ethanol (20.0 mL). To this, a solution of potassium tert-butoxide (2.24 g, 
20.0 mmol) in ethanol (20.0 mL) was added dropwise over 2 h. After complete addition, the 
reaction mixture was stirred for another 1 h at room temperature. A gradual formation of a 
white precipitate was observed. The resulting solid was collected by filtration washed 
sequentially with ethanol (2 x 10.0 mL) and cold (0 °C) diethyl ether (10.0 mL), and dried in 
vacuum to provide the corresponding potassium salts of the carboxylic acids. 
7.2.2. Catalyst development 
7.2.2.1. Protodecarboxylation experiments 
Table 4: Evaluation of the protodecarboxylation catalyst for carboxylates without activating 
ortho substituents. 
 
# [Cu] ligand additive solvent T/°C Yield/% 
1 Cu2O phen - NMP/quin=3/1 190 99 
2 " " KCl " " 14 
3 " " KOTf " " 99 
4 " Ph2phen " " " 50 
5 " " LiCl " " - 
6 " " NaCl " " 16 
7 " " CsCl " " 30 
8 " " MgCl2 " " - 
9 " " CaCl2 " " trace 
10 " " nBu4NCl " " trace 
11 " " KCl quin " 99 
12 " Me4phen " " " 99 
13 " " nBu4NCl " " trace 
14 " " KCl " 170 50 
15 Ag2CO3 - " " 190 - 
Reaction conditions: 3-nitro-benzoic acid (0.5 mmol), Cu2O (5 mol %), ligand (10 mol %), additive (0.5 mmol), 
3 mL of solvent, 190 °C, 16 h. quin = quinoline; NMP = N-methyl-2-pyrrolidone. Yields determined by GC 
analysis using n-tetradecane as the internal standard. 
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7.2.2.2. Cross-coupling experiments 
Table 5: Evaluation of the bimetallic catalyst system for the cross-coupling reaction. 
 
# [Cu] N-ligand [Pd] P-ligand solvent Yield/% 
7.2.2.
-3 
7.2.2.-
4 
1 Cu2O Me4Phen PdBr2 JohnPhos quin 15 70 
2 " Phen " " " 4 60 
3 " Ph2Phen " " " 5 72 
4 " (MeO)2Phen " " " - 18 
5 " Me4Phen " " 
quin/NMP 
(1:1) 
16 40 
6 CuBr " " " " 12 42 
7 CuCl " " " " 14 38 
8 CuI " " " " 19 30 
9 " " " tBu4P·HBF4 " 17 28 
10 " " " PCy3 " 8 28 
11 " " " SPhos " 14 34 
12 " " " DavePhos " 17 25 
13 " " " XPhos " 36 23 
14 " " PdI2 " " 37 24 
15 " " Pd(OAc)2 " " 42 40 
16 " " Pd2(dba)3 " " 7 25 
17 " " Pd(allyl)2Cl2 " " 29 32 
18 " " XPhos−Pd−G2 " " 12 27 
19 " " (MeCN)4Pd(OTf)2 " " 58 50 
20[a] " " " " " 67 38 
21[a][b] " " " " " 38 36 
22[a][c] " " " " " 30 33 
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23[a][d] " " " " " - 6 
24[a][e] " " " " " - trace 
25[a] " " - - " - 25 
26[b] - - (MeCN)4Pd(OTf)2 XPhos " - trace 
27[b] - - - - " - - 
Reaction conditions: 7.2.2.-1 (0.6 mmol), 7.2.2.-2 (0.5 mmol), Cu-source (10 mol%), N-ligand (10 mol%), Pd-
source (2 mol%), P-ligand (5 mol%), 3 mL of solvent, 19 °C, 16 h. Yields determined by GC analysis using n-
tetradecane as the internal standard. NMP = N−methyl−2−pyrrolidone; quin = quinoline. [a] 5 mL of solvent. 
[b] 180 °C. [c] 170 °C. [d] 150 °C. [e] 100 °C. 
 
7.2.3. Synthesis of the biaryls via decarboxylative cross-coupling 
 
Standard procedure: An oven-dried, nitrogen-flushed 20 mL crimp cap vessel was 
charged with the potassium carboxylate (0.60 mmol, 1.2 equiv.), (MeCN)4Pd(OTf)2 (5.7 mg, 
0.01 mmol, 2.0 mol%), XPhos (12.3 mg, 0.025 mmol, 5.0 mol%), copper(I) iodide (9.7 mg, 
0.05 mmol, 10.0 mol %), 3,4,7,8−tetramethyl−1,10−phenanthroline (11.9 mg, 0.05 mmol, 
10.0 mol%), and aryl chloride (0.5 mmol). A degassed mixture of NMP (2.5 mL) and 
quinoline (2.5 mL) was added via syringe. The resulting solution was then stirred at 190 °C 
for 16 h. After the reaction was complete, the mixture was cooled to room temperature, 
diluted with 1 N HCl and extracted with ethyl acetate (3 x 50 mL). The combined organic 
layers were washed with water and brine, dried over MgSO4, filtered, and concentrated in 
vacuo. The residue was purified by column chromatography (SiO2, ethyl acetate/cyclohexane 
gradient) yielding the corresponding biaryl. 
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7.2.3.1. Synthesis of 4’−methyl−2−nitrobiphenyl 
 
[CAS: 70680-21-6] 
The title compound was prepared following general method from potassium 
2−nitrobenzoate (154 mg, 0.75 mmol) and 4−chlorotoluene (64 mg, 60 µL, 0.5 mmol) in a 
mixture of NMP (2.5 mL) and quinoline (2.5 mL). After the reaction, compound was obtained 
by column chromatography as a yellow liquid (85 mg, 80%). 
1H
 
NMR (400 MHz, CDCl3): δ = 7.84 (dd, J = 8.0, 1.1 Hz, 1H), 7.61 (td, J = 7.5, 1.2 Hz, 
1H), 7.49−7.44 (m, 2H), 7.27−7.22 (m, 4H), 7.00 (d, J = 8.5 Hz, 1H), 2.41 ppm (s, 3H); 
13C
 
NMR (101 MHz, CDCl3): δ = 149.38 (s), 138.15 (s), 136.26 (s), 134.36 (s), 132.16 (s), 
131.90 (s), 129.43 (s, 2C), 127.88 (s), 127.72 (s, 2C), 124.00 (s), 21.22 ppm (s); IR (ATR): ṽ 
= 3027, 2922, 1614, 1522, 1475, 1353, 748 cm-1; MS (EI, 70 eV) m/z (%): 213 (75) [M+], 196 
(60), 185 (100), 168 (86), 152 (50), 115 (44); HRMS (EI-TOF) calcd for C13H11NO2: 
213.0790; found: 213.0787. 
7.2.3.2. Synthesis of 4’−methyl−3−nitrobiphenyl 
 
[CAS: 53812-68-3] 
The title compound was prepared following general method from potassium 
3−nitrobenzoate (124 mg, 0.6 mmol) and 4−chlorotoluene (64 mg, 60 µL, 0.5 mmol) in a 
mixture of NMP (2.5 mL) and quinoline (2.5 mL). After the reaction, the title compound was 
obtained by column chromatography as a yellow solid (65 mg, 61%). 
1H NMR (400 MHz, CDCl3): δ = 8.45 (t, J = 1.7 Hz, 1H), 8.18 (dd, J = 8.2, 2.0 Hz, 1H), 7.91 
(d, J = 7.8 Hz, 1H), 7.60 (t, J = 8.0 Hz, 1H), 7.54 (d, J = 8.2 Hz, 2H), 7.32 (d, J = 8.0 Hz, 2H), 
2.44 ppm (s, 3H); 13C NMR (101 MHz, CDCl3): δ = 148.69 (s), 142.75 (s), 138.53 (s), 135.72 
(s), 132.77 (s), 129.84 (s, 2C), 129.60 (s), 126.93 (s, 2C), 121.67 (d, J = 3.6 Hz, 2C), 
21.13 ppm (s); IR (ATR): ṽ = 3029, 2922, 1528, 1511, 1345, 1294, 804, 738 cm-1; MS (EI, 
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70 eV) m/z (%): 213 (100) [M+], 167 (16), 152 (19), 139 (3), 115 (4); HRMS (EI-TOF) calcd 
for C13H11NO2: 213.0790; found: 213.0786; m.p.: 76−77 °C. 
7.2.3.3. Synthesis of 4−methyl−4’−nitrobiphenyl 
 
[CAS: 2143-88-6] 
The title compound was prepared following general method from potassium 
4−nitrobenzoate (135 mg, 0.6 mmol) and 4−chlorotoluene (64 mg, 60 µL, 0.5 mmol) in a 
mixture of NMP (2.5 mL) and quinoline (2.5 mL). After the reaction, the title compound was 
obtained by column chromatography as a yellow solid (55 mg, 51%). 
1H NMR (400 MHz, CDCl3): δ = 8.29 (dt, J = 12.0, 4.0 Hz, 2H), 7.73 (dt, J = 8.0, 4.0 Hz, 
2H), 7.54 (dt, J = 8.0, 4.0 Hz, 2H), 7.32 (d, J = 8.0 Hz, 2H), 2.44 ppm (s, 3H); 13C NMR 
(101 MHz, CDCl3): δ = 147.56 (s), 139.07 (s), 135.83 (s), 129.87 (s, 2C), 127.47 (s, 2C), 
127.21 (s, 2C), 124.09 (s, 2C), 121.34 (s), 21.21 ppm (s); IR (ATR): ṽ = 3080, 2921, 1594, 
1509, 1484, 1337, 1325, 821 cm-1; MS (EI, 70 eV) m/z (%): 213 (100) [M+], 183 (38), 165 
(12), 155 (16), 115 (5); HRMS (EI-TOF) calcd for C13H11NO2: 213.0790; found: 213.0787; 
m.p.: 139−140 °C. 
7.2.3.4. Synthesis of 4'−methylbiphenyl−2−carbonitrile 
 
[CAS: 2143-88-6] 
The title compound was prepared following general method from potassium 
2−cyanobenzoate (139 mg, 0.75 mmol) and 4-chlorotoluene (64 mg, 60 µL, 0.5 mmol) in a 
mixture of NMP (2.5 mL) and quinoline (2.5 mL). After the reaction, the title compound was 
obtained by column chromatography as a yellow solid (74 mg, 76%). 
1H NMR (400 MHz, CDCl3): δ = 7.76 (dd, J = 7.8, 1.0 Hz, 1H), 7.64 (td, J = 7.6, 1.3 Hz, 
1H), 7.52 (dd, J = 7.8, 0.7 Hz, 1H), 7.48-7.46 (m, 2H), 7.43 (td, J = 7.6, 1.2 Hz, 1H), 7.31 (d, 
J = 8.0 Hz, 2H), 2.43 ppm (s, 3H); 13C NMR (101 MHz, CDCl3): δ = 145.57 (s), 138.67 (s), 
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135.30 (s), 133.67 (s), 132.67 (s), 129.95 (s), 129.41 (s, 2C), 128.59 (s, 2C), 127.22 (s), 
118.77 (s), 111.28 (s), 21.18 ppm (s); IR (ATR): ṽ = 3059, 3022, 2916, 2225, 1595, 1517, 
1478, 1441, 1184, 761 cm-1; MS (EI, 70 eV) m/z (%): 193 (100) [M+], 165 (31), 113 (3), 91 
(4); HRMS (EI-TOF) calcd for C14H11N: 193.0891; found: 193.0888; m.p.: 81−82 °C. 
7.2.3.5. Synthesis of 4'−methylbiphenyl−3−carbonitrile 
 
[CAS: 133909-96-3] 
The title compound was prepared following general method from potassium 
3−cyanobenzoate (111 mg, 0.6 mmol) and 4−chlorotoluene (64 mg, 60 µL, 0.5 mmol) in a 
mixture of NMP (2.5 mL) and quinoline (2.5 mL). After the reaction, the title compound was 
obtained by column chromatography as a white solid (68 mg, 70%). 
1H NMR (400 MHz, CDCl3): δ = 7.86 (t, J = 1.8 Hz, 1H), 7.81 (dt, J = 7.9, 1.4 Hz, 1H), 7.62 
(dt, J = 7.6, 1.2 Hz, 1H), 7.54 (t, J = 8.0 Hz, 1H), 7.47 (d, J = 8.0 Hz, 2H), 7.30 (d, J = 8.0 Hz, 
2H), 2.42 ppm (s, 3H); 13C NMR (101 MHz, CDCl3): δ = 142.34 (s), 138.38 (s), 135.96 (s), 
131.26 (s, 2C), 130.47 (s), 130.38 (s), 129.82 (s), 129.52 (s), 126.88 (s, 2C), 118.94 (s), 
112.86 (s), 21.14 ppm (s); IR (ATR): ṽ = 3033, 2919, 2228, 1515, 1474, 1386, 1263, 794 cm-
1; MS (EI, 70 eV) m/z (%): 193 (100) [M+], 178 (10), 165 (17), 140 (4), 91 (7), 75 (5); HRMS 
(EI-TOF) calcd for C14H11N: 193.0891; found: 193.0889; m.p.: 63−64 °C. 
7.2.3.6. Synthesis of 4'−methylbiphenyl−4−carbonitrile 
 
[CAS: 50670-50-3] 
The title compound was prepared following general method from potassium 
4−cyanobenzoate (111 mg, 0.6 mmol) and 4−chlorotoluene (64 mg, 60 µL, 0.5 mmol) in a 
mixture of NMP (2.5 mL) and quinoline (2.5 mL). After the reaction, the title compound was 
obtained by column chromatography as a white solid (53 mg, 54%). 
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1H NMR (400 MHz, CDCl3): δ = 7.70 (q, J = 8.0 Hz, 4H), 7.50 (d, J = 8.0 Hz, 2H), 7.30 (d, J 
= 8.0 Hz, 2H), 5.62−5.60 (m, 1H), 2.43 ppm (s, 3H); 13C NMR (101 MHz, CDCl3): δ = 
145.57 (s), 138.73 (s), 136.23 (s), 132.54 (s, 2C), 129.81 (s, 2C), 127.44 (s, 2C), 127.03 (s, 
2C), 119.03 (s), 110.49 (s), 21.47 ppm (s); IR (ATR): ṽ = 3026, 2918, 2224, 1644, 1603, 
1494, 1396, 808 cm-1; MS (EI, 70 eV) m/z (%): 193 (100) [M+], 178 (8), 165 (19), 91 (6), 75 
(5), 63 (8); HRMS (EI-TOF) calcd for C14H11N: 193.0891; found: 193.0885; m.p.: 
101−102 °C. 
7.2.3.7. Synthesis of 4−methyl−2'−(trifluoromethyl)biphenyl 
 
[CAS: 145486-55-1] 
The title compound was prepared following general method from potassium 
2−trifluoromethylbenzoate (171 mg, 0.75 mmol) and 4−chlorotoluene (64 mg, 60 µL, 
0.5 mmol) in a mixture of NMP (2.5 mL) and quinoline (2.5 mL). After the reaction, the title 
compound was obtained by column chromatography as a colorless liquid (59 mg, 50%). 
1H NMR (200 MHz, CDCl3): δ = 7.76 (d, J = 7.6 Hz, 4H), 7.60-7.42 (m, 2H), 7.34 (dd, J = 
7.5, 0.6 Hz, 1H), 7.24 (s, 4H), 2.43 ppm (s, 3H); 13C NMR (50 MHz, CDCl3): δ = 141.46 (q, 
J = 1.8 Hz, 1C), 137.30 (s), 136.96 (s), 132.14 (s, 2C), 131.23 (s), 128.80 (d, J = 1.5 Hz, 1C), 
128.44 (s, 2C), 127.11 (s), 126.89 (d, J = 2.6 Hz, 1C), 126.01 (q, J = 5.2 Hz, 1C), 120.06 (d, J 
= 142.6 Hz, 1C), 21.20 ppm (s); 19F NMR (376 MHz, CDCl3): δ = −56.83 ppm (s); IR 
(ATR): ṽ = 3030, 2924, 1488, 1448, 1313, 1167, 1125, 1109, 1070, 1035, 767 cm-1; MS (EI, 
70 eV) m/z (%): 236 (100) [M+], 215 (8), 196 (7), 167 (14), 91 (4); HRMS (EI-TOF) calcd 
for C14H11F3: 236.0813; found: 236.0818. 
7.2.3.8. Synthesis of 4−methyl−3'−(trifluoromethyl)biphenyl 
 
[CAS: 97067-19-1] 
The title compound was prepared following general method from potassium 
3−trifluoromethylbenzoate (137 mg, 0.6 mmol) and 4−chlorotoluene (64 mg, 60 µL, 
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0.5 mmol) in a mixture of NMP (2.5 mL) and quinoline (2.5 mL). After the reaction, the title 
compound was obtained by column chromatography as a white solid (58 mg, 50%). 
1H NMR (200 MHz, CDCl3): δ = 7.83 (s, 1H), 7.79−7.74 (m, 1H), 7.61−9.49 (m, 4H), 7.29 
(d, J = 8.2 Hz, 2H), 2.42 ppm (s, 3H); 13C NMR (50 MHz, CDCl3): δ = 141.92 (s), 137.94 (s), 
136.87 (s), 131.10 (d, J = 32.1 Hz, 1C), 130.20 (s), 129.70 (s, 2C), 129.16 (s, 2C), 127.00 (s, 
2C), 123.87 (d, J = 232.7 Hz, 1C), 123.70 (q, J = 4.1 Hz, 1C), 21.11 ppm (s); 19F NMR 
(376 MHz, CDCl3): δ = −62.57 ppm (s); IR (ATR): ṽ = 3029, 2925, 1333, 1261, 1163, 1124. 
1074, 796 cm-1; MS (EI, 70 eV) m/z (%): 236 (100) [M+], 167 (27), 152 (3), 91 (4), 69 
(7); HRMS (EI-TOF) calcd for C14H11F3: 236.0813; found: 236.0816; m.p.: 35−36 °C. 
7.2.3.9. Synthesis of 4−methyl−4'−(trifluoromethyl)biphenyl 
 
[CAS: 97067-18-0] 
The title compound was prepared following general method from potassium 
4−trifluoromethylbenzoate (137 mg, 0.6 mmol) and 4−chlorotoluene (64 mg, 60 µL, 
0.5 mmol) in a mixture of NMP (2.5 mL) and quinoline (2.5 mL). After the reaction, the title 
compound was obtained by column chromatography as a white solid (90 mg, 76%). 
1H NMR (400 MHz, CDCl3): δ = 7.69 (s, 4H), 7.51 (d, J = 8.0 Hz, 2H), 7.29 (d, J = 8.0 Hz, 
2H), 2.42 ppm (s, 3H); 13C NMR (101 MHz, CDCl3): δ = 144.63 (s), 138.14 (s), 136.85 (s), 
129.69 (s, 2C), 129.02 (q, J = 32.7 Hz, 1C), 127.15 (s, 2C), 127.08 (s, 2C), 125.64 (q, J = 3.6, 
2C), 124.34 (s), 21.13 ppm (s); 19F NMR (376 MHz, CDCl3): δ = −62.33 ppm (s); IR (ATR): 
ṽ = 2960, 2925, 1606, 1323, 1166, 1120, 1111, 1071, 809 cm-1; MS (EI, 70 eV) m/z (%): 236 
(100) [M+], 217 (4), 167 (39), 91 (4), 69 (5); HRMS (EI-TOF) calcd for C14H11F3: 236.0813; 
found: 236.0809; m.p.: 130−131 °C. 
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7.2.3.10. Synthesis of 4'−methyl−2−(trifluoromethoxy)biphenyl 
 
[CAS: 1809242-81-6] 
The title compound was prepared following general method from potassium 
2−trifluoromethoxybenzoate (147 mg, 0.6 mmol) and 4−chlorotoluene (64 mg, 60 µL, 
0.5 mmol) in a mixture of NMP (2.5 mL) and quinoline (2.5 mL). After the reaction, the title 
compound was obtained by column chromatography as a colorless liquid (101 mg, 80%). 
1H NMR (200 MHz, CDCl3): δ = 7.66 (dd, J = 7.9, 0.9 Hz, 1H), 7.60−7.42 (m, 2H), 7.34(d, J 
= 7.8 Hz, 1H), 7.24 (s, 4H), 2.43 ppm (s, 3H); 13C NMR (50 MHz, CDCl3): δ = 148.26 (d, J = 
1.8 Hz, 1C), 137.43 (s), 135.28 (s), 133.91 (s), 131.51 (s), 129.07 (s, 2C), 128.99 (s, 2C), 
128.33 (s), 126.97 (s), 123.02 (s), 121.24 (d, J = 1.5 Hz, 1C), 21.19 ppm (s); 19F NMR 
(376 MHz, CDCl3): δ = −57.03 ppm (s); IR (ATR): ṽ = 3030, 2925, 2861, 1485, 1248, 1218, 
1198, 1164, 817 cm-1; MS (EI, 70 eV) m/z (%): 252 (100) [M+], 183 (4), 167 (14), 69 
(9); HRMS (EI-TOF) calcd for C14H11F3O: 252.0762; found: 252.0746. 
7.2.3.11. Synthesis of 4'−methyl−3−(trifluoromethoxy)biphenyl 
 
[CAS: 1809242-82-7] 
The title compound was prepared following general method from potassium 
3−trifluoromethoxybenzoate (147 mg, 0.6 mmol) and 4−chlorotoluene (64 mg, 60 µL, 
0.5 mmol) in a mixture of NMP (2.5 mL) and quinoline (2.5 mL). After the reaction, the title 
compound was obtained by column chromatography as a white solid (77 mg, 61%). 
1H NMR (400 MHz, CDCl3): δ = 7.53-7.43 (m, 5H), 7.28 (d, J = 8.0 Hz, 2H), 7.19 (dt, J = 
8.1, 1.0 Hz, 1H), 2.42 ppm (s, 3H); 13C NMR (101 MHz, CDCl3): δ = 149.67 (s), 143.26 (s), 
137.90 (s), 136.77 (s), 129.98 (s), 129.65 (s, 2C), 126.95 (s, 2C), 125.25 (s), 121.80 (s), 
119.50 (s), 119.22 (s), 21.11 ppm (s); 19F NMR (376 MHz, CDCl3): δ = −57.66 ppm (s); IR 
(ATR): ṽ = 2925, 2867, 1606, 1588, 1474, 1262, 1203, 1150, 787 cm-1; MS (EI, 70 eV) m/z 
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(%): 252 (100) [M+], 167 (3), 152 (2), 69 (3); HRMS (EI-TOF) calcd for C14H11F3O: 
252.0762; found: 252.0756; m.p.: 39−40 °C. 
7.2.3.12. Synthesis of 4−methyl−4’−(trifluoromethoxy)biphenyl 
 
[CAS: 1546954-83-9] 
The title compound was prepared following general method from potassium 
4−trifluoromethoxylbenzoate (147 mg, 0.6 mmol) and 4−chlorotoluene (64 mg, 60 µL, 
0.5 mmol) in a mixture of NMP (2.5 mL) and quinoline (2.5 mL). After the reaction, the title 
compound was obtained by column chromatography as a white solid (63 mg, 50%). 
1H NMR (400 MHz, CDCl3): δ = 7.61−7.57(m, 2H), 7.47 (d, J = 8.0Hz, 2H), 7.29−7.26 (m, 
4H), 2.42 ppm (s, 3H); 13C NMR (101 MHz, CDCl3) δ = 148.42 (d, J = 1.5 Hz, 1C), 139.90 
(s), 137.51 (s), 136.95 (s), 129.59 (s, 2C), 128.21 (s, 2C), 126.92 (s, 2C), 121.19 (s, 2C), 
120.52 (d, J = 127.5 Hz, 1C), 21.08 ppm (s); 19F NMR (376 MHz, CDCl3): δ = −57.81 ppm 
(s); IR (ATR): ṽ = 3033, 2925, 1738, 1609, 1493, 1207, 1152, 806 cm-1; MS (EI, 70 eV) m/z 
(%): 252 (100) [M+], 183 (11), 167 (19), 155 (9), 115 (3), 69 (4); HRMS (EI-TOF) calcd for 
C14H11F3O: 252.0762; found: 252.0762; m.p.: 98−99 °C. 
7.2.3.13. Synthesis of 4−methyl−3’−(methylsulfonyl)biphenyl 
 
[CAS: 1809242-83-8] 
The title compound was prepared following general method from potassium 
3−methylsulfonylbenzoate (143 mg, 0.6 mmol) and 4−chlorotoluene (64 mg, 60 µL, 
0.5 mmol) in a mixture of NMP (2.5 mL) and quinoline (2.5 mL). After the reaction, the title 
compound was obtained by column chromatography as a white solid (74 mg, 60%). 
1H NMR (400 MHz, CDCl3): δ = 8.16 (t, J = 1.8 Hz, 1H), 7.90 (dt, J = 7.7, 1.4 Hz, 1H), 7.87 
(dt, J = 7.8, 1.3 Hz, 1H), 7.64 (t, J = 8.0 Hz, 1H), 7.55−7.52 (m, 2H), 7.30 (d, J = 8.0 Hz, 2H), 
3.11 (s, 3H), 2.43 ppm (s, 3H); 13C NMR (101 MHz, CDCl3): δ = 142.66 (s), 141.08 (s), 
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138.39 (s), 136.07 (s), 131.99 (s), 129.81 (s, 2C), 129.78 (s), 126.99 (s, 2C), 125.59 (s, 2C), 
44.55 (s), 21.14 ppm (s); IR (ATR): ṽ = 3008, 2926, 1469. 1321, 1297, 1146, 958, 775 cm-1; 
MS (EI, 70 eV) m/z (%): 246 (100) [M+], 167 (27), 152 (12), 44 (9); HRMS (EI-TOF) calcd 
for C14H14O2S: 246.0715; found: 246.0714; m.p.: 118−119 °C. 
7.2.3.14. Synthesis of 4−methyl−4’−(methylsulfonyl)biphenyl 
Me
MeO2S
 
[CAS: 893738-58-4] 
The title compound was prepared following general method from potassium 
4−methylsulfonylbenzoate (143 mg, 0.6 mmol) and 4−chlorotoluene (64 mg, 60 µL, 
0.5 mmol) in a mixture of NMP (2.5 mL) and quinoline (2.5 mL). After the reaction, the title 
compound was obtained by column chromatography as a white solid (108 mg, 88%). 
1H NMR (400 MHz, CDCl3): δ = 8.00 (m, 2H), 7.76 (m, 2H), 7.74−7.72 (m, 2H), 7.31 (d, J = 
7.8 Hz,2H), 3.10 (s, 3H), 2.43 ppm (s, 3H); 13C NMR (101 MHz, CDCl3): δ = 146.63 (s), 
138.77 (s), 138.71 (s), 136.18 (s), 129.81 (s, 2C), 127.87 (s, 2C), 127.69 (s, 2C), 127.20 (s, 
2C), 44.63 (s), 21.17 ppm (s); IR (ATR): ṽ = 3010, 2927, 1317, 1297, 1148, 1093, 954, 
807 cm-1; MS (EI, 70 eV) m/z (%): 246 (100) [M+], 230 (30), 183 (36), 167 (22), 152 (12), 63 
(8); HRMS (EI-TOF) calcd for C14H14O2S: 246.0715; found: 246.0714; m.p.: 197−198 °C. 
7.2.3.15. Synthesis of 4’−methyl−3−phenoxybiphenyl 
 
[CAS: 1809242-84-9] 
The title compound was prepared following general method from potassium 
3−phenoxybenzoate (151mg, 0.6 mmol) and 4−chlorotoluene (64 mg, 60 µL, 0.5 mmol) in a 
mixture of NMP (2.5 mL) and quinoline (2.5 mL). After the reaction, the title compound was 
obtained by column chromatography as a colorless liquid (65 mg, 50%). 
1H NMR (400 MHz, CDCl3): δ = 7.47 (d, J = 8.0 Hz, 2H), 7.41−7.32 (m, 4H), 7.26−7.23(m, 
3H), 7.12 (t, J = 8.0 Hz, 1H), 7.08−7.06 (m, 2H), 6.98 (ddd, J = 16.0, 8.0, 1.1 Hz, 1H), 
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2.40 ppm (s, 3H); 13C NMR (101 MHz, CDCl3) δ = 157.60 (s), 157.22 (s), 143.02 (s), 137.60 
(s), 137.41 (s), 129.96 (s), 129.76 (s, 2C), 129.49 (s, 2C), 126.93 (s, 2C), 123.24 (s), 121.86 
(s), 118.89 (s, 2C), 117.43 (s), 117.34 (s), 21.09 ppm (s); IR (ATR): ṽ = 3027, 2920, 1582, 
1567, 1488, 1478, 1219, 903 cm-1; MS (EI, 70 eV) m/z (%): 260 (100) [M+], 232 (8), 217 (7), 
165 (5), 152 (7), 77 (7); HRMS (EI-TOF) calcd for C19H16O: 260.1201; found: 260.1199. 
7.2.3.16. Synthesis of 2−methoxy−4'−methylbiphenyl  
 
[CAS: 92495-53-9] 
The title compound was prepared following general method from potassium 
2−methoxybenzoate (143 mg, 0.75 mmol) and 4−chlorotoluene  (64 mg, 60 µL, 0.5 mmol) in 
a mixture of NMP (2.5 mL) and quinoline (2.5 mL). After the reaction, the title compound 
was obtained by column chromatography as a yellow solid (79 mg, 79%). 
1H NMR (400 MHz, CDCl3): δ = 7.45 (d, J = 8.0 Hz, 2H), 7.34−7.30 (m, 2H), 7.24 (d, J = 
7.9 Hz, 2H), 7.04 (td, J = 7.5, 1.2 Hz, 1H), 7.00 (d, J = 8.5 Hz, 1H), 3.82 (s, 3H), 2.41 ppm (s, 
3H); 13C NMR (101 MHz, CDCl3): δ = 156.47 (s), 136.58 (s), 135.55 (s), 130.77 (s), 130.66 
(s), 129.37 (s, 2C), 128.72 (s, 2C), 128.34 (s), 120.76 (s), 111.11 (s), 55.50 (s), 21.19 ppm (s); 
IR (ATR): ṽ = 3014, 2964, 2920, 1907, 1596, 1484, 1455, 1228, 1020, 757 cm-1; MS (EI, 
70 eV) m/z (%): 198 (100) [M+], 183 (15), 155 (24); HRMS (EI-TOF) calcd for C14H14O: 
198.1045; found: 198.1044.; m.p.: 81−82 °C. 
7.2.3.17. Synthesis of N,N−diethyl−4'−methylbiphenyl−2−carboxamide 
 
[CAS: 937166-55-7] 
The title compound was prepared following general method from potassium 
2−(diethylcarbamoyl)benzoate (195 mg, 0.75 mmol) and 4−chlorotoluene (64 mg, 60 µL, 
0.5 mmol) in a mixture of NMP (2.5 mL) and quinoline (2.5 mL). After the reaction, the title 
compound was obtained by column chromatography as a yellow liquid (114 mg, 85%). 
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1H NMR (400 MHz, CDCl3): δ = 7.44−7.42 (m, 1H), 7.39-7.36 (m, 5H), 7.19 (d, J = 7.9 Hz, 
2H), 3.78−3.72 (m, 1H), 3.07−3.01 (m, 1H), 3.00−2.94 (m, 1H), 2.70−2.64 (m, 1H), 2.38 (s, 
3H), 0.93 (t, J = 7.1 Hz, 3H), 0.75 ppm (t, J = 7.1 Hz, 3H); 13C NMR (101 MHz, CDCl3): δ = 
170.66 (s), 138.31 (s), 137.26 (s), 136.89 (s), 136.26 (s), 129.36 (s), 128.96 (s), 128.86 (s), 
128.67 (s), 127.26 (s), 126.96 (s), 42.22 (s), 38.31 (s), 21.14 (s), 13.38 (s), 11.99 ppm (s); IR 
(ATR): ṽ = 2920, 2932, 2871, 1623, 1456, 1425, 1288, 1220, 1089, 757 cm-1; MS (EI, 70 eV) 
m/z (%): 266 (100) [M+], 195 (89), 165 (25), 152 (21), 72 (10); HRMS (EI-TOF) calcd for 
C18H21NO: 267.1623; found: 267.1614. 
7.2.3.18. Synthesis of 3−fluoro−4'−methylbiphenyl 
 
[CAS: 72093-42-6] 
The title compound was prepared following general method from potassium 
3−fluorobenzoate (109 mg, 0.6 mmol) and 4−chlorotoluene (64 mg, 60 µL, 0.5 mmol) in a 
mixture of NMP (2.5 mL) and quinoline (2.5 mL). After the reaction, the title compound was 
obtained by column chromatography as a white solid (45 mg, 48%). 
1H NMR (400 MHz, CDCl3): δ = 7.49 (d, J = 8.0 Hz, 2H), 7.42−7.35 (m, 2H), 7.30−7.26 (m, 
3H), 7.07−6.99 (m, 1H), 2.42 ppm (s, 3H); 13C NMR (101 MHz, CDCl3) δ = 164.20 (d, J = 
245.7 Hz, 1C), 143.44 (d, J = 8.1 Hz, 1C), 137.71 (s), 137.07 (d, J = 1.5 Hz, 1C), 130.12 (d, J 
= 8.8 Hz, 1C), 129.58 (s, 2C), 126.92 (s, 2C), 122.53 (d, J = 2.9 Hz, 1C), 113.84 (d, J = 
6.0 Hz, 1C), 113.66 (d, J = 6.0 Hz, 1C), 21.11 ppm (s); 19F NMR (376 MHz, CDCl3): δ = 
−113.27 ppm (s); IR (ATR): ṽ = 3032, 2919, 1611, 1588, 1567, 1485, 1473, 1183, 1160, 
875 cm-1; MS (EI, 70 eV) m/z (%): 186 (100) [M+], 171 (9), 165 (31), 133 (6), 91 (8), 74 
(6); HRMS (EI-TOF) calcd for C13H11F: 186.0845; found: 186.0842; m.p.: 40−41 °C. 
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7.2.3.19. Synthesis of 4'−methyl−N,N−dipropylbiphenyl−4−sulfonamide 
 
[CAS: 1809242-85-0] 
The title compound was prepared following general method from potassium 
4−(N,N−dipropylsulfamoyl)benzoate (194 mg, 0.6 mmol) and 4−chlorotoluene (64 mg, 
60 µL, 0.5 mmol) in a mixture of NMP (2.5 mL) and quinoline (2.5 mL). After the reaction, 
the title compound was obtained by column chromatography as a white solid (147 mg, 88%). 
1H NMR (400 MHz, CDCl3): δ = 7.86 (d, J = 8.0 Hz, 2H), 7.69 (d, J = 8.0 Hz, 2H), 7.52 (d, J 
= 8.0 Hz, 2H), 7.29 (d, J = 8.0 Hz, 2H), 3.13−3.10 (m, 4H), 2.43 (s, 3H), 1.64−1.54 (m, 4H), 
0.90 ppm (t, J = 8.0 Hz, 6H). 13C NMR (101 MHz, CDCl3): δ = 144.98 (s), 138.38 (s), 138.35 
(s), 136.46 (s), 129.73 (s, 2C), 127.53 (s, 2C), 127.27 (s, 2C), 127.09 (s, 2C), 50.11 (s, 2C), 
22.10 (s, 2C), 21.16 (s), 11.21 ppm (s, 2C); IR (ATR): ṽ = 2965, 2873, 1468, 1332, 1324, 
1151, 1092, 992, 807 cm-1; MS (EI, 70 eV) m/z (%): 331 (100) [M+], 302 (100), 231 (74), 183 
(8), 167 (14), 152 (5); HRMS (EI-TOF) calcd for C19H25NO2S: 331.1606; found: 331.1610; 
m.p.: 116−117 °C 
7.2.3.20. Synthesis of 2−p−tolylnaphthalene 
 
[CAS: 59115-49-0] 
The title compound was prepared following general method from potassium 2−naphthoate 
(126 mg, 0.6 mmol) and 4−chlorotoluene   (64 mg, 60 µL, 0.5 mmol) in a mixture of NMP 
(2.5 mL) and quinoline (2.5 mL). The yield (17%) was determined by GC analysis using n-
tetradecane as the internal standard. 
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7.2.3.21. Synthesis of 2'−methylbiphenyl−4−carbonitrile  
CN
Me
 
[CAS: 189828-30-6] 
The title compound was prepared following general method from potassium 
2−methylbenzoate  (131 mg, 0.75 mmol) and 4−chlorbenzonitrile (70 mg, 0.5 mmol) in a 
mixture of NMP (2.5 mL) and quinoline (2.5 mL). After the reaction, the title compound was 
obtained by column chromatography as a yellow solid (18 mg, 18%). 
1H NMR (400 MHz, CDCl3): δ = 7.74−7.71 (m, 2H), 7.46−7.43 (m, 2H), 7.33−7.26 (m, 3H), 
7.20 (d, J = 7.3 Hz, 1H), 2.26 ppm (s, 3H); 13C NMR (101 MHz, CDCl3): δ = 146.77 (s), 
139.97 (s), 135.02 (s), 131.95 (s, 2C), 130.64 (s), 129.98 (s, 2C), 129.40 (s), 128.27 (s), 
126.08 (s), 118.95 (s), 110.69 (s), 20.30 ppm (s); IR (ATR): ṽ = 3062, 2924, 2853, 2227, 
1608, 1482, 842, 759 cm-1; MS (EI, 70 eV) m/z (%): 193 (100) [M+], 178 (11), 165 (22), 74 
(6), 50 (10); HRMS (EI-TOF) calcd for C14H11N: 193.0891; found: 193.0890; m.p.: 
64−65 °C. 
7.2.3.22. Synthesis of 2'−phenylbiphenyl −4−carbonitrile 
CN
Ph
 
[CAS: 1071036-11-7] 
The title compound was prepared following general method from potassium 
biphenyl−2−carboxylate (177 mg, 0.75 mmol) and 4−chlorbenzonitrile (70 mg, 0.5 mmol) in 
a mixture of NMP (2.5 mL) and quinoline (2.5 mL). After the reaction, the title compound 
was obtained by column chromatography as a yellow solid (41 mg, 32%). 
1H NMR (400 MHz, CDCl3): δ = 7.52−7.40 (m, 6H), 7.26−7.24 (m, 5H), 7.12−7.08 ppm (m, 
2H). 13C NMR (101 MHz, CDCl3): δ = 146.45 (s), 140,65 (s), 140.60 (s), 138.60 (s), 131.69 
(s, 2C), 130.85 (s), 130.53 (s, 2C), 130.23 (s), 129.79 (s, 2C), 128.56 (s), 128.16 (s, 2C), 
127.75 (s), 126.95 (s), 118.95 (s), 110.22 ppm (s); IR (ATR): ṽ = 3063, 2923, 2225, 1927, 
1604, 1473, 1447, 830, 744 cm-1; MS (EI, 70 eV) m/z (%): 255 (100) [M+], 240 (11), 227 (5), 
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215 (4), 113 (7), 50 (8); HRMS (EI-TOF) calcd for C19H13N: 255.1048; found: 255.1047; 
m.p.: 118−119 °C. 
7.2.3.23. Synthesis of 3−nitrobiphenyl 
 
[CAS: 2113-58-8] 
The title compound was prepared following general method from potassium 
3−nitrobenzoate (124 mg, 0.6 mmol) and chlorobenzene (57 mg, 52 µL, 0.5 mmol) in a 
mixture of NMP (2.5 mL) and quinoline (2.5 mL). After the reaction, the title compound was 
obtained by column chromatography as a white solid (63 mg, 63%). 
1H NMR (400 MHz, CDCl3): δ = 8.47 (t, J = 2.0 Hz, 1H), 8.22 (ddd, J = 8.0, 1.6, 1.0 Hz, 
1H), 7.93 (ddd, J = 8.0, 1.6, 1.0 Hz, 1H), 7.66−7.61 (m, 3H), 7.54−7.49 (m, 2H), 
7.47−7.43 ppm (m, 1H); 13C NMR (101 MHz, CDCl3): δ = 148.70 (s), 142.86 (s), 138.66 (s), 
133.03 (s), 129.69 (s), 129.15 (s, 2C), 128.52 (s), 127.15 (s, 2C), 122.02 (s), 121.95 ppm (s); 
IR (ATR): ṽ = 3084, 2923, 1738, 1531, 1522, 1500, 1347, 1293, 730 cm-1; MS (EI, 70 eV) 
m/z (%): 199 (100) [M+], 152 (28), 141 (8), 115 (5), 76 (6); HRMS (EI-TOF) calcd for 
C12H9NO2: 199.0633; found: 199.0630; m.p.: 57−58 °C. 
7.2.3.24. Synthesis of 4'−butyl−3−nitrobiphenyl 
 
[CAS: 1809242-86-1] 
The title compound was prepared following general method from potassium 
3−nitrobenzoate (124 mg, 0.6 mmol) and 1−butyl−4−chlorobenzene (86 mg, 86 µL, 
0.5 mmol) in a mixture of NMP (2.5 mL) and quinoline (2.5 mL). After the reaction, the title 
compound was obtained by column chromatography as a colorless liquid (73 mg, 57%). 
1H NMR (200 MHz, CDCl3): δ = 8.46 (t, J = 1.9 Hz, 1H), 8.18 (ddd, J = 8.2, 2.2, 0.9 Hz, 
1H), 7.92 (dt, J = 7.7, 1.3 Hz, 1H), 7.60 (t, J = 8.0 Hz, 1H), 7.57−7.55 (m, 2H), 7.32 (d, J = 
8.2 Hz, 2H), 2.69 (t, J = 8.0 Hz, 2H), 1.69−1.62 (m, 2H), 1.45−1.36(m, 2H), 0.96 ppm (t, J = 
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7.3 Hz, 3H). 13C NMR (50 MHz, CDCl3): δ = 148.71 (s), 143.58 (s), 142.84 (s), 135.95 (s), 
132.82 (s), 129.61 (s), 129.22 (s, 2C), 126.98 (s, 2C), 121.72 (s), 121.70 (s), 35.28 (s), 33.55 
(s), 22.36 (s), 13.94 ppm (s); IR (ATR): ṽ = 2956, 2928, 2858, 1529, 1515, 1346, 1101, 
801 cm-1; MS (EI, 70 eV) m/z (%): 255 (73) [M+], 212 (100), 165 (10), 152 (3), 89 
(2); HRMS (EI-TOF) calcd for C16H17NO2: 255.1259; found: 255.1263. 
7.2.3.25. Synthesis of 4'−tert−butyl−3−nitrobiphenyl 
O2N
tBu
 
[CAS: 1809242-87-2] 
The title compound was prepared following general method from potassium 
3−nitrobenzoate (124 mg, 0.6 mmol) and 1−tert−butyl−4−chlorobenzene (86 mg, 86 µL, 
0.5 mmol) in a mixture of NMP (2.5 mL) and quinoline (2.5 mL). After the reaction, the title 
compound was obtained by column chromatography as a colorless liquid (84 mg, 68%). 
1H NMR (400 MHz, CDCl3): δ = 8.46 (t, J = 1.9 Hz, 1H), 8.19 (ddd, J = 8.2, 2.2, 0.9 Hz, 
1H), 7.92 (ddd, J = 8.0, 1.6, 1.0 Hz, 1H), 7.63-7.57 (m, 3H), 7.54−7.52 (m, 2H), 1.39 ppm (s, 
3H). 13C NMR (101 MHz, CDCl3): δ = 151.76 (s), 148.70 (s), 142.69 (s), 135.72 (s), 132.83 
(s), 129.62 (s), 126.79 (s, 2C), 126.12 (s, 2C), 121.74 (s, 2C), 34.65 (s), 31.27 ppm (s, 3C); IR 
(ATR): ṽ = 2962, 2867, 1739, 1528, 1515, 1347, 834 cm-1; MS (EI, 70 eV) m/z (%): 255 (4) 
[M+], 240 (100), 212 (15), 194 (3), 165 (3), 152 (3), 57 (2); HRMS (EI-TOF) calcd for 
C16H17NO2: 255.1259; found: 255.1262. 
7.2.3.26. Synthesis of 3'−nitrobiphenyl−3−carbonitrile 
 
[CAS: 192699-67-5] 
The title compound was prepared following general method from potassium 
3−nitrobenzoate (124 mg, 0.6 mmol) and 3−chlorobenzonitrile (70 mg, 0.5 mmol) in a 
mixture of NMP (2.5 mL) and quinoline (2.5 mL). After the reaction, the title compound was 
obtained by column chromatography as a yellow solid (67 mg, 60%). 
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1H NMR (400 MHz, CDCl3): δ = 8.45 (t, J = 2.0 Hz, 1H), 8.30 (dd, J = 8.2, 1.4 Hz, 1H), 
7.92-9.90 (m, 2H), 7.88 (d, J = 7.9 Hz, 1H), 7.75 (d, J = 7.7 Hz, 1H), 7.70 (t, J = 8.0 Hz, 1H), 
7.65 ppm (t, J = 8.0 Hz, 1H); 13C NMR (101 MHz, CDCl3): δ = 148.78 (s), 140.47 (s), 139.92 
(s), 132.95 (s), 131.91 (s), 131.48 (s), 130.69 (s), 130.21 (s), 130.08 (s), 123.12 (s), 121.98 (s), 
118.28 (s), 113.48 ppm (s); IR (ATR): ṽ = 3067, 2922, 2226, 1520, 1491, 1346, 1266, 
892 cm-1; MS (EI, 70 eV) m/z (%): 224 (100) [M+], 178 (29), 166 (11), 151 (18), 75 
(7); HRMS (EI-TOF) calcd for C13H8N2O2: 224.0586; found: 224.0584; m.p.: 176−177 °C. 
7.2.3.27. Synthesis of 3'−nitrobiphenyl−4−carbonitrile 
O2N
CN
 
[CAS: 39117-72-1] 
The title compound was prepared following general method from potassium 
3−nitrobenzoate (124 mg, 0.6 mmol) and 4−chlorobenzonitrile (69.5 mg, 0.5 mmol) in a 
mixture of NMP (2.5 mL) and quinoline (2.5 mL). After the reaction, the title compound was 
obtained by column chromatography as a yellow solid (77 mg, 67%). 
1H NMR (400 MHz, CDCl3): δ = 8.48 (t, J = 1.9 Hz, 1H), 8.30 (dd, J = 8.2, 1.3 Hz, 1H), 7.94 
(d, J = 7.8 Hz, 1H), 7.83-7.81 (m, 2H), 7.76−7.74 (m, 2H), 7.70 ppm (t, J = 8.0 Hz, 1H); 13C 
NMR (101 MHz, CDCl3): δ = 148.81 (s), 142.98 (s), 140.80 (s), 133.05 (s), 132.95 (s, 2C), 
130.20 (s), 127.88 (s, 2C), 123.33 (s), 122.14 (s), 118.38 (s), 112.38 ppm (s); IR (ATR): ṽ = 
3083, 2924, 2225, 1607, 1519, 1506, 1350, 1293, 804 cm-1; MS (EI, 70 eV) m/z (%): 224 
(100) [M+], 178 (32), 166 (9), 151 (20), 75 (6); HRMS (EI-TOF) calcd for C13H8N2O2: 
224.0586; found: 224.0581; m.p.: 164−165 °C. 
7.2.3.28. Synthesis of 4'−fluoro−3−nitrobiphenyl 
 
[CAS: 10540-32-6] 
The title compound was prepared following general method from potassium 
3−nitrobenzoate (124 mg, 0.6 mmol) and 1−chloro−4−fluorobenzene (67 mg, 54 µL, 
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0.5 mmol) in a mixture of NMP (2.5 mL) and quinoline (2.5 mL). After the reaction, the title 
compound was obtained by column chromatography as a yellow solid (73 mg, 66%). 
1H NMR (400 MHz, CDCl3): δ = 8.42 (t, J = 1.9 Hz, 1H), 8.22 (ddd, J = 8.0, 2.0, 0.9 Hz, 
1H), 7.89−7,87 (m, 1H), 7.64−7.59 (m, 3H), 7.23−7.17 ppm (m, 2H); 13C NMR (101 MHz, 
CDCl3): δ = 164.33 (s), 161.86 (s), 148.70 (s), 141.84 (s), 134.81 (s), 132.86 (s), 129.79 (s), 
128.88 (d, J = 8.2 Hz, 1C), 122.04 (s), 121.80 (s), 116.28 (s), 116.04 ppm (s); 19F NMR 
(376 MHz, CDCl3): δ = −133.42 ppm (s); IR (ATR): ṽ = 3087, 1606, 1528, 1508, 1476, 1346, 
1228, 1165, 831 cm-1; MS (EI, 70 eV) m/z (%): 217 (100) [M+], 170 (29), 159 (15), 151 (3), 
74 (4); HRMS (EI-TOF) calcd for C12H8FNO2: 217.0539; found: 217.0544; m.p.: 66−67 °C. 
7.2.3.29. Synthesis of 2−fluoro−3’−nitrobiphenyl 
 
[CAS: 80254-88-2] 
The title compound was prepared following general method from potassium 3-
nitrobenzoate (124 mg, 0.6 mmol) and 1-chloro-2-fluorobenzene (66 mg, 53 µL, 0.5 mmol) in 
a mixture of NMP (2.5 mL) and quinoline (2.5 mL). After the reaction, the title compound 
was obtained by column chromatography as a yellow solid (56 mg, 52%). 
1H NMR (400 MHz, CDCl3): δ = 8.44 (t, J = 2.5 Hz, 1H), 8.25 (ddd, J = 8.3, 2.3, 1.0 Hz, 
1H), 7.91 (dq, J = 7.7, 1.4 Hz, 1H), 7.64 (t, J = 8.0 Hz, 1H), 7.49 (td, J = 7.7, 1.8 Hz, 1H), 
7.45−7.39 (m, 1H), 7.29 (td, J = 7.5, 1.3 Hz, 1H), 7.22 ppm (ddd, J = 10.7, 8.2, 1.1 Hz, 1H); 
13C NMR (101 MHz, CDCl3) δ = 160.85 (s), 158.38 (s), 148.37 (s), 137.39 (s), 135.04 (d, J = 
3.7 Hz, 1C), 130.48 (d, J = 2.9 Hz, 1C), 130.34 (d, J = 8.1 Hz, 1C), 129.37 (s), 126.60 (d, J = 
13.2 Hz, 1C), 124.31 (dd, J = 89.5. 3.7 Hz, 1C), 122.49 (s), 116.40 ppm (d, J = 22.7 Hz, 1C); 
19F NMR (376 MHz, CDCl3): δ = −117.91 ppm (s); IR (ATR): ṽ = 3091, 2922, 2851, 1961, 
1525, 1496, 1469, 1347, 1204, 741 cm-1; MS (EI, 70 eV) m/z (%): 217 (100) [M+], 170 (41), 
159 (11), 151 (6), 133 (5), 85 (3); HRMS (EI-TOF) calcd for C12H8FNO2: 217.0539; found: 
217.0540; m.p.: 62−63 °C. 
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7.2.3.30. Synthesis of 3−nitro−4'−(trifluoromethyl)biphenyl 
O2N
CF3
 
[CAS: 1138479-19-2] 
The title compound was prepared following general method from potassium 
3−nitrobenzoate (124 mg, 0.6 mmol) and 4−chlorobenzotrifluoride (92 mg, 68 µL, 0.5 mmol) 
in a mixture of NMP (2.5 mL) and quinoline (2.5 mL). After the reaction, the title compound 
was obtained by column chromatography as a yellow solid (80 mg, 60%). 
1H NMR (200 MHz, CDCl3): δ = 8.48 (t, J = 1.9 Hz, 1H), 8.28 (ddd, J = 8.0, 1.6, 0.9 Hz, 
1H), 7.94 (dt, J = 7.7, 1.3 Hz, 1H), 7.79-7.74 (m, 4H), 7.68 ppm (t, J = 8.0 Hz, 1H); 13C 
NMR (50 MHz, CDCl3): δ = 148.78 (s), 142.13 (s), 141.37 (s), 133.14 (s), 130.79 (s), 130.47 
(s), 130.04 (s), 127.56 (s), 126.14 (q, J = 3.6 Hz, 1C), 125.33 (s), 122.93 (s), 122.62 (s), 
122.15 ppm (s); 19F NMR (376 MHz, CDCl3): δ = −62.60 ppm (s); IR (ATR): ṽ = 3081, 
2923, 1618, 1531, 1514, 1346, 1322, 1159, 1110, 1068, 807 cm-1; MS (EI, 70 eV) m/z (%): 
267 (100) [M+], 248 (9), 221 (3), 209 (9), 201 (21), 152 (18), 75 (3); HRMS (EI-TOF) calcd 
for C13H8F3NO2: 267.0507; found: 267.0499; m.p.: 59−60 °C. 
7.2.3.31. Synthesis of (3'−nitrobiphenyl−4−yl)−(phenyl)−methanone 
 
[CAS: 63242-13-7] 
The title compound was prepared following general method from potassium 
3−nitrobenzoate (124 mg, 0.6 mmol) and 4−chlorobenzophenone (109 mg, 0.5 mmol) in a 
mixture of NMP (2.5 mL) and quinoline (2.5 mL). After the reaction, the title compound was 
obtained by column chromatography as a yellow solid (102 mg, 68%). 
1H NMR (400 MHz, CDCl3): δ = 8.53 (t, J = 2.0 Hz, 1H), 8.28 (ddd, J = 8.2, 2.2, 1.0 Hz, 
1H), 7.99 (ddd, J = 8.0, 2.0, 1.0 Hz, 1H), 7.97−7.94 (m, 2H), 7.87-7.84 (m, 2H), 7.78−7.85 
(m, 2H), 7.69 (t, J = 8.0 Hz, 1H), 7.66−7.62 (m, 1H), 7.56-7.51 ppm (m, 2H). 13C NMR 
(101 MHz, CDCl3): δ = 196.02 (s), 148.77 (s), 142.40 (s), 141.65 (s), 137.42 (s), 137.34 (s), 
133.15 (s), 132.66 (s), 130.91 (s, 2C), 130.01 (s, 2C), 129.99 (s), 128.40 (s, 2C), 127.08 (s, 
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2C), 122.84 (s), 122.13 ppm (s); IR (ATR): ṽ = 3088, 3066, 1651, 1603, 1522, 1511, 1347, 
1279, 695 cm-1; MS (EI, 70 eV) m/z (%): 303 (100) [M+], 286 (13), 226 (65), 152 (8), 105 
(31), 77 (30); HRMS (EI-TOF) calcd for C19H13NO3: 303.0895; found: 303.0901; m.p.: 
139−140 °C. 
7.2.3.32. Synthesis of 4'−(methylsulfonyl)−3−nitrobiphenyl 
 
[CAS: 1809242-88-3] 
The title compound was prepared following general method from potassium 
3−nitrobenzoate (124 mg, 0.6 mmol) and 4−chlorophenylmethylsulfone (97 mg, 0.5 mmol) in 
a mixture of NMP (2.5 mL) and quinoline (2.5 mL). After the reaction, the title compound 
was obtained by column chromatography as a yellow solid (69 mg, 50%). 
1H NMR (400 MHz, CDCl3): δ = 8.50 (t, J = 1.9 Hz, 1H), 8.32 (ddd, J = 8.2, 2.1, 0.9 Hz, 
1H), 8.11−8.08 (m, 2H), 7.96 (ddd, J = 7.8, 1.5, 1.1 Hz, 1H), 7.86−7.82 (m, 2H), 7.71 (t, J = 
8.0 Hz, 1H), 3.13 ppm (s, 3H); 13C NMR (101 MHz, CDCl3) δ = 148.83 (s), 144.05 (s), 
140.79 (s), 140.49 (s), 133.24 (s), 130.21 (s), 128.34 (s, 2C), 128.19 (s, 2C), 123.39 (s), 
122.30 (s), 44.57 ppm (s); IR (ATR): ṽ = 3083, 3016, 2930, 1927, 1597, 1525, 1342, 1306, 
1291, 1144, 1087, 967 cm-1; MS (EI, 70 eV) m/z (%): 277 (100) [M+], 262 (43), 214 (72), 198 
(36), 152 (31), 43 (38); HRMS (EI-TOF) calcd for C13H11NO4S: 277.0409; found: 277.0408; 
m.p.: 118−119 °C. 
7.2.3.33. Synthesis of 4'−methoxy−3−nitrobiphenyl 
 
[CAS: 53059-31-7] 
The title compound was prepared following general method from potassium 
3−nitrobenzoate (124 mg, 0.6 mmol) and 4−chloroanisole (73 mg, 63 µL, 0.5 mmol) in a 
mixture of NMP (2.5 mL) and quinoline (2.5 mL). After the reaction, the title compound was 
obtained by column chromatography as a yellow solid (45 mg, 40%). 
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1H NMR (400 MHz, CDCl3): δ = 8.42 (t, J = 1.9, Hz, 1H), 8.16 (ddd, J = 8.0, 1.6, 1.0 Hz, 
1H), 7.88 (d, J = 7.8 Hz, 1H), 7.61−7.57 (m, 3H), 7.05−7.02 (m, 2H), 3.89 ppm (s, 3H); 
13C NMR (101 MHz, CDCl3): δ = 160.04 (s), 148.72 (s), 142.46 (s), 132.51 (s), 131.06 (s), 
129.62 (s), 128.27 (s, 2C), 121.39 (s), 121.36 (s), 114.58 (s, 2C), 55.41 ppm (s); IR (ATR): ṽ 
= 3085, 2964, 2838, 1607, 1527, 1509, 1475, 1346, 1247, 1022, 804 cm-1; MS (EI, 70 eV) m/z 
(%): 229 (100) [M+], 183 (20), 168 (17), 139 (14), 128 (17), 74 (5); HRMS (EI-TOF) calcd 
for C13H11NO3: 229.0739; found: 229.0742; m.p.: 75−76 °C. 
7.2.3.34. Synthesis of methyl−(3'−nitrobiphenyl−4−yl)−sulfane 
 
[CAS: 1355247-56-1] 
The title compound was prepared following general method from potassium 
3−nitrobenzoate (124 mg, 0.6 mmol) and 4−chlorothioanisole (81 mg, 66 µL, 0.5 mmol) in a 
mixture of NMP (2.5 mL) and quinoline (2.5 mL). After the reaction, the title compound was 
obtained by column chromatography as a yellow solid (51 mg, 42%). 
1H NMR (400 MHz, CDCl3): δ = 8.44 (t, J = 1.9 Hz, 1H), 8.19 (ddd, J = 8.0, 1.6, 1.0 Hz, 
1H), 7.90 (ddd, J = 8.0, 1.6, 1.1 Hz, 1H), 7.61 (t, J = 8.0 Hz, 1H), 7.59−7.55 (m, 2H), 
7.39−7.36 (m, 2H), 2.55 ppm (s, 3H); 13C NMR (101 MHz, CDCl3): δ = 148.70 (s), 142.12 
(s), 139.58 (s), 135.06 (s), 132.58 (s), 129.71 (s), 127.36 (s, 2C), 126.72 (s, 2C), 121.84 (s), 
121.48 (s), 15.49 ppm (s). IR (ATR): ṽ = 3074, 2922, 2852, 1594, 1525, 1497, 1344, 1102, 
739 cm-1; MS (EI, 70 eV) m/z (%): 245 (100) [M+], 199 (18), 187 (3), 152 (32), 139 (5), 63 
(3); HRMS (EI-TOF) calcd for C13H11NO2S: 245.0511; found: 245.0513; m.p.: 95−96 °C. 
7.2.3.35. Synthesis of 1−(3−nitrophenyl)naphthalene 
 
[CAS: 94064-81-0] 
The title compound was prepared following general method from potassium 
3−nitrobenzoate (124 mg, 0.6 mmol) and 1−chloronaphthalene (83 mg, 70 µL, 0.5 mmol) in a 
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mixture of NMP (2.5 mL) and quinoline (2.5 mL). After the reaction, the title compound was 
obtained by column chromatography as a yellow liquid (53 mg, 43%). 
1H NMR (400 MHz, CDCl3): δ = 8.39 (t, J = 1.9 Hz, 1H), 8.32 (ddd, J = 8.0, 1.6, 1.0 Hz, 
1H),7.95 (dd, J = 7.9, 4.6 Hz, 2H), 7.85 (dt, J = 7.6, 1.3 Hz, 1H), 7.78 (d, J = 8.4 Hz, 1H), 
7.69 (t, J = 8.0 Hz, 1H), 7.59−7.44 ppm (m, 4H); 13C NMR (101 MHz, CDCl3): δ = 148.29 
(s), 142.39 (s), 137.47 (s), 136.14 (s), 133.76 (s), 131.05 (s), 129.22 (s), 128.79 (s), 128.55 (s), 
127.23 (s), 126.71 (s), 126.17 (s), 125.32 (s), 125.02 (s), 124.85 (s), 122.25 ppm (s); IR 
(ATR): ṽ = 3060, 2922, 1737, 1524, 1508, 1345, 799 cm-1; MS (EI, 70 eV) m/z (%): 249 
(100) [M+], 232 (14), 202 (42), 101 (6), 88 (3), 50 (4); HRMS (EI-TOF) calcd for 
C16H11NO2: 249.0790; found: 249.0789. 
7.2.3.36. Synthesis of 6−(3−nitrophenyl)quinoline 
 
[CAS: 1809242-89-4] 
The title compound was prepared following general method from potassium 
3−nitrobenzoate (124 mg, 0.6 mmol) and 6−chloroquinoline (83 mg, 0.5 mmol) in a mixture 
of NMP (2.5 mL) and quinoline (2.5 mL). After the reaction, the title compound was obtained 
by column chromatography as a yellow solid (90 mg, 70%). 
1H NMR (400 MHz, CDCl3): δ = 8.99 (dd, J = 4.2, 1.6 Hz, 1H), 8.61 (t, J = 1.9 Hz, 1H), 
8.29−8.24 (m, 3H), 8.09 (d, J = 2.0 Hz, 1H), 8.06 (d, J = 7.8 Hz, 1H), 8.01 (dd, J = 8.8, 
2.1 Hz, 1H), 7.70 (t, J = 8.0 Hz, 1H), 7.50 ppm (dd, J = 8.3, 4.2 Hz, 1H); 13C NMR 
(101 MHz, CDCl3): δ = 151.16 (s), 148.83 (s), 148.03 (s), 142.02 (s), 136.71 (s), 136.36 (s), 
133.29 (s), 130.59 (s), 129.96 (s), 128.52 (s), 128.40 (s), 126.18 (s), 122.48 (s), 122.27 (s), 
121.92 ppm (s); IR (ATR): ṽ = 3028, 2970, 1740, 1523, 1500, 1342, 1291, 838 cm-1; MS (EI, 
70 eV) m/z (%): 250 (100) [M+], 204 (18), 176 (6), 150 (2), 88 (4), 75 (3); HRMS (EI-TOF) 
calcd for C15H10N2O2: 250.0742; found: 250.0747; m.p.: 169−170 °C. 
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7.3. ortho-C−H Arylation of Benzoic Acids with Aryl Bromides and 
Chlorides Catalyzed by Ruthenium 
7.3.1. General Methods 
Chemicals and solvents were either purchased (puriss p.A.) from commercial supplier or 
purified by standard techniques.[343] All reactions, if not stated otherwise, were performed in 
oven-dried glassware under a nitrogen atmosphere containing a Teflon-coated stirrer bar and 
dry septum. All reactions were monitored by GC using tetradecane as an internal standard. 
Response factors of the products with regard to n-tetradecane were obtained experimentally 
by analyzing known quantities of the substances. GC analyses were carried out using an HP−5 
capillary column (Phenyl methyl siloxane, 30 m × 320 × 0.25, 100/2.3-30-300/3, 2 min at 
60 °C, heating rate 30 °C/min, 3 or 10 min at 300 °C). Column chromatography was 
performed using a Combi Flash Companion-Chromatography-System (Isco-Systems) and 
Reveleris packed columns (12 g). NMR spectra were recorded on Bruker Avance 400 at 
ambient temperature using CDCl3 as solvent, with proton, carbon, and fluorine resonances at 
400, 101, and 376 MHz respectively. 
7.3.2. Catalyst development 
7.3.2.1. Cross-coupling experiments 
Table 6: Screening experiments for the ortho-arylation of o-tolyl benzoic acid with 
iodobenzene and bromobenzene. 
 
# [Ru] /mol% PhX/eq. base /eq. 
ligand 
/mol% 
solvent/mL Y[a]/% 
1 [Ru(MeCN)6(OTf)2] /4 PhI/1 K2CO3 /1 - PhMe/3 - 
2 " " " - Dioxane/3 trace 
3 " " " - tAmylOH/3 5 
4 " " " - C2H5CN/3 trace 
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5 " " " - H2O/3 - 
6 " " " - NMP/3 12 
7 [(p−cym)Ru Cl2]2 /4 " " - " 25 
8 (COD)RuCl2 /8 " " - " 8 
9 [(C6H6)RuCl2]2 /4 " " - " 16 
10 [(p−cym)RuI2]2 /4 " " - " 15 
11 RuCl3 x 3H2O /8 " " - " 20 
12 (COD)RuCp*Cl /8 " " - " trace 
13 Ru(metallyl)(COD) /8 " " - " 12 
14 RuCl2(PPh3)3 /8 " " - " trace 
15 (NBD)RuCl2 /8 " " - " 16 
16 [(C6Me6)RuCl2]2 /4 " " - " trace 
17 [(p−cym)RuCl2]2 /4 PhI/4 " - " 34 
18 Ru(metallyl)(COD) /8 " " - " 18 
19 (NBD)RuCl2 /8 " " - " 24 
20 [Ru(MeCN)6(OTf)2] /4 " " - " 33 
21 [(C6H6)RuCl2]2 /4 " " - " 35 
22 [(p−cym)RuCl2]2 /4 PhBr/4 GuanCO3 /0.5 - " trace 
23 " " GuanCO3 /1 - " 5 
24 " " K2CO3 /1.1 - " 13 
25 " " " PPh3 /8 " 35 
26 " " " PtBu3 /8 " trace 
27 " " " P(Ad)2Ph /8 " - 
28 " " " P(Mes)3 /8 " trace 
29 " " " PCy3 /8 " 76 
30 " " " Xphos /8 " - 
31 " " " XantPhos /8 " - 
32 " " " P(o−Tol)3 /8  trace 
33 " PhBr/2 " PCy3 /8 " 73 
34 " PhBr/1 " " " 20 
35 " " " PEt2Ph /8 " 65 
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36 " " " POct3 /8 " 78 
37 " " " PMe3 /8 " 3 
38 " " " PiPr3 /8 " 43 
39 " " " PMe3∙HBF4 /8 " 73 
40 " " " PEt3∙HBF4 /8 " 93 
41 " " Cs2CO3 /1.1 " " 84 
42 " " CaCO3 /1.1 " " - 
43 " " Na2CO3 /1.1 " " 84 
44 " " GuanCO3 /1.1 " " - 
45 " " Li2CO3 /1.1 " " 13 
46 " " NH4CO3 /1.1 " " - 
47 " " K2CO3 /1 " " 89 
48 " " K2CO3 /0.8 " " 85 
49 " " K2CO3 /0.5 " " 60 
50 " " K2CO3 /1.1 " NMP/3+1eq. H2O 89 
51 " " " " NMP/3+0.1eq. H2O 89 
52[c] " " " " NMP/3 - 
53 " " " " DMSO/3 25 
54 " " " " DMF/3 trace 
55 " " " " tAmylOH/3 trace 
56 " " " " Dioxane/3 trace 
57 " " " " PhMe/3 trace 
58 [Cp*IrCl2]2 /4 " " " NMP/3 - 
59 Pd(OAc)2 /8 " " " " - 
Reaction conditions: 7.3.2.1.-1 (0.5 mmol), 7.3.2.1.-2, [M], ligand, base, solvent, 100 °C, 18 h under N2-
atmosphere. [a] Yields of corresponding methyl esters determined by GC after esterification with K2CO3 (2 eq.) 
and MeI (5 eq.) in NMP using n-tetradecane as the internal standard; [c] under air atmosphere. 
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Table 7: Screening experiments for the ortho-arylation of o-tolyl benzoic acid with 
chlorobenzene. 
 
# [Ru] /mol% base /eq. ligand /mol% PhCl/eq. Y[a]/% 
1 [(p−cym)RuCl2]2 /4 K2CO3 /1.1 - 4 7 
2 " " PPh3 /8 " trace 
3 " " XPhos /8 " trace 
4 " " PCy3 /8 " trace 
5 " " P(Ad)2CH2Ph /8 " trace 
6 " " PiPr3 /8 " trace 
7 " " PtBu3∙HBF4 /8 " trace 
8 " " PEt3∙HBF4 /8 " 12 
9[b] " " " " 75 
10 " " DL−Phe−OH /8 " 16 
11 " " N−Cbz−L−Phe−OH /8 " 11 
12 " " N−Boc−L−Phe−OH /8 " 17 
13 " " N−Cbz−L−Asn−OH /8 " trace 
14 " " L−Pro−OH /8 " 47 
15 " " DL−Val−OH /8 " 24 
16 " " N−Boc−L−Asn−OH /8 " trace 
17 " " N−Bz−DL−Pro−OH /8 " 15 
18 " " N−Cbz−DL−Val−OH /8 " 18 
19 " " L−Ile−OH /8 " 26 
20 " " L−Pyroglutamic acid /8 " trace 
21 " " N−Boc−L−Pro−OH /8 " 18 
22 " " L−Ala−OH /8 " 11 
23 " " DMPU /8 " 6 
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24 " " N−Cbz−L−Ile−OH /8 " 18 
25 " " DL−pipecolinic acid /8 " 80 
26 " " " 3 72 
27 " " " 2 57 
28 " " " 1.5 48 
29 " " " 1 32 
30[c] " " " " 23 
31[d] " " " " 12 
32[e] " " " " 80 
Reaction conditions: 7.3.2.1.-1 (0.5 mmol), 7.3.2.1.-2 (2 mmol), [(p−cym)RuCl2]2 (4 mol%), K2CO3 (1.1 eq.), 
NMP (3 mL), 120 °C, 18 h. [a] Yields of corresponding methyl esters determined by GC after esterification with 
K2CO3 (2 eq.) and MeI (5 eq.) in NMP using n-tetradecane as the internal standard; [b] 48 h; [c] 1.5 eq. 
7.3.2.1.-2; [d] 2 eq. 7.3.2.1.-2; [e] 140 °C. 
7.3.2.2. Protodecarboxylation experiments 
Table 8: Screening experiments for the protodecarboxylation of 7.3.2.1.-1. In situ and 
sequential one-pot procedure. 
 
# [M] /mol% T/°C N-ligand/mol% t/h 
Y[a]/% 
7.3.2.2.-3 7.3.2.2.-4 
1 Cu2O /10 100 → 170 - 18 + 12 76 9 
2 " 170 - 18 70 10 
3 " 180 - " 41 46 
4 Cu2O /20 " - " 37 51 
5 Cu2O /50 " - " 40 44 
6 Cu2O /10 " 1,10−phen/20 " trace - 
7[b] " 100 → 180 " 18 + 12 77 9 
8[c] " " " " 87 trace 
9[c] " " DL−pipecolinic acid/20 " 88 trace 
10[c] " " Pyridine/20 " 67 20 
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11 CuBr /20 180 - 18 49 32 
12 Ag2O /10 " - " 45 33 
13[d] " 100 → 180 - 18 + 12 69 4 
14 " 160 - 18 68 11 
15[e] Cu2O /10 180 - " 71 11 
16[f] " 100 → 180 - 18 + 12 87 4 
17 " 190 - 18 19 (23) 61 (54) 
18[g] " " - " 10 (13) 63 (71) 
Reaction conditions: 7.3.2.2.-1 (0.5 mmol), 7.3.2.2.-2 (0.5 mmol), [(p-cym)RuCl2]2 (4 mol%), PEt3·HBF4 
(8 mol%), K2CO3 (1.1 eq.), 100 °C for 18 h followed by T for 12 h or T for 18 h, 3 mL NMP.  [a] GC yields after 
esterification with K2CO3 (2 eq.) and MeI (5 eq.) in NMP using n-tetradecane as the internal standard, isolated 
yields in parenthesis; [b] Cu2O and 1,10−phen were added after 18 h; [c] N-ligand was added after 18 h; [d] 
Ag2O and was added after 18 h; [e] 1 eq. H2O was added; [f] Cu2O was added after 18 h; [g] with 
2−fluorobenzoic acid. 
7.3.3. Synthesis of [Ru(2−Me−benzoato2−C6,O1)(p−cymene)(pyridine)] 
 
[CAS: 2036084-13-4] 
The title compound was synthesized following the literature reported procedure,[284] starting 
from potassium 2−methyl benzoate (261 mg, 1.5 mmol), [Ru(p-cym)Cl2]2 (312 mg, 
0.5 mmol), pyridine (79 mg, 8.1µL, 1 mmol) and trimethylamine (715 mg, 983 µL, 7 mmol). 
The title compound was isolated as a red wax (82 mg, 37%). 
1H NMR (400 MHz, CDCl3): δ = 8.54−8.60 (m, 2H), 7.86−7.91 (m, 1H), 7.46 (tt, J = 7.7, 
1.5 Hz, 1H), 7.10 (t, J = 7.3 Hz, 1H), 6.99−7.04 (m, 2H), 6.73 (dd, J = 6.9, 0.6 Hz, 1H), 5.52 
(dd, J = 5.8, 1.0 Hz, 1H), 5.45 (dd, J = 6.0, 0.8 Hz, 1H), 5.22 (dd, J = 5.9, 1.1 Hz, 1H), 4.79 
(dd, J = 5.8, 1.0 Hz, 1H), 2.46 (s, 3H), 2.36 (quin, J = 6.9 Hz, 2H), 1.70 (s, 1H), 0.99 ppm 
(dd, J = 6.8, 1.5 Hz, 6H); 13C NMR (101 MHz, CDCl3): δ = 181.3 (s), 177.5 (s), 153.6 (s), 
140.0 (s), 136.6 (s), 135.5 (s), 134.5 (s), 129.6 (s), 126.6 (s), 124.3 (s), 101.8 (s), 97.9 (s), 87.9 
(s), 87.2 (s), 84.3 (s), 80.2 (s), 30.7 (s), 22.6 (s), 22.2 (s), 19.9 (s), 17.9 ppm (s); IR (ATR): ṽ = 
3050, 2965, 2926, 2872, 1600, 1468, 1443, 1213, 1091, 1008, 907, 759, 692 cm-1; HRMS 
(ESI): m/z = calcd. for C23H25O2NRu+H+: 450.1007; found 450.1001. 
Experimental Section 
 
 122
444.1
445.1446.1
447.1448.1
449.1
450.1
451.1
452.1
453.1
444.1
445.1446.1
447.1
448.1
449.1
450.1
451.1
452.1
453.1
445 450 455
 
7.3.3.1. Mechanistic control experiment 
Table 9: Stoichiometric reaction of preformed ruthenacycle 7.3.3.1.-1 with bromobenzene. 
 
# ligand /mol% Y[a]/% 
1 PEt3·HBF4 (100) 57 
2 - 0 
Reaction conditions: 7.3.3.1.-1 (0.1 mmol), 7.3.3.1.-2 (0.1 mmol), 100 °C for 18 h, 3 mL NMP. [a] GC yields 
after esterification with K2CO3 (2 eq.) and MeI (5 eq.) in NMP using n-tetradecane as the internal standard. 
7.3.4. Synthesis of the corresponding 1,1’−biphenyl−2−carboxylic acids via ortho-C−H 
arylation 
 
Standard procedure A – coupling of aryl bromides: An oven-dried 20 mL vessel was 
charged with [(p−cym)RuCl2]2 (12.2 mg, 0.02 mmol, 4 mol%), triethylphosphonium 
tetrafluoroborate (8.3 mg, 0.04 mmol, 8 mol%), K2CO3 (76 mg, 0.55 mmol, 1.1 eq.), and the 
benzoic acid (0.50 mmol). After the vessel was flushed with 3 alternating vacuum and 
nitrogen purge cycles, NMP (3 mL) and the aryl bromide (0.50 mmol) were added via 
syringe. The resulting mixture was stirred at 100 °C for 18 h. After the reaction was complete, 
simulated 
measured 
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the mixture was allowed to cool to room temperature. NMP (2 mL), K2CO3 (207 mg, 3 eq.) 
and MeI (156 μL, 5 eq.) were added and the mixture was stirred at 60 °C for 2 h. The mixture 
was allowed to cool to room temperature, ethyl acetate (20 mL) was added and the resulting 
mixture was washed with water, aqueous LiCl solution (20%) and brine (20 mL each). The 
organic layer was dried over MgSO4, filtered, and the volatiles were removed under reduced 
pressure. The residue was purified by column chromatography (SiO2, ethyl acetate/hexane 
gradient) yielding the corresponding biaryl. 
Standard procedure B – coupling of aryl chlorides: An oven-dried 20 mL vessel was 
charged with [Ru(p−cym)Cl2]2 (12.2 mg, 0.02 mmol, 4 mol%), DL-pipecolinic acid (5.17 mg, 
0.04 mmol, 8 mol%), K2CO3 (76 mg, 0.55 mmol, 1.1 eq.), and the corresponding carboxylic 
acid (0.50 mmol, 1 eq.). After the vessel was flushed with 3 alternating vacuum and nitrogen 
purge cycles, NMP (3 mL) and the corresponding aryl chloride (2.00 mmol, 4 eq.) were added 
via syringe. The resulting mixture was stirred at 120 °C for 18 h. After the reaction was 
completed, the mixture was allowed to cool to room temperature. NMP (2 mL), K2CO3 
(207 mg, 3 eq.) and MeI (156 μL, 5 eq.) were added and the mixture was stirred at 60 °C for 
2 h. The mixture was allowed to cool to room temperature, ethyl acetate (20 mL) was added 
and the resulting mixture was washed with water, aqueous LiCl solution (20%) and brine 
(20 mL each). The organic layer was dried over MgSO4, filtered, and the volatiles were 
removed under reduced pressure. The residue was purified by column chromatography (SiO2, 
ethyl acetate/hexane gradient) yielding the corresponding biaryl. 
7.3.4.1. Synthesis of methyl−3−methylbiphenyl−2−carboxylate 
 
[CAS: 941320-77-0] 
The title compound was prepared following the general method A from 2–methylbenzoic acid 
(68.8 mg, 0.50 mmol) and bromobenzene (79.3 mg, 53.2 µL, 0.50 mmol). The title compound 
was isolated as colorless oil (105 mg, 93%). 
The title compound was prepared following the general method B from 2–methylbenzoic acid 
(68.8 mg, 0.50 mmol) and chlorobenzene (227 mg, 205 µL, 2.00 mmol). The title compound 
was isolated as colorless oil (85 mg, 75%). 
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1H NMR (400 MHz, CDCl3): δ = 7.30−7.45 (m, 6H), 7.24 (d, J = 7.5 Hz, 2H), 3.60 (s, 3H), 
2.42 ppm (s, 3H); 13C NMR (101 MHz, CDCl3): δ = 170.3 (s), 140.9 (s), 140.2 (s), 135.5 (s), 
133.2 (s), 129.5 (s), 129.1 (s), 128.3 (s), 128.2 (s), 127.4 (s), 127.3 (s), 51.9 (s), 19.7 ppm (s); 
IR (ATR): ṽ = 3062, 2950, 1726, 1463, 1436, 1267, 1122, 1066 cm-1; MS (EI, 70 eV) m/z 
(%): 226 (100) [M+], 195 (90), 165 (22). The analytical data matched those reported in the 
literature.[262] 
7.3.4.2. Synthesis of methyl−4'−methoxy−3−methylbiphenyl−2−carboxylate 
 
[CAS: 1097018-19-3] 
The title compound was prepared following the general method A from 2–methylbenzoic acid 
(68.8 mg, 0.50 mmol) and 4−bromoanisole (93.5 mg, 62.8 µL, 0.50 mmol). The title 
compound was isolated as colorless solid (105 mg, 82%). 
The title compound was prepared following the general method B from 2–methylbenzoic acid 
(68.8 mg, 0.50 mmol) and 4−chloroanisole (291 mg, 251 µL, 2.00 mmol). The title compound 
was isolated as colorless solid (92 mg, 72%). 
1H NMR (400 MHz, CDCl3): δ = 7.28−7.37 (m, 3H), 7.17−7.23 (m, 2H), 6.91−6.97 (m, 2H), 
3.85 (s, 3H), 3.64 (s, 3H), 2.40 ppm (s, 3H); 13C NMR (101 MHz, CDCl3): δ = 170.5 (s), 
159.0 (s), 139.6 (s), 135.3 (s), 133.3 (s), 133.1 (s), 129.3 (s), 129.3 (s), 128.7 (s), 127.2 (s), 
113.7 (s), 55.2 (s), 51.9 (s), 19.7 ppm (s); IR (ATR): ṽ = 2946, 2839, 1726, 1609, 1512, 1440, 
1247, 1183 cm-1; MS (EI, 70 eV) m/z (%):256 (100) [M+], 225 (62), 209 (15), 181 (9), 153 
(8); HRMS (EI-TOF) calcd. for C16H16O3: 256.1099; found: 256.1091; m.p.: 69–70 °C. The 
analytical data matched those reported in the literature.[262] 
 
 
 
Experimental Section 
 
 125 
7.3.4.3. Synthesis of methyl−3,4’−dimethylbiphenyl−2−carboxylate 
 
[CAS: 1097018-21-7] 
The title compound was prepared following the general method B from 2–methylbenzoic acid 
(68.8 mg, 0.50 mmol) and 4−chlorotoluene (258 mg, 241 µL, 2.00 mmol). The title 
compound was isolated as colorless oil (66 mg, 55%).  
1H NMR (400 MHz, CDCl3): δ = 7.32−7.38 (m, 1H), 7.25−7.29 (m, 2H), 7.18−7.24 (m, 4H), 
3.63 (s, 3H), 2.40 (s, 3H), 2.39 ppm (s, 3H); 13C NMR (101 MHz, CDCl3): δ = 170.5 (s), 
140.0 (s), 137.9 (s), 137.0 (s), 135.3 (s), 133.1 (s), 129.4 (s), 129.0 (s), 128.9 (s), 128.0 (s), 
127.2 (s), 51.8 (s), 21.2 (s), 19.7 ppm (s); IR (ATR): ṽ = 2949, 1725, 1265, 1122, 1088, 1067, 
783 cm-1; MS (EI, 70 eV) m/z (%): 240 (100) [M+], 209 (55), 165 (17). The analytical data 
matched those reported in the literature.[262] 
7.3.4.4. Synthesis of methyl−4'−(acetylamino)−3−methylbiphenyl−2−carboxylate 
 
[CAS: 1809272-64-7] 
The title compound was prepared following the general method A from 2−methylbenzoic acid 
(68.8 mg, 0.50 mmol) and N−(4−bromophenyl)−acetamide (109 mg, 0.50 mmol). The title 
compound was isolated as colorless solid (131 mg, 93%). 
1H NMR (400 MHz, CDCl3): δ = 7.52 (m, J = 8.5 Hz, 2H), 7.29−7.40 (m, 4H), 7.18−7.24 (m, 
2H), 3.64 (s, 3H), 2.40 (s, 3H), 2.17 ppm (s, 3H); 13C NMR (101 MHz, CDCl3): δ = 170.5 (s), 
168.3 (s), 139.4 (s), 137.3 (s), 136.7 (s), 135.4 (s), 133.1 (s), 129.5 (s), 129.0 (s), 128.8 (s), 
127.2 (s), 120.0 (s), 119.4 (s), 51.9 (s), 24.6 (s), 19.7 ppm (s); IR (ATR): ṽ = 3322, 3275, 
1679, 1532, 1456, 1320, 1288, 1257 cm-1; MS (EI, 70 eV) m/z (%): 283 (100) [M+], 252 (11), 
241 (43), 235 (12), 209 (50); m.p.: 189–190 °C. The analytical data matched those reported in 
the literature.[262] 
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7.3.4.5. Synthesis of 4'−ethyl−2−methyl−3−methylbiphenyl−2,4'−dicarboxylate 
 
[CAS: 2040483-22-3] 
The title compound was prepared following the general method A from 2–methylbenzoic acid 
(68.8 mg, 0.50 mmol) and ethyl 4–bromobenzoate (116 mg, 82.6 µL, 0.50 mmol). The title 
compound was isolated as colorless oil (124 mg, 83%). 
1H NMR (400 MHz, CDCl3): δ = 8.08 (s, 2H), 7.42–7.46 (m, 2H), 7.36–7.41 (m, 1H), 7.21–
7.29 (m, 2H), 4.41 (q, J = 7.0 Hz, 2H), 3.59 (s, 3H), 2.42 (s, 3H), 1.42 ppm (t, J = 7.2 Hz, 
3H); 13C NMR (101 MHz, CDCl3): δ = 169.9 (s), 166.4 (s), 145.5 (s), 139.2 (s), 135.8 (s), 
133.0 (s), 129.8 (s), 129.6 (s, 2C) 129.4 (s), 128.2 (s), 127.1 (s), 61.0 (s), 51.9 (s), 19.7 (s), 
14.3 ppm (s); IR (ATR): ṽ = 2982, 2951, 1714, 1461, 1438, 1269, 1180, 1103 cm-1; MS (EI, 
70 eV) m/z (%):298 (100) [M+], 266 (14), 253 (41), 239 (11), 195 (29), 165 (11); HRMS (EI–
TOF) calcd. for C18H18O4: 298.1205; found: 298.1203. 
7.3.4.6. Synthesis of methyl−4'−methoxy−3−methylbiphenyl−2−carboxylate 
 
[CAS: 1097018-19-3] 
The title compound was prepared following the general method A from 2–methylbenzoic acid 
(68.8 mg, 0.50 mmol) and 4–bromophenol (87.4 mg, 0. 5 mmol). The title compound was 
isolated as the methyl ether after treatment with MeI and K2CO3 in NMP. yellow oil (67 mg, 
52%). 
1H NMR (400 MHz, CDCl3): δ = 7.28–7.37 (m, 2H), 7.17–7.23 (m, 2H), 6.92–6.96 (m, 2H), 
3.85 (s, 2H), 3.64 (s, 2H), 2.40 ppm (s, 2H); 13C NMR (101 MHz, CDCl3): δ = 170.5 (s), 
159.0 (s), 139.6 (s), 135.3 (s), 133.3 (s), 133.1 (s), 129.3 (s), 129.3 (s), 128.7 (s), 127.2 (s), 
113.7 (s), 55.2 (s), 51.8 (s), 19.6 ppm (s); IR (ATR): ṽ = 2946, 2839, 1726, 1609, 1512, 1440, 
1247, 1183 cm-1; MS (EI, 70 eV) m/z (%):256 (100) [M+], 225 (62), 209 (15), 181 (9), 153 
(8); m.p.: 69–70 °C. The analytical data matched those reported in the literature.[262] 
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7.3.4.7. Synthesis of methyl−4'−benzoyl−3−methylbiphenyl−2−carboxylate 
 
[CAS: 2051922-37-1] 
The title compound was prepared following the general method A from 2–methylbenzoic acid 
(68.8 mg, 0.50 mmol) and (4-bromophenyl)−(phenyl)−methanone (135 mg, 0.50 mmol). The 
title compound was isolated as colorless solid (134 mg, 81%). 
1H NMR (400 MHz, CDCl3): δ = 7.80–7.90 (m, 3H), 7.58–7.65 (m, 1H), 7.47–7.55 (m, 3H), 
7.41 (t, J = 7.7 Hz, 1H), 7.24–7.31 (m, 3H), 3.63 (s, 3H), 2.43 ppm (s, 3H); 13C NMR 
(101 MHz, CDCl3): δ = 196.4 (s), 170.0 (s), 145.2 (s), 139.1 (s), 137.6 (s), 136.4 (s), 135.9 
(s), 133.0 (s), 132.5 (s), 130.3 (s), 130.0 (s), 129.9 (s), 129.7 (s), 128.4 (s), 128.2 (s), 127.2 
(s), 52.0 (s), 19.8 ppm (s); IR (ATR): ṽ = 3066, 2949, 1721, 1655, 1599, 1400, 1315, 
1124 cm-1; MS (EI, 70 eV) m/z (%): 330 (100) [M+], 315 (54), 299 (22), 253 (66), 195 (8), 
165 (13), 105 (60); HRMS (EI–TOF) calcd. for C22H18O3: 330.1256; found: 330.1259; m.p.: 
83–84 °C. 
7.3.4.8. Synthesis of methyl−4'−chloro−3−methylbiphenyl−2−carboxylate 
 
[CAS: 1809272-61-4] 
The title compound was prepared following the general method A from 2–methylbenzoic acid 
(68.8 mg, 0.50 mmol) and 4–chloro bromobenzene (95.7 mg, 58µL, 0.50 mmol). The title 
compound was isolated as colorless oil (80 mg, 61%). 
1H NMR (400 MHz, CDCl3): δ = 7.34–7.40 (m, 3H), 7.28–7.33 (m, 2H), 7.22–7.26 (m, 1H), 
7.16–7.21 (m, 1H), 3.63 (s, 3H), 2.41 ppm (s, 3H); 13C NMR (101 MHz, CDCl3): δ = 170.0 
(s), 139.3 (s), 138.8 (s), 135.6 (s), 133.5 (s), 133.1 (s), 129.5 (s), 129.5 (s), 129.4 (s), 128.5 
(s), 127.1 (s), 51.9 (s), 19.7 ppm (s); IR (ATR): ṽ = 2948, 1725, 1494, 1459, 1395, 1265, 
1121, 835 cm-1; MS (EI, 70 eV) m/z (%):260 (88) [M+], 229 (100), 193 (22), 165 (20). The 
analytical data matched those reported in the literature.[262] 
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7.3.4.9. Synthesis of methyl−3'−methoxy−3−methylbiphenyl−2−carboxylate 
 
[CAS: 2040483-23-4] 
The title compound was prepared following the general method A from 2–methylbenzoic acid 
(68.8 mg, 0.50 mmol) and 3–bromo anisole (95.4 mg, 64.5 µL, 0.50 mmol). The title 
compound was isolated as colorless solid (111 mg, 87%). 
1H NMR (400 MHz, CDCl3): δ = 7.36 (t, J = 7.8 Hz, 1H), 7.28 - 7.33 (m, 1H), 7.21–7.26 (m, 
2H), 6.87–6.99 (m, 3H), 3.83 (s, 3H), 3.63 (s, 3H), 2.41 ppm (s, 3H); 13C NMR (101 MHz, 
CDCl3): δ = 170.3 (s), 159.4 (s), 142.2 (s), 139.9 (s), 135.4 (s), 133.1 (s), 129.4 (s), 129.3 (s), 
129.2 (s), 127.1 (s), 120.6 (s), 113.5 (s), 113.3 (s), 55.2 (s), 51.9 (s), 19.7 ppm (s); IR (ATR): 
ṽ = 2948, 2835, 1725, 1576, 1466, 1433, 1267, 1228 cm-1; MS (EI, 70 eV) m/z (%):256 (94) 
[M+], 224 (100), 182 (12), 153 (9); HRMS (EI–TOF) calcd. for C16H16O3: 256.1099; found: 
256.1082. 
7.3.4.10. Synthesis of methyl−3−methyl−3’−(trifluoromethyl)biphenyl−2−carboxylate 
 
[CAS: 2022197-28-8] 
The title compound was prepared following the general method A from 2–methylbenzoic acid 
(68.8 mg, 0.50 mmol) and 1–bromo–3–(trifluoromethyl)−benzene (114 mg, 70.6 µL, 
0.50 mmol). The title compound was isolated as colorless oil (105 mg, 71%). 
1H NMR (400 MHz, CDCl3): δ = 7.59–7.67 (m, 2H), 7.49–7.58 (m, 2H), 7.40 (t, J = 7.7 Hz, 
1H), 7.26–7.30 (m, 1H), 7.21–7.25 (m, 1H), 3.62 (s, 3H), 2.42 ppm (s, 3H); 13C NMR 
(101 MHz, CDCl3): δ = 169.9 (s), 141.7 (s), 138.6 (s), 135.9 (s), 133.2 (s), 131.6 (s), 131.6 
(s), 130.7 (q), 129.9 (s), 129.7 (s), 128.8 (s), 127.1 (s), 125.1 (q), 124.1 (q), 123.8 (q), 51.9 (s), 
19.8 ppm (s); 19F NMR (376 MHz, CDCl3): δ = –62.59 ppm (s); IR (ATR): ṽ = 2953, 1728, 
1433, 1335, 1263, 1164, 1120, 1067 cm-1; MS (EI, 70 eV) m/z (%):294 (68) [M+], 263 (100), 
215 (8), 165 (13); HRMS (EI–TOF) calcd. for C16H13F3O2: 294.0868; found: 294.0870. 
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7.3.4.11. Synthesis of methyl−3'−tert−butyl−3−methylbiphenyl−2−carboxylate 
 
[CAS: 2051922-36-0] 
The title compound was prepared following the general method A from 2–methylbenzoic acid 
(68.8 mg, 0.50 mmol) and 1–bromo–3–tert–butylbenzene (107 mg, 85.2 µL, 0.50 mmol). The 
title compound was isolated as colorless oil (111 mg, 79%). 
1H NMR (400 MHz, CDCl3): δ = 7.30–7.46 (m, 4H), 7.17–7.28 (m, 3H), 3.60 (s, 3H), 2.42 (s, 
3H), 1.35 ppm (s, 9H); 13C NMR (101 MHz, CDCl3): δ = 170.4 (s), 151.1 (s), 140.6 (s), 140.5 
(s), 135.4 (s), 133.2 (s), 129.4 (s), 128.9 (s), 128.1 (s), 127.2 (s), 125.4 (s), 125.3 (s), 124.2 
(s), 51.8 (s), 34.7 (s), 31.4 (s), 19.7 ppm (s); IR (ATR): ṽ = 2952, 2867, 1727, 1589, 1463, 
1436, 1365, 1117 cm-1; MS (EI, 70 eV) m/z (%):282 (67) [M+], 235 (100), 207 (16), 193 
(42); HRMS (EI–TOF) calcd. for: C19H22O2: 282.1620; found: 282.1624. 
7.3.4.12. Synthesis of methyl−3'−cyano−3−methylbiphenyl−2−carboxylate 
 
[CAS: 2051922-35-9] 
The title compound was prepared following the general method A from 2–methylbenzoic acid 
(68.8 mg, 0.50 mmol) and 3–cyanobromobenzene (91.0 mg, 0.50 mmol). The title compound 
was isolated as colorless oil (65 mg, 52%). 
1H NMR (400 MHz, CDCl3): δ = 7.62–7.68 (m, 2H), 7.57–7.62 (m, 1H), 7.48–7.54 (m, 1H), 
7.37–7.43 (m, 1H), 7.29 (d, J = 7.5 Hz, 1H), 7.18 (d, J = 7.5 Hz, 1H), 3.63 (s, 3H), 2.42 ppm 
(s, 3H); 13C NMR (101 MHz, CDCl3): δ = 169.6 (s), 142.2 (s), 137.8 (s), 136.0 (s), 133.0 (s), 
132.7 (s), 131.7 (s), 131.0 (s), 130.2 (s), 129.7 (s), 129.1 (s), 127.0 (s), 118.6 (s), 112.5 (s), 
52.0 (s), 19.7 ppm (s); IR (ATR): ṽ = 2949, 2231, 1726, 1591, 1460, 1436, 1120, 1068 cm-1; 
MS (EI, 70 eV) m/z (%):251 (64) [M+], 220 (100), 190 (9), 165 (9); HRMS (EI–TOF) calcd. 
for C16H13NO2: 251.0946; found: 251.0950. 
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7.3.4.13. Synthesis of 4'−methoxy−2',3−dimethylbiphenyl−2−carboxylate 
 
[CAS: 2051922-34-8] 
The title compound was prepared following the general method A from 2–methylbenzoic acid 
(68.8 mg, 0.50 mmol) and 1–bromo–4–methoxy–2–methylbenzene (104 mg, 114 µL, 
0.50 mmol). The title compound was isolated as yellow oil (54.0 mg, 40%). 
1H NMR (400 MHz, CDCl3): δ = 7.31 (t, J = 8.0 Hz, 1H), 7.20 (d, J = 7.3 Hz, 1H), 7.01–7.08 
(m, 2H), 6.79 (d, J = 2.5 Hz, 1H), 6.72 (dd, J = 8.3, 2.8 Hz, 1H), 3.83 (s, 3H), 3.52 (s, 3H), 
2.40 (s, 3H), 2.12 ppm (s, 3H); 13C NMR (101 MHz, CDCl3): δ = 169.9 (s), 158.8 (s), 139.6 
(s), 137.5 (s), 135.0 (s), 134.2 (s), 132.6 (s), 130.2 (s), 128.9 (s), 128.7 (s), 127.6 (s), 115.2 (s), 
110.3 (s), 55.1 (s), 51.6 (s), 20.4 (s), 19.7 ppm (s); IR (ATR): ṽ = 2948, 2835, 1728, 1608 , 
1573, 1461, 1266, 1237 cm-1; MS (EI, 70 eV) m/z (%): 270 (100) [M+], 238 (55), 223 (10), 
195 (25), 152 (6); HRMS (EI–TOF) calcd. for C17H18O3: 270.1256; found: 270.1257. 
7.3.4.14. Synthesis of 3',5'−dimethoxy−3−methylbiphenyl−2−carboxylate 
 
[CAS: 1261980-73-7] 
The title compound was prepared following the general method B from 2–methylbenzoic acid 
(68.8 mg, 0.50 mmol) and 5–chloro–1,3–dimethoxybenzene (356 mg, 2.00 mmol). The title 
compound was isolated as colorless oil (97 mg, 68%).  
1H NMR (400 MHz, CDCl3): δ = 7.38 (t, J = 7.8 Hz, 1H), 7.25 (d, J = 7.8 Hz, 2H), 6.60 (d, J 
= 2.3 Hz, 2H), 6.48 (t, J = 2.3 Hz, 1H), 3.78 (s, 6H), 2.46 ppm (s, 3H); 13C NMR (101 MHz, 
CDCl3): δ = 174.9 (s), 160.6 (s), 142.5 (s), 139.9 (s), 135.3 (s), 132.1 (s), 129.7 (s), 129.3 (s), 
127.2 (s), 106.4 (s), 100.1 (s), 55.3 (s), 19.7 ppm (s); IR (ATR): ṽ = 2962, 2937, 2838, 1695, 
1584, 1456, 1421, 1204, 1153, 1063, 907, 727, 695 cm-1. The analytical data matched those 
reported in the literature.[265] 
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7.3.4.15. Synthesis of methyl−3−phenylnaphthalene−2−carboxylate 
 
[CAS: 2051922-33-7] 
The title compound was prepared following the general method A from 2–methylbenzoic acid 
(68.8 mg, 0.50 mmol) and 1–bromonaphthalene (158 mg, 106 µL, 0.75 mmol). The title 
compound was isolated as colorless oil (117 mg, 85%). 
1H NMR (400 MHz, CDCl3): δ = 7.82–7.92 (m, 2H), 7.63–7.69 (m, 1H), 7.46–7.52 (m, 2H), 
7.39–7.45 (m, 2H), 7.29–7.37 (m, 2H), 7.23–7.27 (m, 1H), 3.27 (s, 3H), 2.47 ppm (s, 3H); 13C 
NMR (101 MHz, CDCl3): δ = 169.6 (s), 138.7 (s), 138.4 (s), 135.7 (s), 134.4 (s), 133.4 (s), 
131.9 (s), 129.4 (s), 129.0 (s), 128.4 (s), 128.0 (s), 127.8 (s), 126.6 (s), 126.2 (s), 125.9 (s), 
125.7 (s), 124.9 (s), 51.5 (s), 19.9 ppm (s); IR (ATR): ṽ = 3053, 2948, 1726, 1587, 1508, 
1435, 1394, 1111 cm-1; MS (EI, 70 eV) m/z (%):276 (100) [M+], 245 (50), 202 (12), 107 
(6); HRMS (EI–TOF) calcd. for: C19H16O2: 276.1150; found: 276.1138. 
7.3.4.16. Synthesis of methyl−2’−(hydroxymethyl)−3−methylbiphenyl−2−carboxylate 
 
[CAS: 2051922-32-6] 
The title compound was prepared following the general method A from 2–methylbenzoic acid 
(68.8 mg, 0.50 mmol) and 3–bromobenzyl alcohol (95.4 mg, 0.50 mmol). The title compound 
was isolated as colorless oil (66 mg, 52%). 
1H NMR (400 MHz, CDCl3): δ = 7.53 (dd, J = 7.7, 1.1 Hz, 1H), 7.32–7.42 (m, 2H), 7.23–
7.32 (m, 2H), 7.10 (ddd, J = 12.4, 7.6, 0.9 Hz, 2H), 4.46–4.54 (m, 1H), 4.33–4.40 (m, 1H), 
3.53 (s, 3H), 2.40 ppm (s, 3H); 13C NMR (101 MHz, CDCl3): δ = 170.4 (s), 139.2 (s), 138.8 
(s), 138.6 (s), 135.1 (s), 133.7 (s), 129.4 (s), 129.2 (s), 129.1 (s), 129.1 (s), 128.3 (s), 127.2 
(s), 127.2 (s), 63.1 (s), 52.0 (s), 19.7 ppm (s); IR (ATR): ṽ = 3420, 2949, 1727, 1589, 1438, 
1110, 1066, 1012 cm-1; MS (EI, 70 eV) m/z (%): 239 (29) [M+–OH], 224 (100), 206.0 (60), 
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195 (59), 181 (38), 165 (25); HRMS (EI–TOF) calcd. for C16H14O2: 238,0994; found: 
238.0998 [M+–(H2O)]. 
7.3.4.17. Synthesis of methyl−2−methyl−6−(thiophen−2−yl)benzoate 
 
[CAS: 2051922-31-5] 
The title compound was prepared following the general method A from 2–methylbenzoic acid 
(68.8 mg, 0.50 mmol) and 2–bromothiophene (83.2 mg, 49.5 µL, 0.50 mmol). The title 
compound was isolated as orange oil (100 mg, 86%). 
1H NMR (400 MHz, CDCl3): δ = 7.30–7.36 (m, 3H), 7.18–7.24 (m, 1H), 7.08–7.11 (m, 1H), 
7.03–7.07 (m, 1H), 3.76 (s, 3H), 2.38 ppm (s, 3H); 13C NMR (101 MHz, CDCl3): δ = 170.2 
(s), 141.9 (s), 135.3 (s), 133.3 (s), 132.0 (s), 129.5 (s), 129.3 (s), 127.5 (s), 127.4 (s), 125.9 
(s), 52.1 (s), 19.5 ppm (s); IR (ATR): ṽ = 2948, 2920, 1727, 1589, 1432, 1266, 1119, 
1072 cm-1; MS (EI, 70 eV) m/z (%):232 (100) [M+], 200 (70), 171 (12), 129 (6); HRMS (EI–
TOF) calcd. for: C13H11O2S: 231.0480; found: 231.0490 [M+–H]. 
7.3.4.18. Synthesis of methyl−2−methyl−6−(thiophen−3−yl)benzoate 
 
[CAS: 2022197-36-8] 
The title compound was prepared following the general method A from 2–methylbenzoic acid 
(68.8 mg, 0.50 mmol) and 3–bromothiophene (84 mg, 48.3 µL, 0.50 mmol). The title 
compound was isolated as orange oil (79.0 mg, 68%). 
1H NMR (400 MHz, CDCl3): δ = 7.28–7.32 (m, 2H), 7.20–7.25 (m, 2H), 7.13–7.17 (m, 1H), 
7.10–7.13 (m, 1H), 3.66 (s, 3H), 2.33 ppm (s, 3H); 13C NMR (101 MHz, CDCl3): δ = 170.5 
(s), 140.9 (s), 135.2 (s), 134.3 (s), 133.0 (s), 129.4 (s), 129.0 (s), 127.9 (s), 126.8 (s), 125.6 
(s), 122.3 (s), 52.0 (s), 19.5 ppm (s); IR (ATR): ṽ = 2948, 1723, 1591, 1461, 1437, 1265, 
1119, 1090 cm-1; MS (EI, 70 eV) m/z (%):232 (100) [M+], 200 (85), 171 (13), 
129.(7); HRMS (EI–TOF) calcd. for C13H12O2S: 232.0558; found: 232.0564. 
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7.3.4.19. Synthesis of methyl−3−methoxylbiphenyl−2−carboxylate 
 
[CAS: 773134-32-0] 
The title compound was prepared following the general method A from 2–methoxylbenzoic 
acid (76.8 mg, 0.50 mmol) and bromobenzene (119.0 mg, 79.8 µL, 0.75 mmol). The title 
compound was isolated as colorless solid (117 mg, 97%). 
1H NMR (400 MHz, CDCl3): δ = 7.32–7.45 (m, 6H), 7.01 (dd, J = 7.7, 0.9 Hz, 1H), 6.95 (dd, 
J = 8.3, 0.8 Hz, 1H), 3.90 (s, 3H), 3.64 ppm (s, 3H); 13C NMR (101 MHz, CDCl3): δ = 168.5 
(s), 156.4 (s), 141.2 (s), 140.0 (s), 130.5 (s), 128.3 (s), 128.2 (s), 127.6 (s), 123.0 (s), 122.0 
(s), 109.8 (s), 56.0 (s), 52.1 ppm (s); IR (ATR): ṽ = 2947, 2839, 1730, 1570, 1462, 1257, 
1128, 1108 cm-1; MS (EI, 70 eV) m/z (%):242 (63) [M+], 211 (100), 168 (12), 139 (8); m.p.: 
84–85 °C. The analytical data matched those reported in the literature.[265] 
7.3.4.20. Synthesis of methyl−3−fluorobiphenyl−2−carboxylate 
 
[CAS: 1528793-42-1] 
The title compound was prepared following the general method A from 2–fluorobenzoic acid 
(119 mg, 0.50 mmol) and bromobenzene (119.0 mg, 79.8 µL, 0.75 mmol). The title 
compound was isolated as colorless oil (102 mg, 88%). 
The title compound was prepared following the general method B from 2–fluorobenzoic acid 
(119 mg, 0.50 mmol) and chlorobenzene (227.0 mg, 205 µL, 2 mmol). The title compound 
was isolated as colorless oil (108 mg, 94%). 
1H NMR (400 MHz, CDCl3): δ = 7.35–7.50 (m, 6H), 7.21 (dd, J = 7.9, 0.9 Hz, 1H), 7.14 
(ddd, J = 9.3, 8.3, 1.0 Hz, 1H), 3.69 ppm (s, 3H); 13C NMR (101 MHz, CDCl3): δ = 166.2 (s), 
159.7 (d, J = 251.6 Hz) 142.5 (d, J = 2.7 Hz) 139.3 (d, J = 2.7 Hz) 131.2 (d, J = 8.2 Hz) 128.5 
(s), 128.1 (s), 127.9 (s), 125.5 (d, J = 2.7 Hz) 121.4 (d, J = 16.3 Hz) 114.7 (s), 114.5 (s), 
52.4 ppm (s); 19F NMR (376 MHz, CDCl3): δ = –115.3 ppm (s); IR (ATR): ṽ = 2952, 1732, 
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1612, 1568, 1462, 1261, 1239, 1115 cm-1; MS (EI, 70 eV) m/z (%):230 (79) [M+], 199 (100), 
170 (16). The analytical data matched those reported in the literature.[346] 
7.3.4.21. Synthesis of methyl−3−acetylbiphenyl−2−carboxylate 
 
[CAS: 1097018-12-6] 
The title compound was prepared following the general method A from 2–acetylbenzoic acid 
(82.9 mg, 0.50 mmol) and bromobenzene (119 mg, 80.0 µL, 0.75 mmol). The title compound 
was isolated as yellow solid (79 mg, 62%). 
1H NMR (400 MHz, CDCl3): δ = 7.81–7.86 (m, 1H), 7.53–7.59 (m, 2H), 7.34–7.44 (m, 5H), 
3.67 (s, 3H), 2.65 ppm (s, 3H); 13C NMR (101 MHz, CDCl3): δ = 198.3 (s), 169.7 (s), 141.1 
(s), 135.9 (s), 134.2 (s), 132.9 (s), 129.2 (s), 128.5 (s), 128.3 (s), 127.9 (s), 127.9 (s), 52.3 (s), 
27.6 ppm (s); IR (ATR): ṽ = 2952, 1727, 1677, 1578, 1454, 1428, 1193, 1125 cm-1; MS (EI, 
70 eV) m/z (%): 254 (10) [M+], 239 (100), 207 (7), 179 (6), 152 (9); HRMS (EI–TOF) calcd. 
for C16H14O3: 254.0943; found: 254.0945; m.p.: 92–93 °C. The analytical data matched those 
reported in the literature.[265] 
7.3.4.22. Synthesis of methyl−3−acetamidobiphenyl−2−carboxylate 
 
[CAS: 2051922-30-4] 
The title compound was prepared following the general method A from N–acetylanthranilic 
acid (90.5 mg, 0.50 mmol) and bromobenzene (91.0 mg, 0.50 mmol). The title compound was 
isolated as colorless solid (95 mg, 71%). 
The title compound was prepared following the general method b from N–acetylanthranilic 
acid (90.5 mg, 0.50 mmol) and chlorobenzene (227 mg, 205 µL, 2.00 mmol). The title 
compound was isolated as colorless solid (78 mg, 58%). 
1H NMR (400 MHz, CDCl3): δ = 9.32 (br. s., 1H), 8.39 (d, J = 8.3 Hz, 1H), 7.51 (t, J = 
7.9 Hz, 1H), 7.31–7.43 (m, 3H), 7.24–7.30 (m, 3H), 7.10–7.17 (m, 1H), 3.44 (s, 3H), 
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2.22 ppm (s, 3H); 13C NMR (101 MHz, CDCl3): δ = 169.9 (s), 168.6 (s), 143.0 (s), 141.9 (s), 
137.8 (s), 131.6 (s), 128.2 (s), 127.9 (s), 127.2 (s), 125.6 (s), 120.5 (s), 119.6 (s), 51.9 (s), 
25.1 ppm (s); IR (ATR): ṽ = 3236, 3037, 2949, 1722, 1548, 1466, 1369, 1266 cm-1; MS (EI, 
70 eV) m/z (%):269 (62) [M+], 227 (68), 195 (100), 168 (22), 139 (9); HRMS (EI–TOF) 
calcd. for C16H15NO3: 269.1052; found: 269.1063; m.p.: 162–163 °C. 
7.3.4.23. Synthesis of methyl−3−phenylnaphthalene−2−carboxylate 
 
[CAS: 68376-11-4] 
The title compound was prepared following the general method A from naphthalene–2–
carboxylic acid (70.8 mg, 0.50 mmol) and bromobenzene (119.0 mg, 79.8 µL, 0.75 mmol). 
The title compound was isolated as colorless oil (115 mg, 88%). 
1H NMR (400 MHz, CDCl3): δ = 8.39–8.44 (m, 1H), 7.93–7.99 (m, 1H), 7.86–7.92 (m, 1H), 
7.84 (s, 1H), 7.52–7.65 (m, 2H), 7.34–7.49 (m, 5H), 3.67–3.76 ppm (m, 3H); 13C NMR 
(101 MHz, CDCl3): δ = 169.0 (s), 141.4 (s), 138.8 (s), 134.4 (s), 131.5 (s), 131.0 (s), 129.7 
(s), 129.1 (s), 128.6 (s), 128.5 (s), 128.2 (s), 128.0 (s), 127.8 (s), 127.1 (s), 126.7 (s), 52.1 ppm 
(s); IR (ATR): ṽ = 3055, 3020, 2948, 1717, 1491, 1441, 1276, 1214 cm-1; MS (EI, 70 eV) m/z 
(%):262 (100) [M+], 231 (49), 202 (14). The analytical data matched those reported in the 
literature.[265] 
7.3.4.24. Synthesis of methyl−4−methylbiphenyl−2−carboxylate 
 
[CAS: 152620-33-2] 
The title compound was prepared following the general method A from 3–methylbenzoic acid 
(68.8 mg, 0.50 mmol) and bromobenzene (119.0 mg, 79.8 µL, 0.75 mmol). The title 
compound was isolated as colorless oil (96 mg, 85%). 
The title compound was prepared following the general method B from 3–methylbenzoic acid 
(68.8 mg, 0.50 mmol) and chlorobenzene (227 mg, 205 µL, 0.75 mmol). The title compound 
was isolated as colorless oil (67 mg, 59%). 
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1H NMR (400 MHz, CDCl3): δ = 7.65 (d, J = 0.5 Hz, 1H), 7.27–7.44 (m, 7H), 3.64 (s, 3H), 
2.44 ppm (s, 3H); 13C NMR (101 MHz, CDCl3): δ = 169.4 (s), 141.3 (s), 139.6 (s), 137.1 (s), 
130.7 (s), 130.6 (s), 130.3 (s), 128.4 (s), 128.0 (s), 127.1 (s), 51.9 (s), 21.0 ppm (s); IR (ATR): 
ṽ = 3027, 2949, 1717, 1482, 1434, 1296, 1243, 1089 cm-1; MS (EI, 70 eV) m/z (%):226 (100) 
[M+], 195 (67), 165 (13). The analytical data matched those reported in the literature.[346] 
7.3.4.25. Synthesis of methyl−4−methylbiphenyl−2−carboxylate 
CO2MeCl
 
[CAS: 1092775-67-1] 
The title compound was prepared following the general method A from 3–chlorobenzoic acid 
(79.1 mg, 0.50 mmol) and bromobenzene (79.3 mg, 53.2 µL, 0.50 mmol). The title compound 
was isolated as colorless oil (93.3 mg, 76%). 
1H NMR (400 MHz, CDCl3): δ = 7.80–7.85 (m, 1H), 7.51 (dd, J = 8.2, 2.4 Hz, 1H), 7.35–
7.45 (m, 3H), 7.33 (d, J = 8.3 Hz, 1H), 7.27–7.31 (m, 2H), 3.66 ppm (s, 3H); 13C NMR 
(101 MHz, CDCl3): δ = 167.8 (s), 140.9 (s), 140.1 (s), 133.2 (s), 132.1 (s), 132.0 (s), 131.2 
(s), 129.7 (s), 128.2 (s), 128.1 (s), 127.5 (s), 52.2 ppm (s); IR (ATR): ṽ = 3064, 2950, 1721, 
1472, 1396, 1142, 1107, 1009 cm-1; MS (EI, 70 eV) m/z (%): 246 (94) [M+], 215 (100), 152 
(40), 76 (11). The analytical data matched those reported in the literature.[347] 
7.3.4.26. Synthesis of methyl−3,5−dimethoxybiphenyl−2−carboxylate 
 
[CAS: 131035-40-0] 
The title compound was prepared following the general method A from 2,4–
dimethoxybenzoic acid (92.9 mg, 0.50 mmol) and bromobenzene (79.3 mg, 53.2 µL, 
0.50 mmol). The title compound was isolated as purple oil (114 mg, 84%). 
1H NMR (400 MHz, CDCl3): δ = 7.30–7.43 (m, 5H), 6.50 (s, 2H), 3.87 (s, 3H), 3.85 (s, 3H), 
3.58 ppm (s, 3H); 13C NMR (101 MHz, CDCl3): δ = 168.4 (s), 161.3 (s), 158.1 (s), 142.7 (s), 
140.5 (s), 128.3 (s), 128.0 (s), 127.6 (s), 116.0 (s), 106.1 (s), 97.5 (s), 56.0 (s), 55.5 (s), 
51.9 ppm (s); IR (ATR): ṽ = 2942, 2841, 1726, 1598, 1456, 1415, 1339, 12612 cm-1; MS (EI, 
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70 eV) m/z (%):272 (71) [M+], 241.2 (100). The analytical data matched those reported in the 
literature.[348] 
7.3.4.27. Synthesis of methyl−3−phenyl−1−benzothiophene−2−carboxylate 
CO2MeS
 
[CAS: 58878-44-7] 
The title compound was prepared following the general method A from 1–benzothiophene–2–
carboxylic acid (89.1 mg, 0.50 mmol) and bromobenzene (119 mg, 79.8 µL, 0.75 mmol). The 
title compound was isolated as colorless solid (73 mg, 54%). 
1H NMR (400 MHz, CDCl3): δ = 7.88–7.92 (m, 1H), 7.34–7.57 (m, 8H), 3.80 ppm (s, 3H); 
13C NMR (101 MHz, CDCl3): δ = 162.9 (s), 144.2 (s), 140.4 (s), 134.5 (s), 129.6 (s), 128.1 
(s), 128.0 (s), 127.8 (s), 127.2 (s), 125.3 (s), 124.8 (s), 122.5 (s), 120.0 (s), 52.2 ppm (s); IR 
(ATR): ṽ = 2943, 2845, 1700, 1516, 1440, 1291, 1177, 1155 cm-1; MS (EI, 70 eV) m/z 
(%):268 (100) [M+], 237 (72), 208 (7), 165 (15); m.p.: 65–66 °C. The analytical data matched 
those reported in the literature.[349] 
7.3.4.28. Synthesis of methyl−7−phenylquinoline−6−carboxylate 
 
[CAS: 2051922-29-1] 
The title compound was prepared following the general method A from 6–quinolinecarboxylic 
acid (89.3 mg, 0.50 mmol) and bromobenzene (79.3 mg, 53.2 µL, 0.50 mmol). The title 
compound was isolated as orange oil (53 mg, 40%). 
1H NMR (400 MHz, CDCl3): δ = 9.03 (dd, J = 4.3, 1.8 Hz, 1H), 8.36 (s, 1H), 8.25–8.29 (m, 
1H), 8.13 (s, 1H), 7.39–7.50 (m, 6H), 3.71 ppm (s, 3H); 13C NMR (101 MHz, CDCl3): δ = 
168.6 (s), 152.6 (s), 148.8 (s), 142.5 (s), 140.6 (s), 136.6 (s), 131.1 (s), 130.7 (s), 130.1 (s), 
128.4 (s), 128.2 (s), 127.5 (s), 126.5 (s), 121.8 (s), 52.2 ppm (s); IR (ATR): ṽ = 2948, 1720, 
1623, 1456, 1430, 1342, 1268, 1200 cm-1; MS (EI, 70 eV) m/z (%):263 (100) [M+], 232 (86), 
204 (14), 176 (9); HRMS (EI–TOF) calcd. for C17H13NO2: 263.0936; found: 263.0941. 
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7.3.4.29. Synthesis of methyl−2−phenylnaphthalene−1−carboxylate 
MeO2C
 
[CAS: 109251-89-0] 
The title compound was prepared following the general method B from naphthalene–1–
carboxylic acid (87.8 mg, 0.50 mmol) and chlorobenzene (227 mg, 205 µL, 2.00 mmol). The 
title compound was isolated as colorless solid (120 mg, 92%). 
1H NMR (400 MHz, CDCl3): δ = 7.98 (d, J = 8.3 Hz, 2H), 7.89–7.94 (m, 1H), 7.37–7.63 (m, 
8H), 3.71 ppm (s, 3H); 13C NMR (101 MHz, CDCl3): δ = 170.0 (s), 140.9 (s), 138.0 (s), 132.3 
(s), 130.0 (s), 129.9 (s), 128.5 (s), 128.4 (s), 128.1 (s), 127.6 (s), 127.5 (s), 127.4 (s), 126.3 
(s), 125.0 (s), 52.2 ppm (s); IR (ATR): ṽ = 3051, 2997, 2946, 1716, 1427, 1371, 1341, 
1036 cm-1; MS (EI, 70 eV) m/z (%): 262 (100) [M+], 231 (85), 202 (15); m.p.: 75–76 °C. The 
analytical data matched those reported in the literature.[265] 
7.3.5. Synthesis of the corresponding biaryls via ortho-C−H arylation with in situ 
protodecarboxylation 
 
Standard procedure: An oven–dried 20 mL vessel was charged with [(p–cym)RuCl2]2 
(12.2 mg, 0.02 mmol, 4 mol%), triethylphosphonium tetrafluoroborate (8.32 mg, 0.04 mmol, 
8 mol%), K2CO3 (76 mg, 0.55 mmol, 1.1 eq.), Cu2O (7.23 mg, 0.05 mmol, 10 mol%) and the 
ortho-substituted benzoic acid (0.50 mmol). After the vessel was flushed with 3 alternating 
vacuum and nitrogen purge cycles, NMP (3 mL) and bromobenzene (79.3 mg, 53.2 µL, 
0.50 mmol) were added via syringe. The resulting mixture was stirred at 180 °C for 18 h. 
After the reaction was complete, the mixture was allowed to cool to RT, then ethyl acetate 
(20 mL) was added and the resulting mixture was washed with water, aqueous LiCl solution 
(20%) and brine (20 mL each). The organic layer was dried over MgSO4, filtered, and the 
volatiles were removed under reduced pressure. The residue was purified by column 
chromatography (SiO2, ethyl acetate/hexane gradient) yielding the corresponding biaryl. 
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7.3.5.1. Synthesis of 3−methyl−1,1'−biphenyl 
 
[CAS: 643-93-6] 
The title compound was prepared following the general method for the in situ ortho–C–H 
arylation and protodecarboxylation, starting from 2–methylbenzoic acid (68.8 mg, 
0.50 mmol). The title compound was isolated as colorless oil (45 mg, 54%). 
1H NMR (400 MHz, CDCl3): δ = 7.58–7.65 (m, 2H), 7.39–7.49 (m, 4H), 7.33–7.39 (m, 2H), 
7.19 (d, J = 7.3 Hz, 1H), 2.45 ppm (s, 3H); 13C NMR (101 MHz, CDCl3): δ = 141.3 (s), 141.2 
(s), 138.3 (s), 128.7 (s), 128.6 (s), 128.0 (s), 127.2 (s), 127.1 (s), 124.2 (s), 21.5 ppm (s); IR 
(ATR): ṽ = 3057, 3031, 2916, 1601, 1481, 791, 752, 698 cm-1; MS (EI, 70 eV) m/z (%): 168 
(100) [M+], 165 (19), 153 (15), 152 (18). The analytical data matched those reported in the 
literature.[350] 
7.3.5.2. Synthesis of 3−fluoro−1,1'−biphenyl 
 
[CAS: 2367-22-8] 
The title compound was prepared following the general method for the in situ ortho–C–H 
arylation and protodecarboxylation, starting from 2–fluorobenzoic acid (70.8 mg, 0.50 mmol). 
The title compound was isolated as colorless oil (61 mg, 71%). 
1H NMR (400 MHz, CDCl3): δ = 7.58–7.65 (m, 2H), 7.40–7.49 (m, 5H), 7.32–7.39 (m, 2H), 
7.19 (d, J = 7.3 Hz, 1H), 2.45 ppm (s, 3H); 13C NMR (101 MHz, CDCl3): δ = 113.89 (d, J = 
1.82 Hz, 1C), 114.12 (s), 122.75 (d, J = 2.73 Hz, 1C), 127.08 (s, 2C), 127.82 (s), 128.86 (s, 
2C), 130.18 (d, J = 8.18 Hz, 1C), 139.92 (d, J = 2.73 Hz, 1C), 143.49 (d, J = 7.27 Hz, 1C), 
164.39 ppm (d, J = 246.14 Hz, 1C); 19F NMR (376 MHz, CDCl3): δ = –113.16 ppm (s); IR 
(ATR): ṽ = 3065, 3035, 1576, 1474, 1422, 1260, 1186, 1158, 1076, 877, 788, 755, 695 cm-1; 
MS (EI, 70 eV) m/z (%): 172 (100) [M+], 154 (4), 98 (6), 85 (12), 74 (11). The analytical data 
matched those reported in the literature.[351] 
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7.3.6. Synthesis of 3'−fluoro−1,1':2',1''−terphenyl via ortho-C−H arylation followed by a 
one-pot decarboxylative cross-coupling 
 
An oven–dried 20 mL vessel was charged with [(p–cym)RuCl2]2 (12.2 mg, 0.02 mmol, 
4 mol%), triethylphosphonium tetrafluoroborate (8.32 mg, 0.04 mmol, 8 mol%), K2CO3 
(76 mg, 0.55 mmol, 1.1 eq.), and 2–fluorobenzoic acid (70.8 mg, 0.50 mmol). After the vessel 
was flushed with 3 alternating vacuum and nitrogen purge cycles, NMP (3 mL) and 
bromobenzene (79.3 mg, 53.2 µL, 0.50 mmol) were added via syringe. The resulting mixture 
was stirred at 100 °C for 18 h. After the reaction time, the mixture was allowed to cool to RT, 
then a stock solution of Pd(acac)2 (7.62 mg, 25.0 µmol, 5 mol%) and XPhos (12.0 mg, 
25.0 µmol, 5 mol%) in NMP (1 mL), a slurry of Cu2O (7.16 mg, 0.05 mmol, 10 mol%) in 
NMP (0.5 mL) and bromobenzene (64.0 µL, 0.6 mmol, 1.20 eq.) were added via syringe. The 
vessel was heated at 180 °C for 6 h, then allowed to cool to room temperature. Ethyl acetate 
(20 mL) was added and the resulting mixture was washed with water, aqueous LiCl solution 
(20%) and brine (20 mL each). The organic layer was dried over MgSO4, filtered, and the 
volatiles were removed under reduced pressure. The residue was purified by column 
chromatography (SiO2, cyclohexane isocratic) yielding the title compound as colorless oil 
(68 mg, 55%). 
 
[CAS: 2036084-12-3] 
1H NMR (400 MHz, CDCl3): δ = 6.97–7.35 ppm (m, 13H); 13C NMR (101 MHz, CDCl3): δ 
=160.0 (d, J = 246.1 Hz), 143.3 (d, J = 2.7 Hz), 140.2 (d, J = 2.7 Hz), 134.2 (s), 130.9 (d, J = 
1.9 Hz), 129.8 (s), 128.6 (d, J = 9.1 Hz), 128.2 (d, J = 15.4 Hz), 127.8 (s), 127.8 (s), 127.1 (s), 
126.7 (s), 126.0 (d, J = 3.5 Hz), 114.6 ppm (d, J = 23.6 Hz); 19F NMR (376 MHz, CDCl3): δ 
= –115 ppm; IR (ATR): ṽ = 3053, 3021, 2916, 1601, 1487, 792, 752, 698 cm-1; MS (EI, 
70 eV) m/z (%): 248 (100) [M+], 228 (5); HRMS (EI–TOF) calcd. for C18H13F: 248.1001; 
found: 248.0994. 
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7.4. Regioselective C–H Hydroarylation of Internal Alkynes with 
Arenecarboxylates: Carboxylates as Deciduous Directing Groups 
7.4.1. General Methods 
Chemicals and solvents were either purchased (puriss p.A.) from commercial supplier or 
purified by standard techniques.[343] All reactions, if not stated otherwise, were performed in 
oven-dried glassware under a nitrogen atmosphere containing a Teflon-coated stirrer bar and 
dry septum. All reactions were monitored by GC using tetradecane as an internal standard. 
Response factors of the products with regard to n-tetradecane were obtained experimentally 
by analyzing known quantities of the substances. GC analyses were carried out using an HP−5 
capillary column (Phenyl methyl siloxane, 30 m × 320 × 0.25, 100/2.3-30-300/3, 2 min at 
60 °C, heating rate 30 °C/min, 3 or 10 min at 300 °C). Column chromatography was 
performed using a Combi Flash Companion-Chromatography-System (Isco-Systems) and 
Reveleris packed columns (12 g). NMR spectra were recorded on Bruker Avance 400 at 
ambient temperature using CDCl3 as solvent, with proton, carbon, and fluorine resonances at 
400, 101, and 376 MHz respectively. 
7.4.2. Catalyst development 
7.4.2.1. Optimization of the non-decarboxylative hydroarylation 
Table 10: Catalyst screening for the hydroarylation with diphenylacetylene. 
Me
CO2H
+
[M],
K2CO3 (0.3 eq.)
dioxane/H2O (1:1),
100 °C, 12 h, N2
Me
CO2H
7.4.2.1.-1 7.4.2.1.-2 7.4.2.1.-3
Ph
Ph
Ph
PhH
 
# [M] /4 mol% Yield/%[a] 
1 [(COD)RhCl]2 - 
2 Rh2OAc4 - 
3 RhCl3 - 
4 [RhCp*Cl2]2 - 
5 [IrCp*Cl2]2 - 
6 [Ir(COD)]2 23 
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7 Ru(CO)Cl(PPh3)3H - 
8 RuCl2(PPh3)3 - 
9 RuCl3 - 
10 [(p−cym)RuCl2]2 96 
Reaction conditions: 7.4.2.1.-1 (0.5 mmol), 7.4.2.1.-2 (0.5 mmol), [M]-catalyst (4 mol%), K2CO3 (0.3 eq.) and 
dioxane/H2O = 10:1 (1.1 mL), 100 °C, 12 h. [a] Yields of corresponding methyl esters determined by GC after 
esterification with K2CO3 (2 eq.) and MeI (5 eq.) in NMP using n-tetradecane as the internal standard. 
Table 11: Solvent screening for the hydroarylation with diphenylacetylene. 
Me
CO2H
+
[(p-cym)RuCl2]2 (4 mol%),
K2CO3 (0.3 eq.)
solvent, 100 °C, 12 h, N2
Me
CO2H
7.4.2.1.-1 7.4.2.1.-2 7.4.2.1.-3
Ph
Ph
Ph
PhH
+
Me
H
7.4.2.1.-4
Ph
Ph
 
# solvent (10/1) /1.1 mL Yield/%[a] 
7.4.2.1.-3 7.4.2.1.-4 
1 dioxane/H2O 96 - 
2 NMP/H2O 32 34 
3 DMSO/H2O - - 
4 DMF/H2O - - 
5 MeCN/H2O 8 - 
6 toluene/H2O 64 29 
7 iPrOH/H2O 100 - 
8 tAmOH/H2O 100 - 
9 quin/H2O 2 8 
10 H2O 25 9 
11 toluene 11 20 
12 iPrOH 64 - 
13 tAmOH 88 12 
Reaction conditions: 7.4.2.1.-1 (0.5 mmol), 7.4.2.1.-2 (0.5 mmol), [(p−cym)RuCl2]2 (4 mol%), K2CO3 (0.3 eq.) 
and solvent (1.1 mL), 100 °C, 12 h. [a] Yields of corresponding methyl esters determined by GC after 
esterification with K2CO3 (2 eq.) and MeI (5 eq.) in NMP using n-tetradecane as the internal standard. 
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Table 12: Catalyst screening for the hydroarylation with 1−phenyl−1−propyne. 
Me
CO2H
+
[M],
K2CO3 (0.3 eq.)
dioxane/H2O (1:1),
100 °C, 12 h, N2
Me
CO2H
7.4.2.1.-1 7.4.2.1.-5 7.4.2.1.-6
Me
Ph
Me
PhH
+
Me
CO2H
7.4.2.1.-7
Ph
Me
 
# [M] /4 mol% Yield/%[a] 
7.4.2.1.-6 7.4.2.1.-7 
1 [(COD)RhCl]2 - - 
2 Rh2OAc4 - - 
3 RhCl3 - - 
4 [RhCp*Cl2]2 - - 
5 [IrCp*Cl2]2 - - 
6 [Ir(COD)]2 28 4 
7 Ru(CO)Cl(PPh3)3H - - 
8 RuCl2(PPh3)3 - - 
9 RuCl3 6 - 
10 Ru(acac)3 11 6 
11 (COD)Ru(2−methylallyl)2 26 10 
12 (NBD)RuCl2 37 10 
13 [(C6H6)RuCl2]2 43 17 
14 [(p−cym)RuCl2]2 43 5 
15 [(p−cym)Rul2]2 52 10 
16[b] " 60 6 
Reaction conditions: 7.4.2.1.-1 (0.5 mmol), 7.4.2.1.-5 (0.5 mmol), [M]-catalyst (4 mol%), K2CO3 (0.3 eq.) and 
dioxane/H2O = 10:1 (1.1 mL), 100 °C, 12 h. [a] Yields of corresponding methyl esters determined by GC after 
esterification with K2CO3 (2 eq.) and MeI (5 eq.) in NMP using n-tetradecane as the internal standard. [b] [M]-
catalyst (2 mol%). 
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Table 13: Base screening for the hydroarylation with 1−phenyl−1−propyne. 
 
# base /eq. Yield/%[a] 
7.4.2.1.-6 7.4.2.1.-7 
1 K2CO3 /0.3 60 6 
2 Li2CO3 /0.3 46 8 
3 Na2CO3 /0.3 50 7 
4 Cs2CO3 /0.3 57 5 
5 guanidine carbonate /0.3 61 6 
6 (NH4)2CO3 /0.3 - - 
7 TBAOAc /0.3 51 6 
8 NH4OAc /0.3 - - 
9 KOAc /0.3 47 19 
10 K3PO4 /0.3 54 15 
11 KOPiv /0.3 52 6 
12 KOTf /0.3 - - 
13 KOH /0.3 54 15 
14 guanidine carbonate /0.5 68 7 
15 guanidine carbonate /1.0 - - 
16[b] guanidine carbonate /0.5 74 5 
Reaction conditions: 7.4.2.1.-1 (0.5 mmol), 7.4.2.1.-5 (0.5 mmol), [(p−cym)RuI2]2 (2 mol%), base (0.3 eq.) and 
dioxane/H2O = 10:1 (1.1 mL), 100 °C, 12 h. [a] Yields of corresponding methyl esters determined by GC after 
esterification with K2CO3 (2 eq.) and MeI (5 eq.) in NMP using n-tetradecane as the internal standard. [b] 
tAmOH/H2O = 10:1 (1.1 mL) as the solvent. 
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Table 14: Screening of the amount of base, temperature and ratio of the reactants. 
Me
CO2H
+
[(p-cym)RuI2]2 (2 mol%),
guanidine carbonate
tAmOH/H2O (1:1),
, 12 h, N2
Me
CO2H
Me
Ph
Me
PhH
+
Me
CO2H
Ph
Me
7.4.2.1.-1 7.4.2.1.-5 7.4.2.1.-6 7.4.2.1.-7
 
# eq. guanidine carbonate T/°C Yield/%[a] 
7.4.2.1.-6 7.4.2.1.-7 
1 0.1 100 48 9 
2 0.5 " 74 5 
3 0.7 " - - 
4 0.1 90 47 4 
5 0.5 " 56 3 
6 0.7 " - - 
7 0.5 110 70 13 
8[b] " 100 73 6 
9[c] " " 90(93) 5 
Reaction conditions: 7.4.2.1.-1 (0.5 mmol), 7.4.2.1.-5 (0.5 mmol), [(p−cym)RuI2]2 (2 mol%), guanidine 
carbonate as the base and tAmOH/H2O = 10:1 (1.1 mL), 12 h. [a] Yields of corresponding methyl esters 
determined by GC after esterification with K2CO3 (2 eq.) and MeI (5 eq.) in NMP using n-tetradecane as the 
internal standard. [b] 7.4.2.1.-5 (0.6 mmol). [c] 7.4.2.1.-5 (0.75 mmol). 
7.4.2.2. Optimization of the decarboxylative hydroarylation 
Table 15: Evaluation of the catalyst system for the decarboxylative hydroarylation. 
Me
CO2H
+
[(p-cym)RuICl2]2 (4 mol%),
base, additive, ligand
toluene/H2O (1:1),
, 12 h, N2
Me
CO2H
7.4.2.2.-1 7.4.2.2.-2 7.4.2.2.-3
Ph
Ph
Ph
PhH
+
Me
H
7.4.2.2.-4
Ph
Ph
 
# base /eq. ligand/0.2 eq. additive /eq. T/°C Yield/%[a] 
7.4.2.2.-3 7.4.2.2.-4 
1 K2CO3 /0.3 - - 100 64 29 
2 " L1 - " - 22 
3 guanidine carbonate /0.3 " - " trace 29 
4 guanidine carbonate /0.2 " - " " 34 
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5 " L2 - " " 31 
6 " L3 - " " 26 
7 "  L4 - " " 32 
8 " L5 - " " 28 
9 " L6 - " " 28 
10 " L7 - " 5 32 
11 " L8 - " trace 32 
12 " L1 HOAc/1 eq. " 15 37 
13[b] " " " " 21 53 
14[b] " - " " 28 52 
15[b] " - HOAc/2 eq. " 11 50 
16[b] " - PivOH/1 eq. " 18 50 
17[b] " - TFA/1 eq. " - - 
18[b] " L1 HOAc/1 eq. 120 <5 80 
19[b] " - " " 13 78 
20[c] " L1 " " <5 87(73) 
Reaction conditions: 7.4.2.2.-1 (0.5 mmol), 7.4.2.2.-2 (0.5 mmol), [(p−cym)RuCl2]2 (4 mol%), base, ligand and 
toluene/H2O = 10:1 (1.1 mL), 12 h. [a] Yields of corresponding methyl esters determined by GC after 
esterification with K2CO3 (2 eq.) and MeI (5 eq.) in NMP using n-tetradecane as the internal standard. [b] 
Toluene (1 mL) was used as the solvent. [c] Toluene (2 mL) was used as the solvent. 
 
7.4.3. Mechanistic control experiments for the decarboxylative hydroarylation 
7.4.3.1. H/D-scrambling experiments 
 
Scheme 47: H/D-scrambling experiment in the presence of deuterated acetic acid. 
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Figure 1: 1H−NMR profile of (d)−7.4.3.1.-3 after the H/D-scrambling experiment in the 
presence deuterated acetic acid. 
 
Figure 2: 1H−NMR profile of (d)−7.4.3.1.-4 after the H/D-scrambling experiment in the 
presence of deuterated acetic acid. 
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Scheme 48: H/D-scrambling experiment in the presence of deuterated toluene. 
 
Figure 3: 1H−NMR profile of (d)−7.4.3.1.-4 after the H/D-scrambling experiment in the 
presence of deuterated toluene. 
 
Scheme 49: H/D-scrambling experiment of o−fluoro benzoic acid in the presence of 
deuterated acetic acid. 
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Figure 4: 19F−NMR (H−decoupled) profile of (d)−7.4.3.1.-6  after the H/D-scrambling 
experiment in the presence of deuterated acetic acid. E/Z isomeric mixture is 
caused by the excess of AcOD. 
 
Scheme 50: H/D-scrambling experiment of o-fluoro benzoic acid in the presence of 
deuterated toluene. 
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Figure 5: 19F−NMR (H−decoupled) profile of (d)−7.4.3.1.-6  after the H/D-scrambling 
experiment in the presence of deuterated toluene. No signal for the F-Dortho 
coupling was detected. 
7.4.3.2. ESI-MS measurements 
 
Scheme 51: Standard decarboxylative hydroarylation reaction set-up for in situ ESI-MS 
experiments. 
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Figure 6: ESI-MS measurement of the reaction mixture (t = 0, room temperature). 
 
Figure 7: ESI-MS measurement of the reaction mixture (t = 0, 120 °C). 
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Figure 8: ESI-MS measurement of the reaction mixture (t = 3 h, 120 °C). 
7.4.4. Synthesis of the corresponding vinylarene carboxylic acids via non-
decarboxylative ortho-C−H hydroarylation 
 
Standard procedure: An oven–dried 20 mL vessel was charged with [(p–cym)RuI2]2 
(9.8 mg, 0.01 mmol, 2 mol%), guanidine carbonate (46 mg, 0.25 mmol, 0.5 eq.) and the 
benzoic acid (0.50 mmol). After the vessel was flushed with 3 alternating vacuum and 
nitrogen purge cycles, a degassed mixture of tAmylOH (1 mL) and H2O (0.1 mL), and the 
alkyne (0.75 mmol, 1.5 eq.) was added via syringe. The resulting mixture was stirred at 
100 °C for 18 h. After the reaction was complete, the mixture was allowed to cool to room 
temperature. MeCN (2 mL), K2CO3 (1 mmol) and MeI (2.5 mmol) were added and the 
mixture was stirred at 50 °C for another 2 h. The mixture was allowed to cool to room 
temperature, brine (20 mL) was added and the resulting mixture was extracted with ethyl 
acetate (3 × 20 mL). The combined organic layers were dried over MgSO4, filtered, and the 
volatiles were removed under reduced pressure. The residue was purified by column 
chromatography (SiO2, ethyl acetate/hexane gradient) yielding the hydroarylation products in 
the form of its methyl ester. 
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7.4.4.1. Synthesis of (E)−methyl−2−methyl−6−(1−phenylprop−1−en−2−yl)−benzoate 
 
[CAS: 1642792-71-9] 
The title compound was prepared starting from 2–methylbenzoic acid (68.8 mg, 0.5 mmol) 
and 1–phenyl–1–propyne (94.3 mg, 0.75 mmol). The title compound was isolated as yellow 
liquid (124 mg, 93%). 
1H NMR (400 MHz, CDCl3): δ = 7.37–7.29 (m, 5H), 7.25–7.22 (m, 1H), 7.17–7.12 (m, 2H), 
6.40 (d, J = 0.8 Hz, 1H), 3.80 (s, 3H), 2.37 (s, 3H), 2.20 ppm (d, J = 1.2 Hz, 3H); 13C NMR 
(101 MHz, CDCl3): δ = 170.3 (s), 143.9 (s), 138.1 (s), 137.8 (s), 135.4 (s), 132.5 (s), 129.2 
(s), 129.2 (s), 128.8 (s), 128.7 (s), 128.2 (s), 126.6 (s), 125.3 (s), 52.0 (s), 19.8 (s), 19.7 ppm 
(s); IR (ATR): ṽ = 2922, 1727, 1438, 1265, 1098, 1069, 787, 730, 697 cm-1; MS (EI, 70 eV) 
m/z (%): 266 (100) [M+], 234 (85), 191 (15); HRMS (EI–TOF) calcd. for C18H18O2: 
266.1307; found: 266.1322. 
7.4.4.2. Synthesis of (E)−methyl−2−bromo−6−(1−phenylprop−1−en−2−yl)−benzoate 
 
[CAS: 1914996-24-9] 
The title compound was prepared starting from 2–bromobenzoic acid (104 mg, 0.5 mmol) 
and 1–phenyl–1–propyne (94.3 mg, 0.75 mmol). The title compound was isolated as colorless 
solid (111 mg, 67%). 
1H NMR (400 MHz, CDCl3): δ = 7.52 (dd, J = 7.2 Hz, 1.2 Hz, 1H), 7.38 (t, J = 7.2 Hz, 2H), 
7.31–7.27 (m, 5H), 6.48 (s, 1H), 3.86 (s, 3H), 2.20 ppm (d, J = 1.2 Hz, 3H); 13C NMR 
(101 MHz, CDCl3): δ = 168.3 (s), 145.6 (s), 137.3 (s), 136.5 (s), 134.6 (s), 131.1 (s), 130.5 
(s), 130.4 (s), 128.9 (s), 128.3 (s), 126.91 (s), 126.87 (s), 119.4 (s), 52.5 (s), 19.6 ppm (s); IR 
(ATR): ṽ = 2950, 1729, 1436, 1265, 1117, 1061, 866, 783, 751 cm-1; MS (EI, 70 eV) m/z (%): 
331 (82) [M+], 329 (78) [M+], 300 (65), 299 (100), 298 (65), 297 (93), 191 (64); HRMS (EI–
TOF) calcd. for C17H15BrO2: 332.0235/330.0255; found: 332.0237/330.0257; m.p.: 74–76 °C. 
Experimental Section 
 
 154
7.4.4.3. Synthesis of (E)−methyl−2−chloro−6−(1−phenylprop−1−en−2−yl)−benzoate 
 
[CAS: 1914996-27-2] 
The title compound was prepared starting from 2–chlorobenzoic acid (79.9 mg, 0.5 mmol) 
and 1–phenyl–1–propyne (94.3 mg, 0.75 mmol). The title compound was isolated as yellow 
solid (95 mg, 66%). 
1H NMR (400 MHz, CDCl3): δ = 7.32–7.26 (m, 4H), 7.24–7.23 (m, 1H), 7.22–7.20 (m, 1H), 
7.19–7.17 (m, 2H), 6.40 (s, 1H), 3.78 (s, 3H), 2.12 ppm (d, J = 1.2 Hz, 3H); 13C NMR 
(101 MHz, CDCl3): δ = 167.7 (s), 145.5 (s), 137.3 (s), 136.5 (s), 132.5 (s), 130.9 (s), 130.4 
(s), 130.2 (s), 128.9 (s), 128.3 (s), 127.9 (s), 126.9 (s), 126.3 (s), 52.5 (s), 19.5 ppm (s); IR 
(ATR): ṽ = 2952, 1731, 1438, 1263, 1188, 1117, 1063, 954, 787, 754, 698 cm-1; MS (EI, 
70 eV) m/z (%): 286 (100) [M+], 256 (36), 255 (62), 254 (66), 227 (32), 219 (40), 191 
(40); HRMS (EI–TOF) calcd. for C17H15ClO2: 286.0761; found: 286.0760; m.p.: 73–75 °C. 
7.4.4.4. Synthesis of 
(E)−methyl−2−(1−phenylprop−1−en−2−yl)−6−(trifluoromethyl)benzoate 
 
[CAS: 1914996-28-3] 
The title compound was prepared starting from 2–(trifluoromethyl)benzoic acid (97 mg, 
0.5 mmol) and 1–phenyl–1–propyne (94.3 mg, 0.75 mmol). The title compound was isolated 
as yellow liquid (120 mg, 75%). 
1H NMR (400 MHz, CDCl3): δ = 7.64 (dd, J = 8.8 Hz, 4.0 Hz, 1H), 7.57–7.54 (m, 2H), 7.39 
(t, J = 7.6 Hz, 2H), 7.32–7.26 (m, 4H), 6.46 (s, 1H), 3.85 (s, 3H), 2.22 ppm (d, J = 1.2 Hz, 
3H); 13C NMR (101 MHz, CDCl3): δ = 167.9 (s), 145.0 (s), 137.2 (s), 136.2 (s), 131.7 (d, J = 
1 Hz, 1C), 130.9 (d, J = 2 Hz, 1C), 130.8 (s), 129.4 (s), 128.8 (s), 128.3 (s), 127.5 (s), 127.0 
(s), 124.6 (q, J = 4 Hz, 1C), 123.44 (d, J = 278 Hz, 1C), 52.7 (s), 19.8 ppm (s); IR (ATR): ṽ = 
2952, 1738, 1321, 1168, 1128, 1066, 806, 733, 698 cm-1; MS (EI, 70 eV) m/z (%): 321 (23) 
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[M+], 320 (100), 289 (8), 288 (12), 269 (12), 268 (11), 267 (9); HRMS (EI–TOF) calcd. for 
C18H15F3O2: 320.1024; found: 320.1017. 
7.4.4.5. Synthesis of (E)−methyl−2−acetyl−6−(1−phenylprop−1−en−2−yl)−benzoate 
 
[CAS: 1914996-32-9] 
The title compound was prepared starting from 2–acetylbenzoic acid (82.9 mg, 0.5 mmol) 
and 1–phenyl–1–propyne (94.3 mg, 0.75 mmol). The title compound was isolated as colorless 
solid (77 mg, 52%). 
1H NMR (400 MHz, CDCl3): δ = 77.76 (dd, J = 6.0 Hz, 2.8 Hz, 1H), 7.54–7.49 (m, 2H), 
7.40–7.36 (m, 2H), 7.32–7.31 (m, 2H), 7.29–7.24 (m, 1H), 6.43 (s, 1H), 3.85 (s, 3H), 2.63 (s, 
3H), 2.20 ppm (d, J = 1.2 Hz, 3H); 13C NMR (101 MHz, CDCl3): δ = 198.5 (s), 169.8 (s), 
144.8 (s), 137.4 (s), 136.21 (s), 136.20 (s), 132.4 (s), 132.3 (s), 130.5 (s), 129.1 (s), 128.9 (s), 
128.2 (s), 127.5 (s), 126.8 (s), 52.4 (s), 27.6 (s), 19.8 ppm (s); IR (ATR): ṽ = 2953, 1728, 
1683, 1443, 1261, 1122, 1072, 800, 761, 702 cm-1; MS (EI, 70 eV) m/z (%): 294 (8) [M+], 
263 (30), 262 (100), 247 (39), 219 (46), 191 (20), 44 (12), 43 (24); HRMS (EI–TOF) calcd. 
for C19H18O3: 294.1256; found: 294.1275; m.p.: 95–96 °C. 
7.4.4.6. Synthesis of (E)−methyl−2−methoxy−6−(1−phenylprop−1−en−2−yl)−benzoate 
 
[CAS: 1914996-34-1] 
The title compound was prepared starting from 2–methoxybenzoic acid (76.8 mg, 
0.5 mmol) and 1–phenyl–1–propyne (94.3 mg, 0.75 mmol). The title compound was isolated 
as yellow liquid (101 mg, 71%). 
1H NMR (400 MHz, CDCl3): δ = 7.29–7.27 (m, 2H), 7.26 (t, J = 2.0 Hz, 1H), 7.23–7.21 (m, 
2H), 7.18–7.14 (m,1H), 6.86 (dd, J = 7.6 Hz, 0.8 Hz, 1H), 6.79 (d, J = 8.0 Hz, 1H), 6.39 (s, 
1H), 3.78 (s, 3H), 3.74 (s, 3H), 2.11 ppm (d, J = 1.6 Hz, 3H); 13C NMR (101 MHz, CDCl3): δ 
= 168.5 (s), 156.4 (s), 145.1 (s), 137.7 (s), 137.1 (s), 130.3 (s), 129.6 (s), 128.9 (s), 128.1 (s), 
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126.6 (s), 122.4 (s), 120.1 (s), 109.4 (s), 56.0 (s), 52.2 (s), 19.5 ppm (s); IR (ATR): ṽ = 2954, 
1727, 1573, 1428, 1252, 1102, 1050, 867, 795, 699 cm-1; MS (EI, 70 eV) m/z (%): 283 (20), 
281 (100) [M+], 267 (20), 251 (56), 250 (39), 223 (35), 221 (19); HRMS (EI–TOF) calcd. for 
C18H18O3: 282.1256; found: 282.1257. 
7.4.4.7. Synthesis of (E)−methyl−3−(1−phenylprop−1−en−2−yl)biphenyl−2−carboxylate 
 
[CAS: 1914996-37-4] 
The title compound was prepared starting from biphenyl–2–carboxylic acid (101 mg, 
0.5 mmol) and 1–phenyl–1–propyne (94.3 mg, 0.75 mmol). The title compound was isolated 
as yellow liquid (155 mg, 94%). 
1H NMR (400 MHz, CDCl3): δ = 7.47 (t, J = 4.0 Hz, 1H), 7.42–7.41 (m, 4H), 7.38–7.36 (m, 
3H), 7.34–7.31 (m, 4H), 7.27–7.23 (m, 1H), 6.46 (s, 1H), 3.56 (s, 3H), 2.27 ppm (d, J = 
1.6 Hz, 3H); 13C NMR (101 MHz, CDCl3): δ = 170.0 (s), 144.2 (s), 140.6 (s), 140.3 (s), 137.7 
(s), 137.7 (s), 132.2 (s), 129.6 (s), 129.2 (s), 128.9 (s), 128.4 (s), 128.3 (s), 128.27 (s), 128.2 
(s), 127.5 (s), 127.0 (s), 126.6 (s), 51.9 (s), 19.9 ppm (s); IR (ATR): ṽ = 2984, 1725, 1436, 
1260, 1120, 1068, 869, 759, 702 cm-1; MS (EI, 70 eV) m/z (%): 328 (61) [M+], 297 (24), 296 
(28), 281 (24), 207 (62), 44 (100), 40 (46); HRMS (EI–TOF) calcd. for C23H20O2: 328.1463; 
found: 328.1461. 
7.4.4.8. Synthesis of (E)−methyl−2−ethyl−6−(1−phenylprop−1−en−2−yl)−benzoate 
 
[CAS: 1914996-39-6] 
The title compound was prepared starting from 2–ethylbenzoic acid (75.1 mg, 0.5 mmol) 
and 1–phenyl–1–propyne (94.3 mg, 0.75 mmol). The title compound was isolated as yellow 
liquid (127 mg, 91%). 
1H NMR (400 MHz, CDCl3): δ = 7.39–7.32 (m, 3H), 7.34–7.31 (m, 2H), 7.27–7.2 (m, 1H), 
7.21–7.18 (m, 2H), 6.42 (s, 1H), 3.81 (s, 3H), 2.71 (q, J = 7.6 Hz, 2H), 2.22 (d, J = 1.2 Hz, 
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3H), 1.26 ppm (t, J = 7.6 Hz, 3H); 13C NMR (101 MHz, CDCl3): δ = 170.4 (s), 143.9 (s), 
141.6 (s), 138.1 (s), 137.8 (s), 132.1 (s), 129.32 (s), 129.29 (s), 128.9 (s), 128.2 (s), 127.2 (s), 
126.6 (s), 125.3 (s), 52.0 (s), 26.8 (s), 19.8 (s), 15.6 ppm (s); IR (ATR): ṽ = 2968, 1726, 1444, 
1246, 1076, 729, 698 cm-1; MS (EI, 70 eV) m/z (%): 280 (61) [M+], 248 (24), 233 (28), 219 
(24), 189 (62), 178 (100), 115 (46), 91 (27); HRMS (EI–TOF) calcd. for C19H20O2: 280.1463; 
found: 280.1471. 
7.4.4.9. Synthesis of 
(E)−methyl−3−bromo−2−methyl−6−(1−phenylprop−1−en−2−yl)−benzoate 
 
[CAS: 1914996-41-0] 
The title compound was prepared starting from 3–bromo–2–methylbenzoic acid (111 mg, 
0.5 mmol) and 1–phenyl–1–propyne (94.3 mg, 0.75 mmol). The title compound was isolated 
as colorless liquid (158 mg, 91%). 
1H NMR (400 MHz, CDCl3): δ = 7.55 (d, J = 8.0 Hz, 1H), 7.33 (t, J = 7.2 Hz, 2H), 7.27–7.20 
(m, 3H), 7.00 (d, J = 7.2 Hz, 1H), 6.39 (d, J = 8.4 Hz, 1H), 6.33 (s, 1H), 3.78 (s, 3H), 2.39 (s, 
3H), 2.15 ppm (s, 3H); 13C NMR (101 MHz, CDCl3): δ = 169.4 (s), 142.9 (s), 137.4 (s), 136.9 
(s), 134.7 (s), 134.5 (s), 133.2 (s), 129.8 (s), 128.8 (s), 128.2 (s), 126.8 (s), 126.7 (s), 124.0 
(s), 52.2 (s), 20.4 (s), 19.6 ppm (s); IR (ATR): ṽ = 2949, 1728, 1434, 1251, 1153, 1089, 1017, 
814, 732, 698 cm-1; MS (EI, 70 eV) m/z (%): 346 (100) [M+], 344 (99) [M+], 314 (63), 313 
(45), 312 (53), 233 (57), 206 (55); HRMS (EI–TOF) calcd. for C17H15BrO2: 344.0412; found: 
344.0418. 
7.4.4.10. Synthesis of (E)−dimethyl−4−(1−phenylprop−1−en−2−yl)−isophthalate 
CO2Me
Me
Ph
MeO2C
 
[CAS: 1914996-44-3] 
The title compound was prepared starting from mono–methyl isophthalate (92.9 mg, 
0.5 mmol) and 1–phenyl–1–propyne (94.3 mg, 0.75 mmol). The title compound was isolated 
as yellow liquid (116 mg, 75%). 
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1H NMR (400 MHz, CDCl3): δ = 8.50 (d, J = 2.0 Hz, 1H), 8.16 (dd, J = 8.0 Hz, 1.6 Hz, 1H), 
7.44 (d, J = 8.0 Hz, 1H), 7.39–7.38 (m, 4H), 7.30–7.24 (m, 1H), 6.39 (d, J = 1.2 Hz, 1H), 3.96 
(s, 3H), 3.89 (s, 3H), 2.23 ppm (d, J = 1.2 Hz, 3H); 13C NMR (101 MHz, CDCl3): δ = 167.7 
(s), 166.1 (s), 151.3 (s), 138.5 (s), 137.5 (s), 132.4 (s), 131.3 (s), 130.1 (s), 129.6 (s), 129.0 
(s), 128.81 (s), 128.80 (s), 128.2 (s), 126.8 (s), 52.35 (s), 52.32 (s), 19.8 ppm (s); IR (ATR): ṽ 
= 2952, 1722, 1435, 1306, 1235, 1114, 990, 769. 698 cm-1; MS (EI, 70 eV) m/z (%): 310 (99) 
[M+], 279 (49), 278 (100), 251 (82), 219 (82), 207 (29), 191 (35); HRMS (EI–TOF) calcd. for 
C19H18O4: 310.1205; found: 310.1217. 
7.4.4.11. Synthesis of (E)−methyl−2,3−dichloro−6−(1−phenylprop−1−en−2−yl)−benzoate 
 
[CAS: 1914996-46-5] 
The title compound was prepared starting from 2,3–dichlorobenzoic acid (97.5 mg, 
0.5 mmol) and 1–phenyl–1–propyne (94.3 mg, 0.75 mmol). The title compound was isolated 
as yellow liquid (77 mg, 67%). 
1H NMR (400 MHz, CDCl3): δ = 7.46 (d, J = 8.4 Hz, 1H), 7.36–7.233 (m, 2H), 7.27–7.22 (m, 
3H), 7.17 (d, J = 8.4 Hz, 1H), 6.45 (s, 1H), 3.83 (s, 3H), 2.15 ppm (d, J = 1.2 Hz, 3H); 13C 
NMR (101 MHz, CDCl3): δ = 166.9 (s), 143.5 (s), 137.0 (s), 135.5 (s), 134.4 (s), 131.7 (s), 
130.9 (s), 130.8 (s), 129.3 (s), 128.8 (s), 128.3 (s), 127.3 (s), 127.1 (s), 52.7 (s), 19.4 ppm (s); 
IR (ATR): ṽ = 2951, 1735, 1433, 1243, 1149, 1105, 966, 750, 700 cm-1; MS (EI, 70 eV) m/z 
(%): 322 (73) [M+], 320 (100) [M+], 290 (45), 289 (62), 288 (55), 261 (72), 253 (49); HRMS 
(EI–TOF) calcd. for C17H14Cl2O2: 320.0371; found: 320.0362. 
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7.4.4.12. Synthesis of (E)−methyl−2,4−dimethyl−6−(1−phenylprop−1−en−2−yl)−benzoate 
 
[CAS: 1914996-48-7] 
The title compound was prepared starting from 2,4–dimethylbenzoic acid (76.6 mg, 
0.5 mmol) and 1–phenyl–1–propyne (94.3 mg, 0.75 mmol). The title compound was isolated 
as yellow liquid (124 mg, 88%). 
1H NMR (400 MHz, CDCl3): δ = 7.34–7.28 (m, 4H), 7.21–7.18 (m, 1H), 6.94 (d, J = 10.8 Hz, 
2H), 6.38 (s, 1H), 3.75 (s, 3H), 2.33 (s, 3H), 2.30 (s, 3H), 2.18 ppm (s, 3H); 13C NMR 
(101 MHz, CDCl3): δ = 170.3 (s), 144.1 (s), 139.1 (s), 138.2 (s), 137.8 (s), 135.5 (s), 129.6 
(s), 128.8 (s), 128.77 (s), 128.1 (s), 126.4 (s), 125.9 (s), 51.8 (s), 21.1 (s), 19.7 (s), 19.6 ppm 
(s); IR (ATR): ṽ = 2949, 1724, 1603, 1439, 1264, 1080, 856, 750, 699 cm-1; MS (EI, 70 eV) 
m/z (%): 281 (27), 280 (100) [M+], 279. (7), 249 (11), 248 (8), 233 (10), 189 (9); HRMS (EI–
TOF) calcd. for C19H20O2: 280.1463; found: 280.1456. 
7.4.4.13. Synthesis of (E)−methyl−2−methyl−6−(1−phenylbut−1−en−2−yl)−benzoate 
 
[CAS: 1914996-51-2] 
The title compound was prepared starting from 2–methylbenzoic acid (68.8 mg, 0.5 mmol) 
and 1–butinylbenzene (99.6 mg, 0.75 mmol). The title compound was isolated as colorless 
liquid (98.3 mg, 70%). 
1H NMR (400 MHz, CDCl3): δ = 7.33 (t, J = 7.6 Hz, 2H), 7.27 (t, J = 7.6 Hz, 3H), 7.24–7.20 
(m, 1H), 7.14 (t, J = 7.2 Hz, 2H), 6.39 (s, 1H), 3.77 (s, 3H), 2.62 (q, J = 7.2 Hz, 2H), 2.36 (s, 
3H), 1.02 ppm (t, J = 7.2 Hz, 3H); 13C NMR (101 MHz, CDCl3): δ = 170.3 (s), 143.9 (s), 
141.9 (s), 137.8 (s), 135.3 (s), 133.4 (s), 129.1 (s), 128.9 (s), 128.7 (s), 128. 6 (s), 128.2 (s), 
126.6 (s), 125.4 (s), 51.8 (s), 25.4 (s), 19.8 (s), 12.9 ppm (s); IR (ATR): ṽ = 2970, 1726, 1437, 
1263, 1105, 1070, 785, 698 cm-1; MS (EI, 70 eV) m/z (%): 280 (70) [M+], 249 (30), 248 
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(100), 233 (51), 205 (26), 189 (93), 157 (29); HRMS (EI–TOF) calcd. for C19H20O2: 
280.1463; found: 280.1461. 
7.4.4.14. Synthesis of (E)−methyl−2−methyl−6−(1−phenylhex−1−en−2−yl)−benzoate 
 
[CAS: 1914996-53-4] 
The title compound was prepared starting from 2–methylbenzoic acid (68.8 mg, 0.5 mmol) 
and 1–phenyl–1–hexin (119 mg, 0.75 mmol). The title compound was isolated as yellow 
liquid (81 mg, 53%). 
1H NMR (400 MHz, CDCl3): δ = 7.35 (t, J = 7.6 Hz, 2H), 7.31–7.28 (m, 2H), 7.26–7.22 (m, 
2H), 7.18–7.14 (m, 2H), 6.42 (s, 1H), 3.80 (s, 3H), 2.59 (t, J = 8.0 Hz, 2H), 2.38 (s, 3H), 
1.44–1.38 (m, 2H), 1.33–1.27 (m, 2H), 0.85 ppm (t, J = 8.0 Hz, 3H); 13C NMR (101 MHz, 
CDCl3): δ = 170.3 (s), 142.8 (s), 142.2 (s), 137.8 (s), 135.3 (s), 133.3 (s), 129.4 (s), 128.9 (s), 
128.7 (s), 128.6 (s), 128.2 (s), 126.6 (s), 125.4 (s), 51.8 (s), 32.1 (s), 30.5 (s), 22.9 (s), 19.8 
(s), 13.8 ppm (s); IR (ATR): ṽ = 2955, 1728, 1437, 1264, 1109, 1070, 785, 735, 698 cm-1; MS 
(EI, 70 eV) m/z (%): 308 (28) [M+], 234 (34), 233 (8), 219 (16), 218 (21), 217 (100), 185 
(48); HRMS (EI–TOF) calcd. for C21H24O2: 308.1776; found: 308.1779. 
7.4.4.15. Synthesis of 
(Z)−methyl−2−(3−methoxy−1−phenylprop−1−en−2−yl)−6−methylbenzoate 
 
[CAS: 1914996-55-6] 
The title compound was prepared starting from 2–methylbenzoic acid (68.8 mg, 0.5 mmol) 
and (3–methoxyprop–1–ynyl)–benzene (110 mg, 0.75 mmol). The title compound was 
isolated as yellow liquid (123 mg, 83%). 
1H NMR (400 MHz, CDCl3): δ = 7.41–7.35 (m, 4H), 7.32–7.29 (m, 3H), 7.20–7.17 (m, 1H), 
6.71 (s, 1H), 4.29 (s, 2H), 3.83 (s, 3H), 3.34 (s, 3H), 2.40 ppm (s, 3H); 13C NMR (101 MHz, 
CDCl3): δ = 170.3 (s), 140.8 (s), 138.3 (s), 136.6 (s), 135.5 (s), 133.9 (s), 132.8 (s), 129.14 (s), 
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129.13 (s), 128.9 (s), 128.3 (s), 127.4 (s), 126.2 (s), 71.3 (s), 58.4 (s), 52.0 (s), 19.9 ppm (s); 
IR (ATR): ṽ = 2934, 2225, 1724, 1443, 1266, 1070, 757, 700 cm-1; MS (EI, 70 eV) m/z (%): 
264 (100) [M+–OMe], 249 (88), 237 (68), 234 (68), 221 (66), 177 (55), 162 (90); HRMS (EI–
TOF) calcd. for C19H20O3: 296.1412; found: 296.1416. 
7.4.4.16. Synthesis of 
(E)−methyl−2−(5−hydroxy−1−phenylpent−1−en−2−yl)−6−−benzoate 
 
[CAS: 1914996-58-9] 
The title compound was prepared starting from 2–methylbenzoic acid (68.8 mg, 0.5 mmol) 
and 5–phenylpent–4–yn–1–ol (120 mg, 0.75 mmol). The title compound was isolated as 
colorless liquid (103 mg, 66%). 
1H NMR (400 MHz, CDCl3): δ = 7.33 (t, J = 7.6 Hz, 2H), 7.29–6.20 (m, 4H), 7.14 (t, J = 
7.6 Hz, 2H), 6.44 (s, 1H), 3.79 (s, 3H), 3.53 (t, J = 5.6 Hz, 2H), 2.66 (t, J = 8.0 Hz, 2H), 2.35 
(s, 3H), 1.68–1.61 ppm (m, 2H); 13C NMR (101 MHz, CDCl3): δ = 170.4 (s), 141.8 (s), 141.7 
(s), 137.6 (s), 135.4 (s), 133.3 (s), 130.1 (s), 129.0 (s), 128.9 (s), 128.6 (s), 128.3 (s), 126.7 
(s), 125.3 (s), 62.6 (s), 51.9 (s), 31.3 (s), 28.4 (s), 19.8 ppm (s); IR (ATR): ṽ = 3391, 2949, 
1725, 1439, 1265, 1069, 920, 787, 698 cm-1; MS (EI, 70 eV) m/z (%): 311 (100) [M+], 278 
(88), 234 (68), 189 (68), 115 (66), 91 (55); HRMS (EI–TOF) calcd. for C20H22O3: 310.1569; 
found: 310.1570. 
7.4.4.17. Synthesis of (E)−methyl−2−(1,2−diphenylvinyl)−6−benzoate 
 
[CAS: 1914996-60-3] 
The title compound was prepared starting from 2–methylbenzoic acid (68.8 mg, 0.5 mmol) 
and diphenylacetylene (90 mg, 0.5 mmol). The title compound was isolated as colorless solid 
(162 mg, 99%). 
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1H NMR (400 MHz, DMSO-d6): δ = 7.35–7.24 (m, 5H), 7.17–7.13 (m, 3H), 7.10–7.09 (m, 
2H), 7.06–7.01 (m, 3H), 6.58 (s, 1H), 3.52 (s, 3H), 2.27 ppm (s, 3H); 13C NMR (101 MHz, 
DMSO-d6): δ = 169.2 (s), 142.0 (s), 141.4 (s), 139.5 (s), 136.6 (s), 134.8 (s), 133.2 (s), 129.8 
(s), 129.7 (s), 129.30 (s), 129.28 (s), 129.0 (s), 128.4 (s), 128.1 (s), 127.6 (s), 127.1 (s), 127.1 
(s) 51.8 (s), 19.3 ppm (s); IR (ATR): ṽ = 2950, 1720, 1443, 1263, 1109, 1066, 918, 769, 
696 cm-1; MS (EI, 70 eV) m/z (%): 328 (82) [M+], 295 (78), 269 (65), 252 (100), 165 (65), 
126 (93), 105 (64), 77 (23); HRMS (EI–TOF) calcd. for C23H20O2: 328.1463; found: 
328.1450; m.p.: 104–105 °C. 
7.4.5. Synthesis of the corresponding γ−alkylidene−δ−lactones via 
ortho−C−H hydroarylation followed by in situ esterification with propargylic 
alcohols 
 
Standard procedure: An oven–dried 20 mL vessel was charged with [(p–cym)RuI2]2 
(9.8 mg, 0.01 mmol, 2 mol%), guanidine carbonate (46 mg, 0.25 mmol, 0.5 eq.) and the acid 
(0.50 mmol). After the vessel was flushed with 3 alternating vacuum and nitrogen purge 
cycles, degassed tAmylOH (1 mL), AcOH (28.9 µL, 0.5 mmol, 1 eq.) and the propargylic 
alcohol (0.75 mmol, 1.5 eq.) was added via syringe. The resulting mixture was stirred at 
100 °C for 18 h. After the reaction was complete, the mixture was allowed to cool to room 
temperature. Brine (20 mL) was added and the resulting mixture was extracted with ethyl 
acetate (3 × 20 mL). The combined organic layers were dried over MgSO4, filtered, and the 
volatiles were removed under reduced pressure. The residue was purified by column 
chromatography (SiO2, ethyl acetate/hexane gradient) yielding the corresponding 
isochromanones. 
 
 
 
Experimental Section 
 
 163 
7.4.5.1. Synthesis of (Z)–4–benzylideneisochroman–1–one 
 
[CAS: 90992-13-5] 
The title compound was prepared starting from benzoic acid (123 mg, 1.0 mmol) and 3–
phenyl–2–propyn–1–ol (198 mg, 1.5 mmol). The title compound was isolated as yellow solid 
(212 mg, 89%). 
1H NMR (400 MHz, CDCl3): δ = 8.13 (dd, J = 7.6 Hz, 0.4 Hz, 1H), 7.67–7.60 (m, 2H), 7.47–
7.39 (m, 3H), 7.36–7.32 (m, 1H), 7.23 (t, J = 4.8 Hz, 3H), 5.29 ppm (d, J = 1.2 Hz, 2H); 13C 
NMR (101 MHz, CDCl3): δ = 164.1 (s), 138.2 (s), 135.0 (s), 133.9 (s), 130.2 (s), 129.7 (s), 
129.1 (s), 128.7 (s), 128.5 (s), 128.2 (s), 127.7 (s), 123.4 (s), 123.3 (s), 66.9 ppm (s); IR 
(ATR): ṽ = 1709, 1600, 1270, 1091, 890, 704, 684 cm-1; MS (EI, 70 eV) m/z (%): 236 (100) 
[M+], 207 (85), 178 (15), 105 (45), 76 (27); HRMS (EI–TOF) calcd. for C16H12O2: 236.0837; 
found: 236.0832; m.p.: 122–123 °C. 
7.4.5.2. Synthesis of (Z)–N–(4–benzylidene–1–oxoisochroman–6–yl)–acetamide 
 
[CAS: 1914996-65-8] 
The title compound was prepared starting from 4–acetamidobenzoic acid (90.5 mg, 
0.5 mmol) and 3–phenyl–2–propyn–1–ol (99 mg, 0.75 mmol). The title compound was 
isolated as colorless solid (93.3 mg, 64%). 
1H NMR (400 MHz, CDCl3): δ = 8.23 (d, J = 0.8 Hz, 1H), 8.20 (s, 1H), 8.06 (d, J = 8.4 Hz, 
1H), 7.44–7.34 (m, 4H), 7.19 (d, J = 7.2 Hz, 2H), 5.29 (d, J = 1.2 Hz, 2H), 2.26 ppm (s, 3H); 
13C NMR (101 MHz, CDCl3): δ = 169.2 (s), 164.4 (s), 143.5 (s), 139.9 (s), 135.0 (s), 131.6 
(s), 130.6 (s), 129.2 (s), 128.6 (s), 128.4 (s), 127.6 (s), 119.5 (s), 118.6 (s), 113.3 (s), 67.2 (s), 
24.8 ppm (s); IR (ATR): ṽ = 3296, 1706, 1680, 1586, 1538, 1368, 1262, 1101, 1004, 777, 
694 cm-1; MS (EI, 70 eV) m/z (%): 293 (100) [M+], 164 (85), 222 (15), 194 (45), 165 (27), 
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105 (13); HRMS (EI–TOF) calcd. for C18H15NO3: 293.1052; found: 293.1048; m.p.: 196–
197 °C. 
7.4.5.3. Synthesis of (Z)–4–benzylidene–6–tert–butylisochroman–1–one 
 
[CAS: 1914996-67-0] 
The title compound was prepared starting from 4–tert–butylbenzoic acid (90 mg, 
0.5 mmol) and 3–phenyl–2–propyn–1–ol (99 mg, 0.75 mmol). The title compound was 
isolated as yellow solid (111 mg, 76%). 
1H NMR (400 MHz, CDCl3): δ = 8.09 (d, J = 8.0 Hz, 1H), 7.67 (d, J = 1.6 Hz, 1H), 7.54 (dd, 
J = 8.0 Hz, 1.6 Hz, 1H), 7.44 (t, J = 7.2 Hz, 2H), 7.39–7.35 (m, 1H), 7.27 (t, J = 7.2 Hz, 3H), 
5.31 (d, J = 1.2 Hz, 2H), 1.41 ppm (s, 9H); 13C NMR (101 MHz, CDCl3): δ = 164.4 (s), 157.9 
(s), 138.1 (s), 135.2 (s), 130.2 (s), 129.4 (s), 129.2 (s), 128.60 (s), 128.58 (s), 128.3 (s), 126.5 
(s), 120.9 (s), 120.0 (s), 67.1 (s), 35.4 (s), 31.0 ppm (s); IR (ATR): ṽ = 2963, 1711, 1601, 
1247, 1094, 1006, 698 cm-1; MS (EI, 70 eV) m/z (%): 263 (100) [M+-2CH3], 231 (76), 203 
(68), 101 (45); HRMS (EI–TOF) calcd. for C20H20O2: 292.1463; found: 292.1473; m.p.: 127–
129 °C. 
7.4.5.4. Synthesis of (Z)–4–benzylidene–6–(trifluoromethoxy)–1–one 
 
[CAS: 1914996-70-5] 
The title compound was prepared starting from 4–(trifluoromethoxy)–benzoic acid 
(107 mg, 0.5 mmol) and 3–phenyl–2–propyn–1–ol (99 mg, 0.75 mmol). The title compound 
was isolated as colorless solid (125 mg, 78%). 
1H NMR (400 MHz, CDCl3): δ = 8.23 (d, J = 8.8 Hz, 1H), 7.49–7.44 (m, 3H), 7.42–7.38 (m, 
1H), 7.33–7.29 (m, 2H), 7.26–7.25 (m, 2H), 5.35 ppm (d, J = 1.2 Hz, 2H); 13C NMR 
(101 MHz, CDCl3): δ = 163.1 (s), 153.3 (d, J = 1.8 Hz, 1C), 140.7 (s), 134.6 (s), 132.97 (s), 
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131.5 (s), 129.3 (s), 128.8 (s), 128.76 (s), 126.91 (s), 121.8 (s), 120.7 (s), 119.8 (d, J = 89 Hz, 
1C), 115.0 (s), 67.1 ppm (s); IR (ATR): ṽ = 3053, 1708, 1211, 1162, 1007, 886, 773, 703 cm-
1; MS (EI, 70 eV) m/z (%): 320 (100) [M+], 291 (76), 214 (68), 165 (45), 105 (27); HRMS 
(EI–TOF) calcd. for C17H11F3O3: 320.0660; found: 320.0662; m.p.: 147–148 °C. 
7.4.5.5. Synthesis of (Z)–4–benzylidene–6–methoxyisochroman–1–one 
 
[CAS: 1914996-72-7] 
The title compound was prepared starting from 4–methoxybenzoic acid (152 mg, 
1.0 mmol) and 3–phenyl–2–propyn–1–ol (198 mg, 1.5 mmol). The title compound was 
isolated as yellow solid (216 mg, 81%). 
1H NMR (400 MHz, CDCl3): δ = 8.06 (d, J = 8.8 Hz, 1H), 7.43–7.39 (m, 2H), 7.36–7.32 (m, 
1H), 7.24–7.21 (m, 3H), 7.08 (d, J = 2.4 Hz, 1H), 6.95 (dd, J = 8.4 Hz, 2.4 Hz, 1H), 5.25 (d, J 
= 1.2 Hz, 2H), 3.90 ppm (s, 3H); 13C NMR (101 MHz, CDCl3): δ = 164.0 (s), 163.9 (s), 140.2 
(s), 134.9 (s), 132.4 (s), 129.6 (s), 129.0 (s), 128.4 (s), 128.2 (s), 128.1 (s), 116.1 (s), 115.1 
(s), 107.4 (s), 66.8 (s), 55.5 ppm (s); IR (ATR): ṽ = 2848, 1700, 1596, 1341, 1260, 1226, 
1103, 993, 869, 694 cm-1; MS (EI, 70 eV) m/z (%): 266 (100) [M+], 237 (76), 165 
(45); HRMS (EI–TOF) calcd. for C17H14O3: 266.0943; found: 266.0948; m.p.: 115–117 °C. 
7.4.5.6. Synthesis of (Z)–4–benzylidene–6–iodoisochroman–1–one 
 
[CAS: 1914996-74-9] 
The title compound was prepared starting from 4–iodobenzoic acid (253 mg, 1.0 mmol) 
and 3–phenyl–2–propyn–1–ol (198 mg, 1.5 mmol). The title compound was isolated as 
colorless solid (218 mg, 60%). 
1H NMR (400 MHz, CDCl3): δ = 8.05 (d, J = 0.8 Hz, 1H), 7.85–7.80 (m, 2H), 7.46–7.36 (m, 
3H), 7.24 (t, J = 7.2 Hz, 3H), 5.30 ppm (d, J = 1.2 Hz, 2H); 13C NMR (101 MHz, CDCl3): δ 
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= 163.7 (s), 139.6 (s), 137.9 (s), 134.6 (s), 132.5 (s), 131.5 (s), 131.0 (s), 129.1 (s), 128.6 (s), 
128.6 (s), 126.4 (s), 122.6 (s), 102.1 (s), 66.9 ppm (s); IR (ATR): ṽ = 1702, 1582, 1247, 1009, 
773, 751, 697, 679 cm-1; MS (EI, 70 eV) m/z (%): 361 (100) [M+], 333 (76), 178 (45), 127 
(33), 105 (15); HRMS (EI–TOF) calcd. for C16H11IO2: 361.9804; found: 361.9807; m.p.: 
169–170 °C. 
7.4.5.7. Synthesis of (Z)–4–benzylidene–8–methylisochroman–1–one 
 
[CAS: 1914996-77-2] 
The title compound was prepared starting from 2–methylbenzoic acid (68.8 mg, 0.5 mmol) 
and 3–phenyl–2–propyn–1–ol (99 mg, 0.75 mmol). The title compound was isolated as 
yellow solid (103 mg, 82%). 
1H NMR (400 MHz, CDCl3): δ = 7.50–7.48 (m, 2H), 7.45–7.40 (m, 2H), 7.38–7.34 (m, 1H), 
7.31–7.29 (m, 1H), 7.25–7.23 (m, 3H), 5.20 (d, J = 1.2 Hz, 2H), 2.74 ppm (d, J = 0.8 Hz, 3H); 
13C NMR (101 MHz, CDCl3): δ = 163.5 (s), 142.9 (s), 139.9 (s), 135.2 (s), 132.9 (s), 132.3 
(s), 129.6 (s), 129.2 (s), 129.0 (s), 128.5 (s), 128.1 (s), 122.0 (s), 121.9 (s), 66.1 (s), 22.4 ppm 
(s); IR (ATR): ṽ = 1704, 1593, 1470, 1257, 1074, 989, 779, 695 cm-1; MS (EI, 70 eV) m/z 
(%): 250 (23) [M+], 232 (85), 178 (74), 115 (100), 89 (27); HRMS (EI–TOF) calcd. for 
C17H14O2: 250.0994; found: 250.1010; m.p.: 111–112 °C. 
7.4.5.8. Synthesis of (Z)–4–benzylidene–8–chloroisochroman–1–one 
 
[CAS: 1914996-80-7] 
The title compound was prepared starting from 4–iodobenzoic acid (160 mg, 1.0 mmol) 
and 3–phenyl–2–propyn–1–ol (198 mg, 1.5 mmol). The title compound was isolated as 
yellow solid (189 mg, 70%). 
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1H NMR (400 MHz, CDCl3): δ = 7.56–7.50 (m, 3H), 7.45–7.41 (m, 2H), 7.38–7.35 (m, 1H), 
7.28 (s, 1H), 7.23 (d, J = 7.2 Hz, 2H), 5.18 ppm (d, J = 0.8 Hz, 2H); 13C NMR (101 MHz, 
CDCl3): δ = 160.7 (s), 141.6 (s), 136.7 (s), 134.7 (s), 133.5 (s), 132.0 (s), 131.3 (s), 129.1 (s), 
128.6 (s), 128.5 (s), 128.1 (s), 122.8 (s), 121.248 (s), 66.1 ppm (s); IR (ATR): ṽ = 1717, 1588, 
1220, 1110, 1066, 1007, 796, 703 cm-1; MS (EI, 70 eV) m/z (%): 270 (100) [M+], 241 (76), 
207 (45), 178 (33), 151 (15), 105 (10); HRMS (EI–TOF) calcd. for C16H11ClO2: 
270.0448/272.0423; found: 270.0423/272.0422; m.p.: 159–160 °C. 
7.4.5.9. Synthesis of (Z)–8–acetyl–4–benzylideneisochroman–1–one 
 
[CAS: 1914996-82-9] 
The title compound was prepared starting from 2–acetylbenzoic acid (166 mg, 1.0 mmol) 
and 3–phenyl–2–propyn–1–ol (198 mg, 1.5 mmol). The title compound was isolated as 
yellow solid (189 mg, 68%). 
1H NMR (400 MHz, CDCl3): δ = 7.74–7.66 (m, 2H), 7.46–7.36 (m, 3H), 7.33–7.24 (m, 4H), 
5.31 (d, J = 1.5 Hz, 2H), 2.57 ppm (s, 3H); 13C NMR (101 MHz, CDCl3): δ = 204.0 (s), 162.9 
(s), 146.0 (s), 139.2 (s), 134.74 (s), 133.9 (s), 131.4 (s), 129.1 (s), 128.7 (s), 128.6 (s), 127.3 
(s), 126.0 (s), 124.4 (s), 120.2 (s), 66. 8 (s), 30.8 ppm (s); IR (ATR): ṽ = 1695, 1580, 1359, 
1266, 1116, 1067, 752, 695 cm-1; MS (EI, 70 eV) m/z (%): 278 (100) [M+], 178 (33), 151 
(15), 105 (10); HRMS (EI–TOF) calcd. for C18H14O3: 278.0943; found: 278.0936; m.p.: 167–
168 °C. 
7.4.5.10. Synthesis of (Z)–4–benzylidene–8–methoxyisochroman–1–one 
 
[CAS: 1914996-85-2] 
The title compound was prepared starting from 2–methoxybenzoic acid (154 mg, 
1.0 mmol) and 3–phenyl–2–propyn–1–ol (198 mg, 1.5 mmol). The title compound was 
isolated as colorless solid (207 mg, 78%). 
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1H NMR (400 MHz, CDCl3): δ = 7.47 (d, J = 8.0 Hz, 1H), 7.35–7.22 (m, 3H), 7.19–7.10 (m, 
4H), 6.92 (d, J = 8.4 Hz, 1H), 5.05 (d, J = 0.8 Hz, 2H), 3.87 ppm (s, 3H); 13C NMR 
(101 MHz, CDCl3): δ = 161.0 (s), 160.8 (s), 141.0 (s), 134.8 (s), 134.5 (s), 129.9 (s), 128.8 
(s), 128.7 (s), 128.2 (s), 127.9 (s), 115.6 (s), 111.8 (s), 111.7 (s), 65.7 (s), 55.9 ppm (s); IR 
(ATR): ṽ = 2838, 1717, 1577, 1466, 1256, 1212, 1063, 982, 804, 776, 692 cm-1; MS (EI, 
70 eV) m/z (%): 266 (100) [M+], 237 (76), 165 (45), 115 (30), 76 (23); HRMS (EI–TOF) 
calcd. for C17H14O3: 266.0943; found: 266.0941; m.p.: 129–130 °C. 
7.4.5.11. Synthesis of (Z)–4–benzylidene–8–phenylisochroman–1–one 
 
[CAS: 1914996-87-4] 
The title compound was prepared starting from 2–biphenylcarboxylic acid (198 mg, 
1.0 mmol) and 3–phenyl–2–propyn–1–ol (198 mg, 1.5 mmol). The title compound was 
isolated as yellow solid (162 mg, 52%). 
1H NMR (400 MHz, CDCl3): δ = 7.71–7.64 (m, 2H), 7.50–7.41 (m, 9H), 7.37 (s, 1H), 7.32–
7.30 (m, 2H), 5.31 ppm (d, J = 1.2 Hz, 2H); 13C NMR (101 MHz, CDCl3): δ = 162.6 (s), 
145.7 (s), 141.1 (s), 140.1 (s), 135.0 (s), 132.7 (s), 131.9 (s), 130.4 (s), 129.0 (s), 128.5 (s), 
128.3 (s), 128.2 (s), 127.9 (s), 127.2 (s), 122.9 (s), 121.8 (s), 66.1 ppm (s); IR (ATR): ṽ = 
1716, 1573, 1466, 1252, 1220, 1107, 994, 752, 695 cm-1; MS (EI, 70 eV) m/z (%): 312 (66) 
[M+], 294 (100), 265 (45), 178 (30), 105 (25); HRMS (EI–TOF) calcd. for C22H16O2: 
312.1150; found: 312.1125; m.p.: 184–185 °C. 
7.4.5.12. Synthesis of (Z)–methyl–4–benzylidene–1–oxoisochroman–7–carboxylate 
 
[CAS: 1914996-90-9] 
The title compound was prepared starting from mono–methyl isophthalate (186 mg, 
1.0 mmol) and 3–phenyl–2–propyn–1–ol (198 mg, 1.5 mmol). The title compound was 
isolated as colorless solid (256 mg, 87%). 
Experimental Section 
 
 169 
1H NMR (400 MHz, CDCl3): δ = 8.61 (d, J = 1.2 Hz, 1H), 8.11 (dd, J = 8.4 Hz, 2.0 Hz, 1H), 
7.60 (d, J = 8.0 Hz, 1H), 7.33–7.29 (m, 2H), 7.27–7.23 (m, 2H), 7.12 (d, J = 6.8 Hz, 2H), 5.20 
(d, J = 1.6 Hz, 2H), 3.80 ppm (s, 3H); 13C NMR (101 MHz, CDCl3): δ = 164.4 (s), 159.7 (s), 
138.7 (s), 134.0 (s), 130.7 (s), 130.3 (s), 129.6 (s), 128.6 (s), 127.7 (s), 126.2 (s), 123.4 (s), 
123.2 (s), 114.1 (s), 67.2 (s), 55.3 ppm (s); IR (ATR): ṽ = 2960, 1730, 1712, 1605, 1428, 
1305, 1218, 1091, 767, 688 cm-1; MS (EI, 70 eV) m/z (%): 294 (66) [M+], 265 (100), 178 
(45), 152 (30), 105 (25); HRMS (EI–TOF) calcd. for C18H14O4: 294.0892; found: 294.0903; 
m.p.: 115–117 °C. 
7.4.5.13. Synthesis of (Z)–4–benzylidene–7–phenylisochroman–1–one 
 
[CAS: 1914996-93-2] 
The title compound was prepared starting from biphenyl–3–carboxylic acid (198 mg, 
1.0 mmol) and 3–phenyl–2–propyn–1–ol (198 mg, 1.5 mmol). The title compound was 
isolated as yellow solid (154 mg, 49%). 
1H NMR (400 MHz, CDCl3): δ = 8.43 (d, J = 2.0 Hz, 1H), 7.92 (dd, J = 8.0 Hz, 2.0 Hz, 1H), 
7.78 (d, J = 8.4 Hz, 1H), 7.70–7.67 (m, 2H), 7.52–7.44 (m, 4H), 7.44–7.37 (m, 4H), 7.33 (s, 
1H), 7.28–7.27 (m, 2H), 5.38 ppm (d, J = 1.2 Hz, 2H); 13C NMR (101 MHz, CDCl3): δ 
= 164.3 (s), 141.8 (s), 139.1 (s), 137.1 (s), 135.2 (s), 132.5 (s), 129.7 (s), 129.2 (s), 129.0 (s), 
128.7 (s), 128.6 (s), 128.4 (s), 128.1 (s), 127.7 (s), 126.9 (s), 124.1 (s), 123.8 (s), 67.2 ppm 
(s); IR (ATR): ṽ = 3031, 1713, 1449, 1221, 1096, 1004, 831, 764, 693 cm-1; MS (EI, 70 eV) 
m/z (%): 312 (65) [M+], 294 (100), 265 (55), 178 (30), 105 (25); HRMS (EI–TOF) calcd. for 
C22H16O2: 312.1150; found: 312.1139; m.p.: 185–186 °C. 
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7.4.5.14. Synthesis of (Z)–4–benzylidene–7–bromoisochroman–1–one 
 
[CAS: 1914996-96-5] 
The title compound was prepared starting from 3–bromobenzoic acid (205 mg, 1.0 mmol) 
and 3–phenyl–2–propyn–1–ol (198 mg, 1.5 mmol). The title compound was isolated as 
colorless solid (239 mg, 76%). 
1H NMR (400 MHz, CDCl3): δ = 8.31 (d, J = 2.0 Hz, 1H), 7.77 (dd, J = 8.4 Hz, 2.0 Hz, 1H), 
7.57 (d, J = 8.4 Hz, 1H), 7.48–7.37 (m, 3H), 7.29 (s, 1H), 7.25 (d, J = 7.6 Hz, 2H), 5.34 ppm 
(d, J = 1.2 Hz, 2H); 13C NMR (101 MHz, CDCl3): δ = 163.0 (s), 137.2 (s), 137.0 (s), 134.8 
(s), 133.1 (s), 130.6 (s), 129.2 (s), 128.7 (s), 128.6 (s), 127.0 (s), 125.2 (s), 124.9 (s), 122.9 
(s), 67.1 ppm (s); IR (ATR): ṽ = 2924, 1713, 1590, 1422, 1233, 1093, 1007, 821 cm-1; MS 
(EI, 70 eV) m/z (%): 314 (65) [M+], 269 (100), 207 (55), 178 (30), 152 (25), 105 (13); HRMS 
(EI–TOF) calcd. for C16H11BrO2: 313.9942/315.9924; found: 313.9934/315.9916; m.p.: 140–
141 °C. 
7.4.5.15. Synthesis of (Z)–4–benzylidene–6–methoxy–7–nitroisochroman–1–one 
 
[CAS: 1914996-99-8] 
The title compound was prepared starting from 4–methoxy–3–nitrobenzoic acid (201 mg, 
1.0 mmol) and 3–phenyl–2–propyn–1–ol (198 mg, 1.5 mmol). The title compound was 
isolated as yellow solid (139 mg, 45%). 
1H NMR (400 MHz, CDCl3): δ = 8.58 (s, 1H), 7.50–7.38 (m, 4H), 7.30–7.24 (m, 3H), 5.33 
(d, J = 1.2 Hz, 2H), 4.11 ppm (s, 3H); 13C NMR (101 MHz, CDCl3): δ = 162.2 (s), 156.6 (s), 
144.0 (s), 139.6 (s), 134.2 (s), 133.4 (s), 129.3 (s), 129.2 (s), 128.8 (s), 128.4 (s), 126.5 (s), 
115.9 (s), 107.5 (s), 66.9 (s), 57.0 ppm (s); IR (ATR): ṽ = 2929, 1705, 1603, 1520, 1294, 
1237, 1026, 691 cm-1; MS (EI, 70 eV) m/z (%): 311 (100) [M+], 282 (76), 235 (55), 178 (30), 
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105 (13); HRMS (EI–TOF) calcd. for C17H13NO5: 311.0794; found: 311.0807; m.p.: 161–
163 °C. 
7.4.5.16. Synthesis of (Z)–4–benzylidene–6–fluoro–8–methylisochroman–1–one 
 
[CAS: 1914997-02-6] 
The title compound was prepared starting from 4–fluoro–2–methylbenzoic acid (156 mg, 
1.0 mmol) and 3–phenyl–2–propyn–1–ol (198 mg, 1.5 mmol). The title compound was 
isolated as colorless solid (220 mg, 82%). 
1H NMR (400 MHz, CDCl3): δ = 7.45–7.35 (m, 3H), 7.25–7.22 (m, 3H), 7.16 (dd, J = 9.6 Hz, 
2.4 Hz, 1H), 6.99 (dd, J = 9.6 Hz, 2.0 Hz, 1H), 5.19 (d, J = 1.2 Hz, 2H), 2.72 ppm (s, 3H); 13C 
NMR (101 MHz, CDCl3): δ = 165.9 (s), 163.3 (s), 162.8 (s), 147.1 (d, J = 7 Hz, 1C), 142.7 
(d, J = 9 Hz, 1C), 134.8 (s), 130.8 (s), 129.1 (s), 128.62 (s), 128.58 (s), 128.4 (s), 119.3 (d, J = 
21 Hz, 1C), 118.6 (d, J = 3 Hz, 1C), 108.5 (d, J = 22 Hz, 1C), 66.0 (s), 22.8 ppm (s); IR 
(ATR): ṽ = 2342, 1704, 1585, 1495, 1239, 1093, 881, 750, 697 cm-1; MS (EI, 70 eV) m/z (%): 
268 (100) [M+], 239 (76), 196 (55), 133 (30), 107 (13); HRMS (EI–TOF) calcd. for 
C17H13FO3: 268.0900; found: 268.0886; m.p.: 153–155 °C. 
7.4.5.17. Synthesis of (Z)–4–benzylidene–3–methylisochroman–1–one 
 
[CAS: 334872-10-5] 
The title compound was prepared starting from benzoic acid (61.7 mg, 0.5 mmol) and 4–
phenylbut–3–yn–2–ol (113 mg, 0.75 mmol). The title compound was isolated as yellow solid 
(75.3 mg, 60%). 
1H NMR (400 MHz, CDCl3): δ = 8.16 (d, J = 8.0 Hz, 1H), 7.68–7.67 (m, 2H), 7.52–7.42 (m, 
3H), 7.40–7.36 (m, 1H), 7.30–7.27 (m, 2H), 7.14 (s, 1H), 5.75 (q, J = 6.8 Hz, 1H), 1.64 ppm 
(d, J = 6.8 Hz, 3H); 13C NMR (101 MHz, CDCl3): δ = 163.7 (s), 137.3 (s), 135.2 (s), 134.2 
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(s), 132.9 (s), 130.0 (s), 129.0 (s), 128.8 (s), 128.7 (s), 128.2 (s), 124.4 (s), 123.6 (s), 73.9 (s), 
21.8 ppm (s); IR (ATR): ṽ = 2980, 1705, 1599, 1372, 1238, 1094, 1043, 933, 755, 701 cm-1; 
MS (EI, 70 eV) m/z (%): 250 (23) [M+], 207 (85), 178 (74), 152 (100), 77 (27); HRMS (EI–
TOF) calcd. for C17H14O2: 250.0994; found: 250.0992; m.p.: 160–162 °C. 
7.4.5.18. Synthesis of (Z)–4–(4–fluorobenzylidene)–isochroman–1–one 
 
[CAS: 1914997-05-9] 
The title compound was prepared starting from benzoic acid (61.7 mg, 0.5 mmol) and 3–
(4–fluorophenyl)–prop–2–yn–1–ol (113 mg, 0.75 mmol). The title compound was isolated as 
yellow solid (71 mg, 56%). 
1H NMR (400 MHz, CDCl3): δ = 8.17 (d, J = 8.0 Hz, 1H), 7.68–7.66 (m, 2H), 7.53–7.48 (m, 
1H), 7.25–7.22 (m, 3H), 7.16–7.12 (m, 2H), 5.30 ppm (s, 2H); 13C NMR (101 MHz, CDCl3): 
δ = 164.1 (s), 163.7 (s), 161.2 (s), 138.2 (s), 134.1 (s), 131.2 (d, J = 4 Hz, 1C), 130.9 (d, J = 
8 Hz, 1C), 130.4 (s), 129.0 (s), 128.6 (s), 128.01 (s), 123.4 (s), 115.7 (d, J = 21 Hz, 1C), 
66.9 ppm (s); IR (ATR): ṽ = 1709, 1596, 1505, 1224, 1099, 873, 759 cm-1; MS (EI, 70 eV) 
m/z (%): 254 (100) [M+], 225 (85), 196 (74), 145 (75), 102 (45); HRMS (EI–TOF) calcd. for 
C16H11FO2: 254.0739; found: 254.0743; m.p.: 139–141 °C. 
7.4.5.19. Synthesis of (Z)–4–(4–methoxybenzylidene)–isochroman–1–one 
 
[CAS: 1914997-08-2] 
The title compound was prepared starting from benzoic acid (61.7 mg, 0.5 mmol) and 3–
(4–methoxyphenyl)–prop–2–yn–1–ol (122 mg, 0.75 mmol). The title compound was isolated 
as yellow solid (104 mg, 78%). 
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1H NMR (400 MHz, CDCl3): δ = 8.80 (d, J = 8.0 Hz, 1.6 Hz, 1H), 8.29 (dd, J = 1.6 Hz, 1H), 
7.76 (d, J = 8.4 Hz, 1H), 7.47–7.44 (m, 2H), 7.41–7.38 (m, 2H), 7.26 (d, J = 7.6 Hz, 2H), 5.35 
(d, J = 1.2 Hz, 2H), 3.96 ppm (s, 3H); 13C NMR (101 MHz, CDCl3): δ = 164.4 (s), 159.7 (s), 
138.7 (s), 134.0 (s), 130.7 (s), 130.3 (s), 129.6 (s), 128.6 (s), 127.8 (s), 126.3 (s), 123.4 (s), 
123.2 (s), 114.1 (s), 67.2 (s), 55.4 ppm (s); IR (ATR): ṽ = 2840, 1711, 1599, 1510, 1256, 
1234, 1092, 985, 828, 756, 687 cm-1; MS (EI, 70 eV) m/z (%): 266 (100) [M+], 237 (72), 219 
(82), 165 (39), 108 (45), 69 (28); HRMS (EI–TOF) calcd. for C17H14O3: 266.0943; found: 
266.0943; m.p.: 118–119 °C. 
7.4.5.20. Synthesis of (Z)–5–benzylidene–3–methyl–5,6–dihydro–2H–pyran–2–one 
 
The title compound was prepared starting from methacrylic acid (86.1 mg, 1.0 mmol) and 
3–phenyl–2–propyn–1–ol (198 mg, 1.5 mmol). The title compound was isolated as yellow 
solid (124 mg, 62%). 
1H NMR (400 MHz, CDCl3): δ = 7.41–7.37 (m, 2H), 7.33–7.29 (m, 1H), 7.15 (d, J = 7.6 Hz, 
2H), 6.92–6.91 (m, 1H), 6.62 (s, 1H), 5.33 (d, J = 2.0 Hz, 2H), 2.02 ppm (s, 3H); 13C NMR 
(101 MHz, CDCl3): δ = 164.4 (s), 141.4 (s), 134.9 (s), 132.0 (s), 128.9 (s), 128.86 (s), 128.7 
(s), 128.3 (s), 125.9 (s), 67.8 (s), 17.2 ppm (s); IR (ATR): ṽ = 1701, 1451, 1212, 1114, 1042, 
929, 761, 698 cm-1; MS (EI, 70 eV) m/z (%): 200 (100) [M+], 171 (76), 128 (55), 105 
(13); HRMS (EI–TOF) calcd. for C13H12O2: 200.0837; found: 200.0851; m.p.: 146–147 °C. 
7.4.5.21. Synthesis of (Z)–4–(thiophen–2–ylmethylene)–isochroman–1–one 
 
[CAS: 1914997-10-6] 
The title compound was prepared starting from benzoic acid (61.7 mg, 0.5 mmol) and 3–
(thiphen–2–yl)–prop–2–yn–1–ol (104 mg, 0.75 mmol). The title compound was isolated as 
yellow solid (61 mg, 51%). 
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1H NMR (400 MHz, CDCl3): δ = 8.17 (dd, J = 8.4 Hz, 0.8 Hz, 1H), 7.68–7.62 (m, 2H), 7.49–
7.45 (m, 2H), 7.32 (s, 1H), 7.14–7.12 (m, 2H), 5.49 ppm (d, J = 1.2 Hz, 2H); 13C NMR 
(101 MHz, CDCl3): δ = 164.0 (s), 138.1 (s), 137.9 (s), 134.0 (s), 130.5 (s), 130.1 (s), 128.7 
(s), 127.9 (s), 127.8 (s), 125.5 (s), 123.02 (s), 122.97 (s), 121.1 (s), 67.2 ppm (s); IR (ATR): ṽ 
= 1712, 1460, 1254, 1098, 978, 757, 718 cm-1; MS (EI, 70 eV) m/z (%): 242 (100) [M+], 213 
(72), 197 (82), 184 (39), 152 (45), 130 (28); HRMS (EI–TOF) calcd. for C13H12SO2: 
242.0402; found: 242.0397; m.p.: 154–156 °C. 
7.4.6. Synthesis of the corresponding vinylarenes via decarboxylative ortho-
C−H hydroarylation 
 
Standard procedure: An oven–dried 20 mL vessel was charged with [(p–cym)RuCl2]2 
(12.2 mg, 0.02 mmol, 4 mol%), guanidine carbonate (18.2 mg, 0.1 mmol, 0.2 eq.), the 
(hetero)–arenecarboxylic acid (0.50 mmol) and diphenylacetylene (90 mg, 0.5 mmol, 1 eq.). 
After the vessel was flushed with 3 alternating vacuum and nitrogen purge cycles, degassed 
toluene (2 mL), AcOH (28.9 µL, 0.5 mmol, 1 eq.) and 2-picoline (9.9 µL, 0.1 mmol, 0.2 eq.) 
was added via syringe. The resulting mixture was stirred at 120 °C for 18 h. After the reaction 
was complete, the mixture was allowed to cool to room temperature. Brine (20 mL) was 
added and the resulting mixture was extracted with ethyl acetate (3 × 20 mL). The combined 
organic layers were dried over MgSO4, filtered, and the volatiles were removed under reduced 
pressure. The residue was purified by column chromatography (SiO2, ethyl acetate/hexane 
gradient) yielding the corresponding vinylarenes. 
7.4.6.1. Synthesis of (E)–(1–m–tolylethene–1,2–diyl)–dibenzene 
 
[CAS: 70603-13-3] 
The title compound was prepared starting from 2–methylbenzoic acid (68.8 mg, 0.5 mmol) 
and diphenylacetylene (89.1 mg, 0.5 mmol). The title compound was isolated as colorless 
liquid (99 mg, 73%). 
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1H NMR (400 MHz, DMSO-d6): δ = 7.43–7.37 (m, 3H), 7.23 (t, J = 7.6 Hz, 1H), 7.15–7.10 
(m, 7H), 7.07–7.05 (m, 2H), 7.01–6.99 (m, 2H), 2.29 ppm (s, 3H); 13C NMR (101 MHz, 
DMSO-d6): δ = 142.5 (s), 141.8 (s), 140.0 (s), 137.4 (s), 136.9 (s), 129.7 (s), 129.2 (s), 128.9 
(s), 128.3 (s), 128.2 (s), 128.0 (s), 127.6 (s), 127.57 (s), 126.9 (s), 124.4 (s), 21.09 ppm (s); IR 
(ATR): ṽ = 1600, 1492, 1444, 782, 692 cm-1. The analytical data matched those reported in 
the literature.[352] 
7.4.6.2. Synthesis of (E)–(1–(3–chlorophenyl)–ethene–1,2–diyl)–dibenzene 
 
[CAS: 1892558-41-6] 
The title compound was prepared starting from 2–chlorobenzoic acid (79.9 mg, 0.5 mmol) 
and diphenylacetylene (89.1 mg, 0.5 mmol). The title compound was isolated as colorless 
liquid (140 mg, 96%). 
1H NMR (400 MHz, CDCl3): δ = 7.30–7.26 (m, 4H), 7.20–7.17 (m, 2H), 7.15–7.11 (m, 3H), 
7.09–7.05 (m, 3H), 6.97–6.95 (m, 2H), 6.90 ppm (s, 1H); 13C NMR (101 MHz, CDCl3): δ 
= 145.3 (s), 141.3 (s), 139.6 (s), 136.9 (s), 134.2 (s), 130.3 (s), 129.6 (s), 129.4 (s), 129.2 (s), 
128.8 (s), 128.0 (s), 127.7 (s), 127.6 (s), 127.4 (s), 127.1 (s), 125.8 ppm (s); IR (ATR): ṽ = 
1590, 1472, 14445, 1076, 873, 779, 706, 690 cm-1; MS (EI, 70 eV) m/z (%): 292 (75) [M+], 
290 (10); HRMS (EI–TOF) calcd. for C20H15Cl: 290.0862; found: 290.0860. 
7.4.6.3. Synthesis of (E)–(1–(3–methoxyphenyl)–ethene–1,2–diyl)–dibenzene 
 
[CAS: 479206-43-4] 
The title compound was prepared starting from 2–methoxybenzoic acid (76.1 mg, 
0.5 mmol) and diphenylacetylene (89.1 mg, 0.5 mmol). The title compound was isolated as 
colorless liquid (109 mg, 76%). 
1H NMR (400 MHz, CDCl3): δ = 7.39–7.35 (m, 3H), 7.29–7.28 (m, 1H), 7.26–7,24 (m, 2H), 
7.20–7.14 (m, 3H), 7.08–7.06 (m, 2H), 7.02 (s, 1H), 6.98–6.95 (m, 1H), 6.93 (t, J = 2.1 Hz, 
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1H), 6.90–6.87 (m, 1H), 3.83 ppm (s, 3H); 13C NMR (101 MHz, CDCl3): δ = 159.4 (s), 144.9 
(s), 142.4 (s), 140.2 (s), 137.2 (s), 130.3 (s), 129.5 (s), 129.1 (s), 128.6 (s), 128.3 (s), 127.9 
(s), 127.4 (s), 126.7 (s), 120.2 (s), 113.4 (s), 112.8 (s), 55.1 ppm (s); IR (ATR): ṽ = 1594, 
1484, 1267, 1209, 1045, 870, 776, 691 cm-1. The analytical data matched those reported in the 
literature.[353] 
7.4.6.4. Synthesis of ethane–1,1,2–triyltribenzene 
 
[CAS: 58-72-0] 
The title compound was prepared starting from 2–methoxybenzoic acid (76.1 mg, 
0.5 mmol) and diphenylacetylene (89.1 mg, 0.5 mmol). The title compound was isolated as 
colorless liquid (109 mg, 76%). 
1H NMR (400 MHz, CDCl3): δ = 7.39–7.31 (m, 8H), 7.26–7.23 (m, 2H), 7.19–7.13 (m, 3H), 
7.08–7.05 (m, 2H), 7.00 ppm (s, 1H); 13C NMR (101 MHz, CDCl3): δ = 143.4 (s), 142.6 (s), 
140.3 (s), 137.4 (s), 130.4 (s), 129.5 (s), 128.6 (s), 128.2 (s), 128.1 (s), 127.4 (s), 127.6 (s), 
127.5 (s), 127.4 (s), 126.7 ppm (s); IR (ATR): ṽ = 3022, 1598, 1491, 1444, 1074, 758, 
690 cm-1. The analytical data matched those reported in the literature.[354] 
7.4.6.5. Synthesis of (E)–(1–(3–iodophenyl)–ethene–1,2–diyl)–dibenzene 
 
[CAS: 1914997-23-1] 
The title compound was prepared starting from 4–iodobenzoic acid (127 mg, 0.5 mmol) 
and diphenylacetylene (89.1 mg, 0.5 mmol). The title compound was isolated as colorless 
solid (98.2 mg, 51%). 
1H NMR (400 MHz, CDCl3): δ = 7.72 (t, J = 1.2 Hz, 1H), 7.62 (dt, J = 7.6 Hz, 1.2 Hz, 1H), 
7.36–7.33 (m, 3H), 7.26–7.23 (m, 1H), 7.20–7.18 (m, 2H), 7.15–7.12 (m, 3H), 7.06–7.01 (m, 
3H), 6.94 ppm (s, 1H); 13C NMR (101 MHz, CDCl3): δ = 145.8 (s), 141.1 (s), 139.6 (s), 136.9 
(s), 136.3 (s), 130.3 (s), 129.8 (s), 129.6 (s), 129.2 (s), 128.8 (s), 128.0 (s), 127.7 (s), 127.1 
(s), 127.0 (s), 94.4 ppm (s); IR (ATR): ṽ = 1580, 1487, 1064, 869, 780, 759, 690 cm-1; MS 
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(EI, 70 eV) m/z (%): 382 (75) [M+], 256 (10), 179 (100); HRMS (EI–TOF) calcd. for C20H15I: 
382.0219; found: 382.0206; m.p.: 97–98 °C. 
7.4.6.6. Synthesis of (E)–(1–(3–ethylphenyl)–ethene–1,2–diyl)–dibenzene 
 
[CAS: 1914997-22-0] 
The title compound was prepared starting from 2–ethylbenzoic acid (75.1 mg, 0.5 mmol) 
and diphenylacetylene (89.1 mg, 0.5 mmol). The title compound was isolated as colorless 
liquid (119 mg, 84%). 
1H NMR (400 MHz, CDCl3): δ = 7.36–7.34 (m, 3H), 7.26–7.21 (m, 4H), 7.17–7.12 (m, 5H), 
7.06–7.04 (m, 2H), 6.99 (s, 1H), 2.65 (q, J = 7.6 Hz, 2H), 1.25 ppm (t, J = 7.6 Hz, 3H); 13C 
NMR (101 MHz, CDCl3): δ = 144.1 (s), 143.4 (s), 142.8 (s), 140.4 (s), 137.5 (s), 130.4 (s), 
129.5 (s), 128.6 (s), 128.1 (s), 128.0 (s), 127.9 (s), 127.3 (s), 127.1 (s), 126.6 (s), 125.2 (s), 
28.9 (s), 15.7 ppm (s); IR (ATR): ṽ = 2964, 1599, 1492, 1444, 1075, 793, 753, 691 cm-1; MS 
(EI, 70 eV) m/z (%): 284 (64) [M+], 269 (88), 154 (100); HRMS (EI–TOF) calcd. for C22H20: 
284.1565; found: 284.1570. 
7.4.6.7. Synthesis of (E)–3–(1,2–diphenylvinyl)–phenol 
 
[CAS: 1892558-46-1] 
The title compound was prepared starting from 2–hydroxybenzoic acid (64.7 mg, 
0.5 mmol) and diphenylacetylene (89.1 mg, 0.5 mmol). The title compound was isolated as 
colorless liquid (83 mg, 63%). 
1H NMR (400 MHz, CDCl3): δ = 7.36–7.32 (m, 3H), 7.22–7.19 (m, 3H), 7.17–7.11 (m, 3H), 
7.03–7.01 (m, 2H), 6.98 (s, 1H), 6.97–6.94 (m, 1H), 6.79–6.76 (m, 2H), 4.66 ppm (s, 1H); 13C 
NMR (101 MHz, CDCl3): δ = 155.3 (s), 145.2 (s), 142.0 (s), 140.1 (s), 137.2 (s), 130.3 (s), 
129.6 (s), 129.4 (s), 128.7 (s), 128.4 (s), 128.0 (s), 127. 5 (s), 126.8 (s), 120.2 (s), 114.4 ppm 
(s); IR (ATR): ṽ = 1596, 1578, 1492, 1444, 1271,1191, 695 cm-1; MS (EI, 70 eV) m/z (%): 
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255 (100) [M+-OH], 178 (55); HRMS (EI–TOF) calcd. for C20H16O: 270.1201; found: 
270.1202. 
7.4.6.8. Synthesis of (E)–(1–p–tolylethene–1,2–diyl)–dibenzene 
 
[CAS: 84224-86-2] 
The title compound was prepared starting from 3–methylbenzoic acid (68.8 mg, 0.5 mmol) 
and diphenylacetylene (89.1 mg, 0.5 mmol). The title compound was isolated as colorless 
solid (83.6 mg, 62%). 
1H NMR (400 MHz, CDCl3): δ = 7.35–7.32 (m, 3H), 7.24–7.20 (m, 4H), 7.16–7.10 (m, 5H), 
7.04–7.02 (m, 2H), 6.95 (s, 1H), 2.37 ppm (s, 3H); 13C NMR (101 MHz, CDCl3): δ = 142.4 
(s), 140.6 (s), 140.5 (s), 137.5 (s), 137.4 (s), 130.4 (s), 129.5 (s), 128.9 (s), 128.6 (s), 127.9 
(s), 127.5 (s), 127.3 (s), 126.6 (s), 21.1 ppm (s); IR (ATR): ṽ = 1597, 1491, 1442, 1072, 807, 
754, 693 cm-1; HRMS (EI–TOF) calcd. for C21H18: 270.1409; found: 270.1406; m.p.: 69–
70 °C. The analytical data matched those reported in the literature.[353] 
7.4.6.9. Synthesis of (E)–4–(3–(1,2–diphenylvinyl)–phenyl)–morpholine 
 
[CAS: 1914997-24-2] 
The title compound was prepared starting from 4–morpholinobenzoic acid (107 mg, 
0.5 mmol) and diphenylacetylene (89.1 mg, 0.5 mmol). The title compound was isolated as 
yellow liquid (112 mg, 66%). 
1H NMR (400 MHz, CDCl3): δ = 7.34–7.32 (m, 3H), 7.23–7.20 (m, 3H), 7.16–7.11 (m, 3H), 
7.04–7. 02 (m, 2H), 6.96 (s, 1H), 6.91–6.83 (m, 3H), 3.85 (t, J = 4.8 Hz, 4H), 3.14 ppm (t, J = 
4.8 Hz, 4H); 13C NMR (101 MHz, CDCl3): δ = 151.2 (s), 144.6 (s), 143.0 (s), 140.3 (s), 137.4 
(s), 130.4 (s), 129.5 (s), 128.9 (s), 128.5 (s), 128.1 (s), 127.9 (s), 127.4 (s), 126.7 (s), 119.9 
(s), 115.2 (s), 114.9 (s), 66.9 (s), 49.4 ppm (s); IR (ATR): ṽ = 1592, 1488, 1444, 1254, 1119, 
930, 779, 692 cm-1; MS (EI, 70 eV) m/z (%): 341 (25) [M+], 313 (55), 269 (42), 255 
(100); HRMS (EI–TOF) calcd. for C24H23NO: 341.1780; found: 341.1781. 
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7.4.6.10. Synthesis of (E)–3–(1,2–diphenylethenyl)–thiophene 
 
[CAS: 93080-10-5] 
The title compound was prepared starting from 2–thiophenecarboxylic acid (64.7 mg, 
0.5 mmol) and diphenylacetylene (89.1 mg, 0.5 mmol). The title compound was isolated as 
colorless liquid (83 mg, 63%). 
1H NMR (400 MHz, CDCl3): δ = 7.41–7.36 (m, 3H), 7.34–7.31 (m, 2H), 7.29–7.28 (m, 2H), 
7.16–7.11 (m, 3H), 7.06 (s, 1H), 7.00 (dd, J = 8.0 Hz, 2 Hz, 2H), 6.92 ppm (q, J = 2.4 Hz, 
1H); 13C NMR (101 MHz, CDCl3): δ = 145.1 (s), 140.2 (s), 137.3 (s), 137.0 (s), 129.8 (s), 
129.4 (s), 128.7 (s), 127.9 (s), 127.5 (s), 126.6 (s), 126.6 (s), 125.9 (s), 125.6 (s), 123.0 ppm 
(s); IR (ATR): ṽ = 1597, 1493, 1444, 1072, 864, 779, 752, 691 cm-1. The analytical data 
matched those reported in the literature.[355] 
7.5. Doubly Regioselective C–H Hydroarylation of Unsymmetrical 
Alkynes Using Carboxylates as Deciduous Directing Groups 
7.5.1. General Methods 
Chemicals and solvents were either purchased (puriss p.A.) from commercial supplier or 
purified by standard techniques.[343] All reactions, if not stated otherwise, were performed in 
oven-dried glassware under a nitrogen atmosphere containing a Teflon-coated stirrer bar and 
dry septum. All reactions were monitored by GC using tetradecane as an internal standard. 
Response factors of the products with regard to n-tetradecane were obtained experimentally 
by analyzing known quantities of the substances. GC analyses were carried out using an HP−5 
capillary column (Phenyl methyl siloxane, 30 m × 320 × 0.25, 100/2.3-30-300/3, 2 min at 
60 °C, heating rate 30 °C/min, 3 or 10 min at 300 °C). Column chromatography was 
performed using a Combi Flash Companion-Chromatography-System (Isco-Systems) and 
Reveleris packed columns (12 g). NMR spectra were recorded on Bruker Avance 400 at 
ambient temperature using CDCl3 as solvent, with proton, carbon, and fluorine resonances at 
400, 101, and 376 MHz respectively. 
Experimental Section 
 
 180
7.5.2. Catalyst development 
7.5.2.1. Optimization of the regioselective decarboxylative C−H hydroarylation with 
unsymmetrical alkynes and conventional heating 
Table 16: Screening experiments for the regioselective decarboxylative C−H hydroarylation 
with 1−phenyl−1−propyne. 
 
# [M]/4 mol% solvent base/eq. add. A/eq. add. B/eq. 1:2 Yield/%/[a] 
3 4 5 
1 [(p−cym)RuCl2]2 PhMe GuanCO3/0.2 AcOH/1 2−picoline/0.2 1:1 25 n.d. 21 
2 [(p−cym)RuI2]2 " " " " " 29 " 19 
3 [(C6Me6)RuCl2]2 " " " " " 16 " 32 
4 [(C6Me3)RuCl2]2 " " " " " 13 " 29 
5 [(C6H6)RuCl2]2 " " " " " 8 " 23 
6 [(p−cym)RuCl2]2 NMP " " " " 22 trace 27 
7 [(p−cym)RuI2]2 " " " " " 22 " 23 
8 [(C6Me6)RuCl2]2 " " " " " 38 " 20 
9 [C6Me3)RuCl2]2 " " " " " 15 " 16 
10 [(C6H6)RuCl2]2 " " " " " 9 " 16 
11 [(C6Me6)RuCl2]2 C6Me3 " " " " 15 " 30 
12 " DMF " " " " n.d. " n.d. 
13 " DMAc " " " " 21 " 23 
14 " NCyP " " " " 18 " 23 
15 " PC " " " " 18 " trace 
16 " NMP " " " 1:1.5 53 3 23 
17 " " " PivOH/1 " " 42 " 33 
18 " " " AdCO2H/1 " " 44 " 36 
19 " " " TFA/1 " " n.d. n.d. n.d. 
20 " " " MesCO2H/1 " " 62 trace 27 
21 " " " AcOH/1 - " 64 `` 32 
22 " " - " - " n.d. n.d. n.d. 
23 " " GuanCO3/0.2 - - " " " " 
24 " " Li2CO3/0.2 AcOH/1 - " 16 14 13 
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25 " " K2CO3/0.2 " - " 31 16 18 
26 " " Cs2CO3/0.2 " - " 23 9 8 
27 " " K2CO3/0.05 " - " 16 9 9 
28 " " K2CO3/0.1 " - " 39 3 5 
29 " " K2CO3/0.3 " - " 23 25 6 
30 " " K2CO3/0.5 " - " 21 22 4 
31 " " K2CO3/1 " - " 24 17 3 
32 " " K2CO3/0.1 " GuanCO3/0.2 " 43 7 25 
33 " " " " GuanCO3/0.05 " 60 9 13 
34 " " " MesCO2H/0.5 - " 80 13 4 
35 " " " MesCO2H/1 - " 59 11 5 
36 " " " MesCO2H/0.5 GuanCO3/0.05 " 63 12 8 
37 " " " MesCO2H/1 " " 71 2 n.d. 
38 " " DABCO/1 " " " 12 trace 45 
39 " " NEt3/1 " " " 15 " 18 
40 " " Quinuclidine/1 " " " 11 " 40 
Reaction conditions: 1 (0.5 mmol), 2, [M] (4 mol%), base, solvent, 120 °C, 16 h under N2-atmosphere. [a] Yields 
of corresponding methyl esters determined by GC after esterification with K2CO3 (2 eq.) and MeI (5 eq.) in NMP 
using n-tetradecane as the internal standard. 
Table 17: Evaluation of organic bases for the decarboxylative hydroarylation with 
1−phenyl−1−propyne. 
CO2H
+
[(p-cym)RuCl2]2 (4 mol%),
base (1 eq.)
PhMe, 120 °C,
16 h, N2
H
Me
Ph
Me
PhHMeO MeO
+
H
Ph
MeMeO
CO2H
Me
PhMeO
+
1 2 3 4 5
 
# base /1 eq. Yield/%[a] 
3 4 5 
1 triethylamine 13 n.d. 47 
2 TMEDA 9 " 14 
3 diisopropylethylamin 15 " 26 
4 N−Me−tetramethylpiperidine 16 " 38 
5 Quinuclidine 11 " 54 
6 DBU 5 " 10 
7 N−Me−pyrrolidine 10 " 10 
8 TBAOH∙30H2O 41 3 24 
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9 TBAOAc 40 11 8 
Reaction conditions: 1 (0.5 mmol), 2 (0.75 mmol), [(p−cym)RuCl2]2 (4 mol%), base, PhMe (2 mL), 120 °C, 16 h 
under N2-atmosphere. [a] Yields of corresponding methyl esters determined by GC after esterification with 
K2CO3 (2 eq.) and MeI (5 eq.) in NMP using n-tetradecane as the internal standard. 
7.5.2.2. Optimization of the microwave conditions for the regioselective decarboxylative 
C−H hydroarylation with unsymmetrical alkynes 
Table 18: Screening of microwave conditions for simple benzoic acid. 
 
# t /min µW T /°C Yield/%[a] 
7.5.2.2.-3 7.5.2.2.-4 7.5.2.2.-5 
1 0.5 
200 53 18 trace 
180 44 13 " 
170 45 15 " 
160 44 9 " 
2 1 
200 52 14 8 
180 51 11 trace 
170 48 11 " 
3 3 
200 56 13 7 
180 51 12 7 
170 50 12 7 
4 5 
200 56 14 trace 
180 60 8 n.d. 
180[b] 40 16 12 
170 50 11 trace 
160 47 10 " 
150 51 10 " 
140 29 trace " 
130 15 `` n.d. 
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120 10 15 trace 
5 10 
180 55 11 " 
170 27 7 " 
160 50 12 " 
150 45 8 " 
140 18 trace " 
6 15 
180 25 7 " 
150 43 9 " 
120 20 22 " 
7 30 180 29 6 " 
Reaction conditions: 7.5.2.2.-1 (0.5 mmol), 7.5.2.2.-2 (0.75 mmol), [(C6Me6)RuCl2]2 (4 mol%), K2CO3 
(10 mol%), NMP (1 mL), µW-irradiation, t, under N2-atmosphere. [a] Yields of corresponding methyl esters 
determined by GC after esterification with K2CO3 (2 eq.) and MeI (5 eq.) in NMP using n-tetradecane as the 
internal standard. [c] conventional heating after 16 h. 
7.5.3. Mechanistic control experiments for the deciduous character of the CO2H group 
 
Scheme 52: Standard decarboxylative hydroarylation reaction set-up. 
 
Scheme 53: Decarboxylative reaction set-up reported by Hartwig and Zhao.[338] 
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Scheme 54: Standard reaction condition vs prolonged reaction time. 
7.5.4. Synthesis of [Ru(4−ΟMe-benzoato2−C6,O1)(hexamethylbenzene)(pyridine)] 
 
[CAS: 2079114-43-3] 
The title compound was synthesized following the literature reported procedure,[284] starting 
from potassium 4−methoxy benzoate (285 mg, 1.5 mmol), [Ru(hexamethylbenzene)Cl2]2 
(334 mg, 0.5 mmol), pyridine (79 mg, 8.1µL, 1 mmol) and trimethylamine (715 mg, 983 µL, 
7 mmol). The title compound was isolated as a yellow solid (148 mg, 60%). 
1H NMR (400 MHz, CDCl3): δ = 8.29−8.42 (m, 2H), 7.46 (tt, J = 7.7, 1.6 Hz, 1H), 7.38 (d, J 
= 2.5 Hz, 1H), 7.35 (d, J = 8.3 Hz, 1H), 6.98−7.09 (m, 2H), 6.44 (dd, J = 8.3, 2.5 Hz, 1H), 
3.86 (s, 3H), 1.94 ppm (s, 18H); 13C NMR (101 MHz, CDCl3): δ = 181.3 (s), 160.6 (s), 153.2 
(s), 136.4 (s), 131.0 (s), 129.1 (s), 124.4 (s), 120.0 (s), 112.7 (s), 106.1 (s), 93.4 (s), 54.9 (s), 
15.2 ppm (s); IR (ATR): ṽ = 2917, 1600, 1573, 1445, 1430, 1385, 1308, 1242, 1222, 1207, 
1167, 1144, 1067, 1026, 855, 777, 761, 696 cm-1; HRMS (ESI): m/z = calcd. for 
C25H29O3NRu+H+: 494.1276; found 494.0033; m.p.: 144 °C, decomposition. 
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7.5.4.1. Mechanistic control experiments 
 
Scheme 55: Reaction starting from a preformed ruthenacycle. 
7.5.5. ESI-MS measurements 
 
Scheme 56: Standard decarboxylative hydroarylation reaction set-up for ESI-MS 
experiments. 
measured
Ru
Cl
 
 
Scheme 57: ESI-MS measurement of the reaction mixture (t = 0, room temperature). 
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Scheme 58: ESI−MS measurement of the reaction mixture (t = 0, 120°C). 
measured
Ru
MeO
Me
Ph
Ph
Me
  
Scheme 59: ESI-MS measurement of the reaction mixture (t = 3h, 120°C). 
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7.5.6. Synthesis of the corresponding vinylarenes via decarboxylative ortho-C-
H hydroarylation of unsymmetrical alkynes 
 
Standard procedure A – conventional hating: An oven-dried 20 mL vessel was charged 
with [(hexamethylbenzene)RuCl2]2 (13.4 mg, 0.02 mmol, 4 mol%), guanidine carbonate 
(4.6 mg, 0.025 mmol, 5 mol%), 2,4,6-trimethylbenzoic acid (82.9 mg, 0.5 mmol, 1 eq.), 
potassium carbonate (6.98 mg, 0.05 mmol, 10 mol%) and the benzoic acid (0.5 mmol). After 
the vessel was flushed with 3 alternating vacuum and nitrogen purge cycles, degassed NMP 
(1 mL) and the internal alkyne (0.75 mmol) were added via syringe. The resulting mixture 
was stirred at 120 °C for 16 h. After the reaction was complete, the mixture was allowed to 
cool to room temperature. Lithium chloride (20%) was added and the resulting mixture was 
extracted with ethyl acetate (3 × 20 mL). The organic layers were washed with brine (20 mL). 
The combined organic layers were dried over MgSO4, filtered, and the volatiles were removed 
under reduced pressure. The residue was purified by column chromatography (SiO2, ethyl 
acetate/pentane or cyclohexane gradient) yielding the corresponding vinylarenes. 
Standard procedure B – microwave conditions: An oven-dried 2 mL microwave vial 
was charged with [(hexamethylbenzene)RuCl2]2 (13.4 mg, 0.02 mmol, 4 mol%), guanidine 
carbonate (9 mg, 0.05 mmol, 10 mol%), 2,4,6-trimethylbenzoic acid (41 mg, 0.25 mmol, 
0.5 eq.), and the benzoic acid (1 mmol). After the vessel was flushed with 3 alternating 
vacuum and nitrogen purge cycles, degassed NMP (2 mL) and the internal alkyne (0.5 mmol) 
were added via syringe. The resulting mixture was first stirred in a water bath at 50 °C for 
10 minutes then irradiated in the microwave at 180 °C for 5 minutes at a maximum power of 
50 W, the air-jet cooled. Lithium chloride (20%) was added and the resulting mixture was 
extracted with ethyl acetate (3 × 20 mL). The organic layers were washed with brine (20 mL). 
The combined organic layers were dried over MgSO4, filtered, and the volatiles were 
removed under reduced pressure. The residue was purified by column chromatography (SiO2, 
ethyl acetate/pentane or cyclohexane gradient) yielding the corresponding vinylarenes. 
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7.5.6.1. Synthesis of 1−((E)−2−(3−methoxyphenyl)−prop−1−enyl)−benzene 
 
[CAS: 721428-17-7] 
The title compound was prepared following general procedure A, starting from 4–
methoxybenzoic acid (90 mg, 0.5 mmol) and 1–phenyl–1–propyne (88 mg, 95.7 µL, 
0.75 mmol). The title compound was isolated as colorless liquid (80 mg, 71%). 
The title compound was prepared following general procedure B, starting from 4–
methoxybenzoic acid (180 mg, 1 mmol) and 1–phenyl–1–propyne (59 mg, 64 µL, 0.5 mmol). 
The title compound was isolated as colorless liquid (85 mg, 76%). 
1H NMR (400 MHz, CDCl3): δ = 7.32–7.39 (m, 4H), 7.19–7.30 (m, 2H), 7.08–7.13 (m, 1H), 
7.03–7.06 (m, 1H), 6.79–6.85 (m, 2H), 3.83 (s, 3H), 2.25 ppm (d, J = 1.3 Hz, 3H); 13C NMR 
(101 MHz, CDCl3): δ = 159.6 (s), 145.5 (s), 138.2 (s), 137.3 (s), 129.2 (s), 129.1 (s), 128.2 
(s), 127.8 (s), 126.5 (s), 118.6 (s), 112.4 (s), 112.0 (s), 77.3 (s), 76.7 (s), 55.3 (s), 17.5 ppm 
(s); IR (ATR): ṽ = 3022, 2996, 2941, 2834, 1597, 1576, 1485 ,1427, 1284, 1219, 1170, 852, 
775 cm-1; MS (EI, 70 eV) m/z (%): 225 (19), 224 (100) [M+], 223 (13), 209 (63), 208 (15), 
194 (24), 193 (14); HRMS (EI–TOF) calcd. for C16H16O: 224.1201; found: 224.1209. 
7.5.6.2. Synthesis of 1–methyl–3–((E)–1–phenylprop–1–en–2–yl)–benzene 
 
[CAS: 58662-09-2] 
The title compound was prepared following general procedure A, starting from 2–
methylbenzoic acid (69.5 mg, 0.5 mmol) and 1–phenyl–1–propyne (88 mg, 95.7 µL, 
0.75 mmol). The title compound was isolated as colorless liquid (75 mg, 72%). 
The title compound was prepared following general procedure B, starting from 2–
methylbenzoic acid (140 mg, 1 mmol) and 1–phenyl–1–propyne (59 mg, 64 µL, 0.5 mmol). 
The title compound was isolated as colorless liquid (73 mg, 71%). 
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1H NMR (400 MHz, CDCl3): δ = 7.33–7.42 (m, 6H), 7.24–7.31 (m, 2H), 7.13 (d, J = 7.0 Hz, 
1H), 6.84 (d, J = 1.3 Hz, 1H), 2.42 (s, 3H), 2.30 ppm (d, J = 1.3 Hz, 3H); 13C NMR 
(101 MHz, CDCl3): δ = 144.0 (s), 138.4 (s), 137.8 (s), 137.5 (s), 129.1 (s), 128.2 (s), 128.1 
(s), 127.9 (s), 127.5 (s), 126.8 (s), 126.4 (s), 123.1 (s), 77.3 (s), 76.7 (s), 21.6 (s), 17.5 ppm 
(s); IR (ATR): ṽ = 3023, 2958, 2927, 2871, 1601, 1493, 1455 ,1377, 781, 698 cm-1; MS (EI, 
70 eV) m/z (%): 209 (16), 208 (100) [M+], 194 (13), 193 (85), 178 (27), 115 (21), 89 
(12); HRMS (EI–TOF) calcd. for C16H16: 208.1243; found: 208.1252. 
7.5.6.3. Synthesis of 1–ethyl–3–((E)–1–phenylprop–1–en–2–yl)–benzene 
 
[CAS: 2079113-53-2] 
The title compound was prepared following general procedure A, starting from 2–
ethylbenzoic acid (75.1 mg, 0.5 mmol) and 1–phenyl–1–propyne (88 mg, 95.7 µL, 
0.75 mmol). The title compound was isolated as colorless liquid (89 mg, 80%). 
1H NMR (400 MHz, CDCl3): δ = 7.23–7.33 (m, 6H) 7.21 (d, J = 8.0 Hz, 1H) 7.15 (s, 1H) 
7.05 (s, 1H) 6.74 (d, J = 1.3 Hz, 1H) 2.60 (d, J = 7.5 Hz, 2H) 2.19 (d, J = 1.5 Hz, 3H) 
1.18 ppm (t, J = 7.5 Hz, 3H); 13C NMR (101 MHz, CDCl3): δ = 144.2 (s), 144.0 (s), 138.4 (s), 
137.6 (s), 129.1 (s), 128.3 (s), 128.1 (s), 127.5 (s), 126.8 (s), 126.4 (s), 125.6 (s), 123.4 (s), 
77.3 (s), 76.7 (s), 29.0 (s), 17.6 (s), 15.7 ppm (s); IR (ATR): ṽ = 3023, 2958, 2927, 2871, 
1601, 1493, 1455 ,1377, 781, 698 cm-1; MS (EI, 70 eV) m/z (%): 223 (21), 222 (100) [M+], 
208 (9), 207 (44), 193 (14), 129 (10), 115 (26), 89 (12); HRMS (EI–TOF) calcd. for C17H18: 
222.1400; found 222.1409. 
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7.5.6.4. Synthesis of 1–((Z)–1–phenylprop–1–en–2–yl)–3–(E)–prop–1–enyl)–benzene 
 
[CAS: 2079113-54-3] 
The title compound was prepared following general procedure A, starting from 2–
allylbenzoic acid (83 mg, 0.5 mmol) and 1–phenyl–1–propyne (88 mg, 95.7 µL, 0.75 mmol). 
The title compound was isolated as colorless liquid (75 mg, 61%). 
1H NMR (400 MHz, CDCl3): δ = 7.48 (t, J = 2.0 Hz, 1H), 7.34–7.41 (m, 5H), 7.22–7.34 (m, 
4H), 6.84 (d, J = 1.5 Hz, 1H), 6.42–6.51 (m, 1H), 6.30 (dd, J = 15.7, 6.7 Hz, 1H), 2.29 (d, J = 
1.5 Hz, 3H), 1.92 ppm (dd, J = 6.5, 1.8 Hz, 3H); 13C NMR (101 MHz, CDCl3): δ = 143.9 (s), 
138.0 (s), 137.6 (s), 137.2 (s), 130.7 (s), 128.8 (s), 128.1 (s), 127.8 (s), 127.3 (s), 126.1 (s), 
125.6 (s), 124.3 (s), 124.2 (s), 123.4 (s), 76.9 (s), 76.7 (s), 76.4 (s), 18.2 (s), 17.2 ppm (s); IR 
(ATR): ṽ = 3021, 2913, 1700, 1597, 1576, 1491 ,1443, 1377, 961, 771 cm-1; MS (EI, 70 eV) 
m/z (%): 235 (19), 234 (100) [M+], 220 (8), 219 (45), 204 (9), 191 (10), 115 (13); HRMS 
(EI–TOF) calcd. for C18H18: 234.1407; found 234.1409. 
7.5.6.5. Synthesis of 1–methoxy–3–((Z)–1–phenylprop–1–en–2–yl)–benzene 
 
[CAS: 721428-17-7] 
The title compound was prepared following general procedure A, starting from 2–
methoxybenzoic acid (77 mg, 0.5 mmol) and 1–phenyl–1–propyne (88 mg, 95.7 µL, 
0.75 mmol). The title compound was isolated as colorless liquid (88 mg, 79%). 
1H NMR (400 MHz, CDCl3): δ = 7.28 (d, J = 2.3 Hz, 4H), 7.12–7.23 (m, 2H), 7.01–7.06 (m, 
1H), 6.95 –6.99 (m, 1H), 6.72–6.78 (m, 2H), 3.75 (s, 3H), 2.18 ppm (d, J = 1.3 Hz, 3H); 13C 
NMR (101 MHz, CDCl3): δ = 159.6 (s), 145.5 (s), 138.2 (s), 137.3 (s), 129.2 (s), 129.1 (s), 
128.2 (s), 127.8 (s), 126.5 (s), 118.6 (s), 112.4 (s), 112.0 (s), 77.3 (s), 76.7 (s), 55.3 (s), 
17.5 ppm (s); IR (ATR): ṽ = 3022, 2996, 2941, 2834, 1597, 1576, 1485 ,1427, 1284, 1219, 
1170, 852, 775 cm-1; MS (EI, 70 eV) m/z (%): 225 (19), 224 (100) [M+], 223 (13), 209 (63), 
Experimental Section 
 
 191 
208 (15), 194 (24), 193 (14); HRMS (EI–TOF) calcd. for C16H16O: 224.1201; found 
224.1208. 
7.5.6.6. Synthesis of 1–phenoxy–3–((Z)–1–phenylprop–1–en–2–yl)–benzene 
 
[CAS: 2079113-55-4] 
The title compound was prepared following general procedure A, starting from 2–
phenoxybenzoic acid (109 mg, 0.5 mmol) and 1–phenyl–1–propyne (88 mg, 95.7 µL, 
0.75 mmol). The title compound was isolated as colorless liquid (130 mg, 99%). 
The title compound was prepared following general procedure B, starting from 2–
phenoxybenzoic acid (218 mg, 1 mmol) and 1–phenyl–1–propyne (59 mg, 64 µL, 0.5 mmol). 
The title compound was isolated as colorless liquid (110 mg, 84%). 
1H NMR (400 MHz, CDCl3): δ = 7.30–7.42 (m, 8H), 7.27–7.30 (m, 1H), 7.22 (s, 1H) 7.10–
7.15 (m, 1H), 7.06 (d, J = 8.3 Hz, 2H), 6.88–7.00 (m, 1H), 6.86 (s, 1H), 2.27 ppm (s, 3H); 13C 
NMR (101 MHz, CDCl3): δ = 157.3 (s), 157.1 (s), 145.9 (s), 138.1 (s), 136.7 (s), 129.7 (s), 
129.5 (s), 129.1 (s), 128.2 (s), 128.2 (s), 128.1 (s), 126.6 (s), 125.3 (s), 123.1 (s), 121.0 (s), 
118.7 (s), 117.6 (s), 116.8 (s), 77.3 (s), 77.2 (s), 76.7 (s), 17.4 ppm (s); IR (ATR): ṽ = 3052, 
3021, 2915, 1591, 1572, 1485, 1431, 127, 1218, 1163,1071, 1086, 916, 749 cm-1; MS (EI, 
70 eV) m/z (%): 287 (19), 286 (100) [M+], 271 (40), 193 (20), 178 (20), 77 (15); HRMS (EI–
TOF) calcd. for C21H18O: 286.1358; found 286.1358. 
7.5.6.7. Synthesis of 1–hydroxy–3–((Z)–1–phenylprop–1–en–2–yl)–benzene 
 
[CAS: 2079113-56-5] 
The title compound was prepared following general procedure A, starting from 2–
hydroxybenzoic acid (90 mg, 0.5 mmol) and 1–phenyl–1–propyne (88 mg, 95.7 µL, 
0.75 mmol). The title compound was isolated as colorless liquid as the corresponding 
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methylether after treatment with MeI (5 eq.) and K2CO3 (2 eq.) at 60 °C in NMP (93 mg, 
83%). 
1H NMR (400 MHz, CDCl3): δ = 7.32–7.39 (m, 4H), 7.19–7.30 (m, 2H), 7.08–7.13 (m, 1H), 
7.03–7.06 (m, 1H), 6.79–6.85 (m, 2H), 3.83 (s, 3H), 2.25 ppm (d, J = 1.3 Hz, 3H); 13C NMR 
(101 MHz, CDCl3): δ = 159.6 (s), 145.5 (s), 138.2 (s), 137.3 (s), 129.2 (s), 129.1 (s), 128.2 
(s), 127.8 (s), 126.5 (s), 118.6 (s), 112.4 (s), 112.0 (s), 77.3 (s), 76.7 (s), 55.3 (s), 17.5 ppm 
(s); IR (ATR): ṽ = 3022, 2996, 2941, 2834, 1597, 1576, 1485 ,1427, 1284, 1219, 1170, 852, 
775 cm-1; MS (EI, 70 eV) m/z (%): 225 (19), 224 (100) [M+], 223 (13), 209 (63), 208 (15), 
194 (24), 193 (14); HRMS (EI–TOF) calcd. for C16H16O: 224.1201; found 224.1209. 
7.5.6.8. Synthesis of 1–(3–((E)–1–phenylprop–1–en–2–yl)–phenyl)–ethanone 
 
[CAS: 568572-33-8] 
The title compound was prepared following general procedure A, starting from 2–
acetylbenzoic acid (83 mg, 0.5 mmol) and 1–phenyl–1–propyne (88 mg, 95.7 µL, 
0.75 mmol). The title compound was isolated as colorless liquid (91 mg, 77%). 
1H NMR (400 MHz, CDCl3): δ = 8.10–8.18 (m, 1H), 7.89 (dt, J = 7.6, 1.5 Hz, 1H), 7.74 (dt, J 
= 8.1, 1.5 Hz, 1H), 7.49 (t, J = 7.7 Hz, 1H), 7.37–7.43 (m, 4H), 7.29 (dt, J = 6.0, 2.9 Hz, 1H), 
6.88–6.92 (m, 1H), 2.66 (s, 3H), 2.33 ppm (d, J = 1.5 Hz, 3H); 13C NMR (101 MHz, CDCl3): 
δ = 198.3 (s), 144.5 (s), 137.9 (s), 137.2 (s), 136.5 (s), 130.6 (s), 129.1 (s), 128.7 (s), 128.6 (s), 
128.2 (s), 128.2 (s), 127.1 (s), 126.7 (s), 125.7 (s), 77.3 (s), 77.0 (s), 76.7 (s), 26.8 (s), 
17.5 ppm (s); IR (ATR): ṽ = 3061, 3022, 1681, 1596, 1577, 1491, 1423, 1355, 1283, 1259, 
1228, 792, 750, 692 cm-1; MS (EI, 70 eV) m/z (%): 237 (26), 236 (100) [M+], 221 (64), 193 
(54), 178 (39), 50 (13), 43 (57); HRMS (EI–TOF) calcd. for C17H16O: 236.1200; found 
236.1201. 
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7.5.6.9. Synthesis of phenyl–(3–((E)–1–phenylprop–1–en–2–yl)–phenyl)–methanone 
 
[CAS: 2079113-61-2] 
The title compound was prepared following general procedure A, starting from 2–
benzoylbenzoic acid (83 mg, 0.5 mmol) and 1–phenyl–1–propyne (88 mg, 95.7 µL, 
0.75 mmol). The title compound was isolated as colorless solid (131 mg, 88%). 
1H NMR (400 MHz, CDCl3): δ = 7.99 (t, J = 1.9 Hz, 1H), 7.86 (dd, J = 8.4, 1.4 Hz, 2H), 7.76 
(dt, J = 7.8, 1.6 Hz, 1H), 7.70 (dt, J = 7.7, 1.4 Hz, 1H), 7.59–7.65 (m, 1H) 7.47–7.54 (m, 3H), 
7.35–7.41 (m, 4H), 7.24–7.30 (m, 2H), 6.90 (d, J = 1.5 Hz, 1H), 2.32 ppm (d, J = 1.5 Hz, 3H); 
13C NMR (101 MHz, CDCl3): δ = 196.9 (s), 144.2 (s), 137.9 (s), 137.7 (s), 137.6 (s), 136.5 
(s), 132.5 (s), 130.1 (s), 129.9 (s), 129.9 (s), 129.1 (s), 128.9 (s), 128.7 (s), 128.3 (s), 128.2 
(s), 128.2 (s), 127.4 (s), 126.7 (s), 77.3 (s), 77.2 (s), 76.7 (s), 17.5 ppm (s); IR (ATR): ṽ = 
3059, 3024, 1656, 1595, 1576, 1491, 1446, 1337, 1317, 1284, 1239, 1177, 1144, 1074, 948, 
912 cm-1; MS (EI, 70 eV) m/z (%): 299 (22), 298 (100) [M+], 280 (23), 221 (10), 178 (72), 
105 (67), 77 (48); HRMS (EI–TOF) calcd. for C22H18O: 298.1351; found 298.1358; m.p.: 
64–67 °C. 
7.5.6.10. Synthesis of 1–(methylsulfonyl)–3–((E)–1–phenylprop–1–en–2yl)–benzene 
 
[CAS: 2079113-62-3] 
The title compound was prepared following general procedure A, starting from 2–
methylsulfonylbenzoic acid (83.2 mg, 0.5 mmol) and 1–phenyl–1–propyne (88 mg, 95.7 µL, 
0.75 mmol). The title compound was isolated as colorless liquid (130 mg, 95%). 
The title compound was prepared following general procedure B, starting from 2– 
methylsulfonylbenzoic acid (168 mg, 1 mmol) and 1–phenyl–1–propyne (59 mg, 64 µL, 
0.5 mmol). The title compound was isolated as colorless liquid (90 mg, 66%). 
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1H NMR (400 MHz, CDCl3): δ = 8.10 (t, J = 1.9 Hz, 1H), 7.87 (dt, J = 7.8, 1.6 Hz, 1H), 7.81 
(dt, J = 8.1, 1.5 Hz, 1H), 7.59 (t, J = 7.8 Hz, 1H), 7.34–7.44 (m, 4H), 7.30 (d, J = 6.8 Hz, 1H), 
6.90–6.96 (m, 1H), 3.11 (s, 3H), 2.32 ppm (d, J = 1.5 Hz, 3H); 13C NMR (101 MHz, CDCl3): 
δ = 145.4 (s), 140.7 (s), 137.4 (s), 135.5 (s), 131.1 (s), 129.8 (s), 129.4 (s), 129.1 (s), 128.3 (s), 
127.0 (s), 125.7 (s), 124.7 (s), 77.3 (s), 76.7 (s), 44.5 (s), 17.4 ppm (s); IR (ATR): ṽ = 3059, 
3021, 2927, 1297, 1142,1097, 1086, 955, 760, 744 cm-1; MS (EI, 70 eV) m/z (%): 272 (100) 
[M+], 85 (63), 68 (47), 57 (46), 54 (68), 43 (61), 41 (72); HRMS (EI–TOF) calcd. for 
C16H16O2S: 272.0871; found 272.0861. 
7.5.6.11. Synthesis of 1–fluoro–3–((Z)–1–phenylprop–1–en–2–yl)–benzene 
 
[CAS: 2079113-63-4] 
The title compound was prepared following general procedure A, starting from 2–
fluorobenzoic acid (71 mg, 0.5 mmol) and 1–phenyl–1–propyne (88 mg, 95.7 µL, 
0.75 mmol). The title compound was isolated as colorless solid (86 mg, 81%). 
1H NMR (400 MHz, CDCl3): δ = 7.31–7.43 (m, 6H), 7.27–7.31 (m, 1H), 7.20–7.26 (m, 1H), 
6.95–7.03 (m, 1H), 6.87 (s, 1H), 2.28 ppm (d, J = 1.3 Hz, 3H); 13C NMR (101 MHz, CDCl3): 
δ = 162.9 (d, J = 244.3 Hz), 146.2 (d, J = 7.3 Hz), 137.9 (s), 136.2 (d, J = 2.7 Hz), 129.7 (d, J 
= 8.2 Hz), 129.1 (s), 128.5 (s), 128.2 (s), 126.7 (s), 121.6 (d, J = 2.7 Hz), 113.9 (d, J = 
20.89 Hz), 112.9 (d, J = 21.8 Hz), 17.4 ppm (s); 19F NMR (376 MHz, CDCl3): δ = -
113.55 ppm; IR (ATR): ṽ = 2980, 1718, 1371, 1207, 1157 ,1029, 781 cm-1; MS (EI, 70 eV) 
m/z (%): 213 (15), 212 (100) [M+], 197 (62), 196 (19), 177 (16), 115 (13), 50 (12); HRMS 
(EI–TOF) calcd. for C15H13F: 212.1005; found 212.1005. 
7.5.6.12. Synthesis of 1−((E)−2−(3−hydroxyphenyl)−prop−1−enyl)−benzene 
 
[CAS: 2079113-56-5] 
The title compound was prepared following general procedure A, starting from 4–
hydroxybenzoic acid (70 mg, 0.5 mmol) and 1–phenyl–1–propyne (88 mg, 95.7 µL, 
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0.75 mmol). The title compound was isolated as colorless liquid as the corresponding 
methylether after treatment with MeI (5 eq.) and K2CO3 (2 eq.) at 60 °C in NMP (79 mg, 
80%). 
1H NMR (400 MHz, CDCl3): δ = 7.35–7.42 (m, 4H), 7.21–7.34 (m, 2H), 7.11–7.16 (m, 1H), 
7.05–7.09 (m, 1H), 6.82–6.90 (m, 2H), 3.86 (s, 3H), 2.28 ppm (d, J = 1.3 Hz, 3H); 13C NMR 
(101 MHz, CDCl3): δ = 159.6 (s), 145.5 (s), 138.2 (s), 137.3 (s), 129.2 (s), 129.1 (s), 128.2 
(s), 127.8 (s), 126.5 (s), 118.6 (s), 112.4 (s), 112.0 (s), 77.3 (s), 76.7 (s), 55.3 (s), 17.5 ppm 
(s); IR (ATR): ṽ = 3022, 2996, 2941, 2834, 1597, 1576, 1485 ,1427, 1284, 1219, 1170, 852, 
775 cm-1; MS (EI, 70 eV) m/z (%): 225 (19), 224 (100) [M+], 223 (13), 209 (63), 208 (15), 
194 (24), 193 (14); HRMS (EI–TOF) calcd. for C16H16O: 224.1201; found 224.1208. 
7.5.6.13. Synthesis of 1−((E)−2−m−tolylprop−1−enyl)−benzene 
 
[CAS: 58662-09-2] 
The title compound was prepared following general procedure A, starting from 4–
methylbenzoic acid (75.1 mg, 0.5 mmol) and 1–phenyl–1–propyne (88 mg, 95.7 µL, 
0.75 mmol). The title compound was isolated as colorless liquid (65 mg, 62%). 
The title compound was prepared following general procedure B, starting from 4–
methylbenzoic acid (150.2 mg, 1 mmol) and 1–phenyl–1–propyne (59 mg, 64 µL, 0.5 mmol). 
The title compound was isolated as colorless liquid (68 mg, 64%). 
1H NMR (400 MHz, CDCl3): δ = 7.21–7.32 (m, 6H), 7.13–7.20 (m, 2H), 7.02 (d, J = 7.0 Hz, 
1H), 6.73 (d, J = 1.3 Hz, 1H), 2.30 (s, 3H), 2.18 ppm (d, J = 1.5 Hz, 3H); 13C NMR 
(101 MHz, CDCl3): δ = 144.0 (s), 138.4 (s), 137.8 (s), 137.5 (s), 129.1 (s), 128.2 (s), 128.1 
(s), 127.9 (s), 127.5 (s), 126.8 (s), 126.4 (s), 123.1 (s), 77.3 (s), 76.7 (s), 21.5 (s), 17.5 ppm 
(s); IR (ATR): ṽ = 3021, 2917, 1600, 1582, 1499, 1442, 1376, 859, 779, 754, 694 cm-1; MS 
(EI, 70 eV) m/z (%): 209 (16), 208 (100) [M+], 194 (13), 193 (85), 178 (27), 115 (21), 89 
(12); HRMS (EI–TOF) calcd. for C16H16: 208.1243; found 208.1250. 
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7.5.6.14. Synthesis of 1−((E)−2−(3−fluorophenyl)−prop−1−enyl)−benzene 
 
[CAS: 2079113-63-4] 
The title compound was prepared following general procedure A, starting from 4–
fluorobenzoic acid (71 mg, 0.5 mmol) and 1–phenyl–1–propyne (88 mg, 95.7 µL, 
0.75 mmol). The title compound was isolated as colorless liquid (60 mg, 56%). 
The title compound was prepared following general procedure B, starting from 4–
fluorobenzoic acid (142 mg, 1 mmol) and 1–phenyl–1–propyne (59 mg, 64 µL, 0.5 mmol). 
The title compound was isolated as colorless liquid (75 mg, 71%). 
1H NMR (400 MHz, CDCl3): δ = 77.39–7.43 (m, 1H), 7.35–7.39 (m, 3H), 7.30–7.34 (m, 2H), 
7.20–7.30 (m, 3H), 6.95–7.04 (m, 1H), 6.88 (s, 1H), 2.28 ppm (d, J = 1.3 Hz, 3H); 13C NMR 
(101 MHz, CDCl3): δ = 162.9 (d, J = 244.3 Hz), 146.2 (d, J = 7.3 Hz), 137.9 (s), 136.2 (d, J = 
2.7 Hz), 129.7 (d, J = 8.2 Hz), 129.1 (s), 128.5 (s), 128.2 (s), 126.7 (s), 121.6 (d, J = 2.7 Hz), 
113.9 (d, J = 20.89 Hz), 112.9 (d, J = 21.8 Hz), 17.4 ppm (s); 19F NMR (376 MHz, CDCl3): δ 
= -113.55 ppm; IR (ATR): ṽ = 2980, 1718, 1371, 1207, 1157 ,1029, 781 cm-1; MS (EI, 
70 eV) m/z (%): 213 (15), 212 (100) [M+], 197 (62), 196 (19), 177 (16), 115 (13), 50 
(12); HRMS (EI–TOF) calcd. for C15H13F: 212.1005; found 212.1000. 
7.5.6.15. Synthesis of 1−((E)−2−(3−bromophenyl)−prop−1−enyl)−benzene 
 
[CAS: 1361147-98-9] 
The title compound was prepared following general procedure A, starting from 4–
bromobenzoic acid (103 mg, 0.5 mmol) and 1–phenyl–1–propyne (88 mg, 95.7 µL, 
0.75 mmol). The title compound was isolated as colorless liquid (78 mg, 57%). 
1H NMR (400 MHz, CDCl3): δ = 7.68 (t, J = 1.9 Hz, 1H), 7.41–7.47 (m, 2H), 7.34–7.41 (m, 
4H), 7.22–7.31 (m, 2H), 6.84 (s, 1H), 2.27 ppm (d, J = 1.3 Hz, 3H); 13C NMR (101 MHz, 
CDCl3): δ = 146.1 (s), 137.8 (s), 136.1 (s), 130.0 (s), 129.8 (s), 129.1 (s), 128.8 (s), 128.2 (s), 
126.8 (s), 124.6 (s), 122.5 (s), 77.3 (s), 76.7 (s), 17.4 ppm (s); IR (ATR): ṽ = 3060, 3021, 
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1589, 1558, 1474 ,1441, 1247, 1062, 863, 777, 742, 692 cm-1; MS (EI, 70 eV) m/z (%): 275 
(18), 274 (100) [M+], 273 (18), 272 (96), 259 (18), 193 (33), 178 (60); HRMS (EI–TOF) 
calcd. for C15H1379Br: 272.0201; found 272.0189. calcd. for C15H1381Br: 274.0180; found 
274.0163. 
7.5.6.16. Synthesis of 1−((E)−2−(4−bromophenyl)−prop−1−enyl)−benzene 
 
[CAS: 580002-13-7] 
The title compound was prepared following general procedure A, starting from 3–
bromobenzoic acid (103 mg, 0.5 mmol) and 1–phenyl–1–propyne (88 mg, 95.7 µL, 
0.75 mmol). The title compound was isolated as colorless solid (58 mg, 43%). 
1H NMR (400 MHz, CDCl3): δ = 7.44–7.51 (m, 2H), 7.31–7.40 (m, 5H), 7.22–7.28 (m, 1H), 
6.81 (s, 1H), 2.24 ppm (d, J = 1.3 Hz, 3H); 13C NMR (101 MHz, CDCl3): δ = 142.8 (s), 137.9 
(s), 136.2 (s), 131.3 (s), 129.1 (s), 128.2 (s), 128.1 (s), 127.6 (s), 126.7 (s), 121.0 (s), 17.3 ppm 
(s); IR (ATR): ṽ = 3060, 3021, 1589, 1558, 1474 ,1441, 1247, 1062, 863, 777, 742, 692 cm-1; 
MS (EI, 70 eV) m/z (%): 275 (18), 274 (100) [M+], 273 (18), 272 (96), 259 (18), 193 (33), 
178 (60); HRMS (EI–TOF) calcd. for C15H1379Br: 272.0201; found 272.0201. calcd. for 
C15H1381Br: 274.0180; found 274.0200; m.p.: 79–80 °C. 
7.5.6.17. Synthesis of 4−((E)−1−phenylprop−1−en−2−yl)−benzonitrile 
 
[CAS: 2079113-70-3] 
The title compound was prepared following general procedure A, starting from 3–
cyanobenzoic acid (75.1 mg, 0.5 mmol) and 1–phenyl–1–propyne (88 mg, 95.7 µL, 
0.75 mmol). The title compound was isolated as colorless solid (46 mg, 42%). 
1H NMR (400 MHz, CDCl3): δ = 7.60–7.69 (m, 4H), 7.36–7.44 (m, 4H), 7.27–7.33 (m, 1H), 
6.93 (s, 1H), 2.30 ppm (d, J = 1.3 Hz, 3H); 13C NMR (101 MHz, CDCl3): δ = 148.4 (s), 137.4 
(s), 135.7 (s), 132.2 (s), 130.4 (s), 129.1 (s), 128.3 (s), 127.1 (s), 126.6 (s), 119.0 (s), 110.5 
(s), 17.1 ppm (s); IR (ATR): ṽ = 2950, 2226, 1598, 1501, 1444, 1407, 1377, 1180, 1117, 
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1080, 1062, 842, 827, 758, 711, 696 cm-1; MS (EI, 70 eV) m/z (%): 220 (25), 219.(100) [M+], 
218 (15), 204 (78), 203 (14), 115 (14), 50 (14); HRMS (EI–TOF) calcd. for C15H1379Br: 
272.0201; found 272.0201. calcd. for C16H13N: 219.1048; found 298.1053; m.p.: 35–36 °C. 
7.5.6.18. Synthesis of 1,2−dihydroxy−5−((E)−1−phenylprop−1−enyl)−benzene 
 
[CAS: 2079113-73-6] 
The title compound was prepared following general procedure A, starting from 2,4–
dihydroxybenzoic acid (103 mg, 0.5 mmol) and 1–phenyl–1–propyne (88 mg, 95.7 µL, 
0.75 mmol). The title compound was isolated as colorless liquid as the corresponding 
methylether after treatment with MeI (5 eq.) and K2CO3 (2 eq.) at 60 °C in NMP (104 mg, 
82%). 
1H NMR (400 MHz, CDCl3): δ = 7.34–7.50 (m, 4H), 7.22–7.30 (m, 1H), 6.79–6.99 (m, 1H), 
6.69 (d, J = 2.3 Hz, 2H), 6.37–6.50 (m, 1H), 3.85 (s, 6H), 2.27 ppm (d, J = 1.5 Hz, 3H); 13C 
NMR (101 MHz, CDCl3): δ = 161.0 (s), 146.6 (s), 138.4 (s), 137.7 (s), 129.5 (s), 128.5 (s), 
128.2 (s), 126.8 (s), 104.8 (s), 99.4 (s), 77.6 (s), 77.5 (s), 77.3 (s), 55.7 (s), 17.9 ppm (s); IR 
(ATR): ṽ = 2997, 2943, 2837, 1588, 1454 ,1421, 1348, 1329, 1203, 1152, 1067, 1048, 833, 
751, 699 cm-1; MS (EI, 70 eV) m/z (%): 255 (19), 254 (100) [M+], 253 (32), 239 (56), 224 
(14), 223 (12), 208 (14); HRMS (EI–TOF) calcd. for C17H18O2: 254.1307; found 254.1319. 
7.5.6.19. Synthesis of 1,2−dimethoxy−5−((E)−1−phenylprop−1−enyl)−benzene 
 
[CAS: 2079113-76-9] 
The title compound was prepared following general procedure A, starting from 2,4–
dimethoxybenzoic acid (93 mg, 0.5 mmol) and 1–phenyl–1–propyne (88 mg, 95.7 µL, 
0.75 mmol). The title compound was isolated as colorless liquid (78 mg, 61%). 
1H NMR (400 MHz, CDCl3): δ = 7.34–7.50 (m, 4H), 7.22–7.30 (m, 1H), 6.79–6.99 (m, 1H), 
6.69 (d, J = 2.3 Hz, 2H), 6.37–6.50 (m, 1H), 3.85 (s, 6H), 2.27 ppm (d, J = 1.5 Hz, 3H); 13C 
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NMR (101 MHz, CDCl3): δ = 161.0 (s), 146.6 (s), 138.4 (s), 137.7 (s), 129.5 (s), 128.5 (s), 
128.2 (s), 126.8 (s), 104.8 (s), 99.4 (s), 77.6 (s), 77.5 (s), 77.3 (s), 55.7 (s), 17.9 ppm (s); IR 
(ATR): ṽ = 2997, 2943, 2837, 1588, 1454 ,1421, 1348, 1329, 1203, 1152, 1067, 1048, 833, 
751, 699 cm-1; MS (EI, 70 eV) m/z (%): 255 (19), 254 (100) [M+], 253 (32), 239 (56), 224 
(14), 223 (12), 208 (14); HRMS (EI–TOF) calcd. for C17H18O2: 254.1307; found 254.1316. 
7.5.6.20. Synthesis of 1,3−dimethyl−5−((Z)−1−phenylprop−1−en−2−yl)−benzene 
 
[CAS: 2079113-76-2] 
The title compound was prepared following general procedure A, starting from 2,4–
dimethylbenzoic acid (76 mg, 0.5 mmol) and 1–phenyl–1–propyne (88 mg, 95.7 µL, 
0.75 mmol). The title compound was isolated as colorless liquid (93 mg, 84%). 
1H NMR (400 MHz, CDCl3): δ = 7.28 (d, J = 1.8 Hz, 4H), 7.14 (s, 1H), 7.06 (s, 2H), 6.86 (s, 
1H), 6.72 (d, J = 1.3 Hz, 1H), 2.27 (s, 6H), 2.18 ppm (d, J = 1.5 Hz, 3H); 13C NMR 
(101 MHz, CDCl3): δ = 144.1 (s), 138.4 (s), 137.7 (s), 137.6 (s), 129.1 (s), 128.8 (s), 128.8 
(s), 128.5 (s), 128.1 (s), 127.8 (s), 127.4 (s), 126.3 (s), 126.0 (s), 125.7 (s), 123.9 (s), 77.3 (s), 
76.7 (s), 21.4 (s), 21.3 (s), 17.6 ppm (s); IR (ATR): ṽ = 3021, 2916, 2861, 1599, 1493, 1443, 
1375, 841, 749, 696 cm-1; MS (EI, 70 eV) m/z (%): 223 (19), 222 (100) [M+], 208 (9), 207 
(52), 192 (17), 115 (14), 91 (9); HRMS (EI–TOF) calcd. for C17H18: 222.1409; found 
222.1413. 
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7.5.6.21. Synthesis of 2−((E)−1−phenylprop−1−en−2−yl)−naphthalene 
Me
Ph
H
 
[CAS: 52520-45-3] 
The title compound was prepared following general procedure A, starting from 2–
naphthoic acid (88 mg, 0.5 mmol) and 1–phenyl–1–propyne (88 mg, 95.7 µL, 0.75 mmol). 
The title compound was isolated as colorless solid (50 mg, 40%). 
1H NMR (400 MHz, CDCl3): δ = 7.97 (d, J = 1.3 Hz, 1H), 7.83–7.92 (m, 3H), 7.71–7.78 (m, 
1H), 7.40–7.54 (m, 6H), 7.30 (td, J = 6.0, 2.9 Hz, 1H), 7.04 (d, J = 1.0 Hz, 1H), 2.42 ppm (d, 
J = 1.3 Hz, 3H); 13C NMR (101 MHz, CDCl3): δ = 141.1 (s), 138.4 (s), 137.2 (s), 133.5 (s), 
132.7 (s), 129.3 (s), 128.3 (s), 128.2 (s), 128.2 (s), 127.8 (s), 127.6 (s), 126.6 (s), 126.2 (s), 
125.8 (s), 124.7 (s), 124.4 (s), 17.5 ppm (s); IR (ATR): ṽ = 3055, 1595, 1571, 1486, 1444, 
1386, 1275, 1130, 1072, 853, 810, 742, 716, 695 cm-1; MS (EI, 70 eV) m/z (%): 245 (24), 244 
(100) [M+], 243 (11), 230 (11), 229 (61), 228 (20), 115 (9); HRMS (EI–TOF) calcd. for 
C19H16: 244.1252; found 244.1244; m.p.: 137–139 °C. 
7.5.6.22. Synthesis of 7−((E)−1−phenylprop−1−en−2−yl)−quinoline 
Me
Ph
H
N
 
[CAS: 2079113-84-9] 
The title compound was prepared following general procedure A, starting from 6–
quinolinecarboxylic acid (89.3 mg, 0.5 mmol) and 1–phenyl–1–propyne (88 mg, 95.7 µL, 
0.75 mmol). The title compound was isolated as orange solid (44 mg, 36%). 
1H NMR (400 MHz, CDCl3): δ = 8.93 (dd, J = 4.1, 1.6 Hz, 1H), 8.24 (d, J = 1.0 Hz, 1H), 
8.16 (ddd, J = 8.3, 1.5, 0.8 Hz, 1H), 7.82 (d, J = 1.3 Hz, 2H), 7.36–7.45 (m, 5H), 7.30 (td, J = 
5.8, 2.8 Hz, 1H), 7.10 (d, J = 1.3 Hz, 1H), 2.43 ppm (d, J = 1.3 Hz, 3H); 13C NMR 
(101 MHz, CDCl3): δ = 150.7 (s), 148.4 (s), 144.7 (s), 138.0 (s), 136.5 (s), 135.7 (s), 129.3 
(s), 129.2 (s), 128.2 (s), 127.5 (s), 127.4 (s), 126.8 (s), 126.0 (s), 125.1 (s), 120.8 (s), 17.3 ppm 
(s); IR (ATR): ṽ = 3021, 2917, 2340, 1740, 1614, 1593, 1495, 1441, 1383, 1320, 835, 826, 
753, 714, 693 cm-1; MS (EI, 70 eV) m/z (%): 245 (25), 244 (100) [M+], 229 (12), 202 (3), 115 
(4); HRMS (EI–TOF) calcd. for C18H15N: 245.1204; found 245.1175; m.p.: 50–51 °C. 
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7.5.6.23. Synthesis of 1−((E)−1−(3−methyl−4−nitrophenyl)−prop−1−enyl)−benzene 
 
[CAS: 2079113-87-2] 
The title compound was prepared following general procedure A, starting from 2–methyl-
3-nitrobenzoic acid (91 mg, 0.5 mmol) and 1–phenyl–1–propyne (88 mg, 95.7 µL, 
0.75 mmol). The title compound was isolated as orange solid (69 mg, 55%). 
1H NMR (400 MHz, CDCl3): δ = 8.01–8.08 (m, 1H), 7.46–7.50 (m, 2H), 7.36–7.45 (m, 4H), 
7.31 (d, J = 6.8 Hz, 1H), 6.91–6.97 (m, 1H), 2.68 (s, 3H), 2.31 ppm (d, J = 1.5 Hz, 3H); 13C 
NMR (101 MHz, CDCl3): δ = 148.9 (s), 147.6 (s), 137.4 (s), 135.5 (s), 134.0 (s), 130.6 (s), 
130.2 (s), 129.1 (s), 128.3 (s), 127.1 (s), 125.0 (s), 124.3 (s), 77.3 (s), 76.7 (s), 21.0 (s), 
17.3 ppm (s); IR (ATR): ṽ = 3025, 2997, 2915, 2858, 1599, 1578, 1510, 1488, 1445, 1337, 
1813, 1207, 1184, 1069, 870, 827, 760, 753, 701 cm-1; MS (EI, 70 eV) m/z (%): 254 (19), 253 
(100) [M+], 238 (9), 236 (15), 206 (8), 192 (18), 191 (11); HRMS (EI–TOF) calcd. for 
C16H15NO2: 253.1103; found 253.1110; m.p.: 61–62 °C. 
7.5.6.24. Synthesis of 2−((E)−1−phenylprop−1−en−2−yl)−naphthalene 
 
[CAS: 52520-45-3] 
The title compound was prepared following general procedure A, starting from 1–
naphthoic acid (88 mg, 0.5 mmol) and 1–phenyl–1–propyne (88 mg, 95.7 µL, 0.75 mmol). 
The title compound was isolated as colorless solid (109 mg, 89%). 
1H NMR (400 MHz, CDCl3): δ = 7.94–7.99 (m, 1H), 7.82–7.91 (m, 3H), 7.74 (dd, J = 8.5, 
2.0 Hz, 1H), 7.49 (ddd, J = 7.6, 5.5, 1.8 Hz, 2H), 7.39–7.45 (m, 4H), 7.29 (d, J = 2.8 Hz, 1H), 
7.03 (d, J = 1.3 Hz, 1H), 2.42 ppm (d, J = 1.5 Hz, 3H); 13C NMR (101 MHz, CDCl3): δ 
= 141.1 (s), 138.3 (s), 137.2 (s), 133.4 (s), 132.7 (s), 129.2 (s), 128.2 (s), 128.2 (s), 128.1 (s), 
127.8 (s), 127.5 (s), 126.5 (s), 126.2 (s), 125.8 (s), 124.7 (s), 124.4 (s), 77.3 (s), 76.7 (s), 
17.5 ppm (s); IR (ATR): ṽ = 3055, 1595, 1571, 1486, 1444, 1386, 1275, 1130, 1072, 853, 
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810, 742, 716, 695 cm-1; MS (EI, 70 eV) m/z (%): 245 (24), 244 (100) [M+], 243 (11), 230 
(11), 229 (61), 228 (20), 115 (9); HRMS (EI–TOF) calcd. for C19H16: 244.1252; found 
244.1246; m.p.: 137–138 °C. 
7.5.6.25. Synthesis of (E)−1,2−diphenylprop−1−ene 
 
[CAS: 833-81-8] 
The title compound was prepared following general procedure A, starting from benzoic 
acid (61 mg, 0.5 mmol) and 1–phenyl–1–propyne (88 mg, 95.7 µL, 0.75 mmol). The title 
compound was isolated as colorless liquid (39 mg, 40%). 
The title compound was prepared following general procedure B, starting from 4–
fluorobenzoic acid (150.2 mg, 1 mmol) and 1–phenyl–1–propyne (59 mg, 64 µL, 0.5 mmol). 
The title compound was isolated as colorless liquid (58 mg, 60%). 
1H NMR (400 MHz, CDCl3): δ = 7.49–7.60 (m, 2H), 7.20–7.45 (m, 8H), 6.85 (d, J = 1.0 Hz, 
1H), 2.30 ppm (d, J = 1.3 Hz, 3H); 13C NMR (101 MHz, CDCl3): δ = 144.0 (s), 138.4 (s), 
137.4 (s), 129.1 (s), 128.3 (s), 128.1 (s), 127.7 (s), 127.2 (s), 126.4 (s), 126.0 (s), 17.5 ppm (s). 
The analytical data matched those reported in the literature.[356],[357],[358] 
7.5.6.26. Synthesis of 1,2,5−trimethoxy−3−((E)−1−phenylprop−1−en−2−yl)−benzene 
 
[CAS: 2079113-93-0] 
The title compound was prepared following general procedure A, starting from 2,4,5–
trimethoxybenzoic acid (107 mg, 0.5 mmol) and 1–phenyl–1–propyne (88 mg, 95.7 µL, 
0.75 mmol). The title compound was isolated as colorless solid (86 mg, 60%). 
1H NMR (400 MHz, CDCl3): δ = 7.35–7.45 (m, 4H), 7.21–7.31 (m, 2H), 6.59 (d, J = 1.5 Hz, 
1H), 6.48 (d, J = 3.0 Hz, 1H), 6.40 (d, J = 3.0 Hz, 1H), 3.88 (s, 3H), 3.83 (s, 3H), 3.76 (s, 3H), 
2.28 ppm (d, J = 1.5 Hz, 3H); 13C NMR (101 MHz, CDCl3): δ = 156.1 (s), 153.7 (s), 140.5 
(s), 138.3 (s), 137.5 (s), 129.7 (s), 129.3 (s), 128.5 (s), 126.8 (s), 104.8 (s), 99.3 (s), 77.6 (s), 
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77.3 (s), 61.2 (s), 56.2 (s), 55.9 (s), 19.5 ppm (s); IR (ATR): ṽ = 2939, 2837, 1588, 1482, 
1463, 1419, 1338, 1274, 1224, 1199, 1174, 1157,1135, 1100, 1006, 830, 773, 749, 698 cm-1; 
MS (EI, 70 eV) m/z (%): 285 (20), 284 (100) [M+], 269 (48), 253 (15), 241 (10), 103 (9), 91 
(14); HRMS (EI–TOF) calcd. for C18H20O3: 284.1412; found 284.1410; m.p.: 71–73 °C. 
7.5.6.27. Synthesis of ethyl–(2E)–3–(3–methoxyphenyl)–3–phenylprop–2–enoate 
 
[CAS: 329968-30-1] 
The title compound was prepared following general procedure A, starting from 4–
methoxybenzoic acid (90 mg, 0.5 mmol) and ethyl–3–phenylpropiolate (133 mg, 127 µL, 
0.75 mmol). The title compound was isolated as colorless liquid (102 mg, 72%). 
The title compound was prepared following general procedure B, starting from 4–
methoxybenzoic acid (180 mg, 1 mmol) and ethyl–3–phenylpropiolate (88.7 mg, 84.7 µL, 
0.5 mmol). The title compound was isolated as colorless liquid (58 mg, 41%). 
1H NMR (400 MHz, CDCl3): δ = 7.28–7.46 (m, 6H), 7.01–7.12 (m, 3H), 6.90 (dd, J = 8.2, 
2.6 Hz, 1H), 4.29 (q, J = 7.0 Hz, 2H), 3.85 (s, 3H), 1.22 ppm (t, J = 7.0 Hz, 3H); 13C NMR 
(101 MHz, CDCl3): δ = 169.5 (s), 159.7 (s), 138.3 (s), 135.6 (s), 135.1 (s), 131.3 (s), 129.7 
(s), 128.4 (s), 128.3 (s), 128.2 (s), 118.9 (s), 113.8 (s), 112.0 (s), 61.3 (s), 55.3 (s), 13.9 ppm 
(s); IR (ATR): ṽ = 2967, 2836, 1603, 1718, 1596, 1578, 1488, 1371, 1287, 1215, 1184, 1156, 
1023, 691 cm-1; MS (EI, 70 eV) m/z (%): 283 (19), 282 (100) [M+], 237 (11), 209 (30), 194 
(10), 135 (12), 107 (11); HRMS (EI–TOF) calcd. for C18H18O2: 282.1256; found 282.1249. 
7.5.6.28. Synthesis of (Z)–2–(3–Methoxyphenyl)–3–phenylprop–2–en–1–ol 
 
[CAS: 1694650-56-0] 
The title compound was prepared following general procedure A, starting from 4–
methoxybenzoic acid (90 mg, 0.5 mmol) and 1–(3–hydroxyprop–1–ynyl)–benzene (105 mg, 
110 µL, 0.75 mmol). The title compound was isolated as colorless liquid (96 mg, 80%). 
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The title compound was prepared following general procedure B, starting from 4–
methoxybenzoic acid (180 mg, 1 mmol) and 1–(3–hydroxyprop–1–ynyl)–benzene (70 mg, 
73.3 µL, 0.5 mmol). The title compound was isolated as colorless liquid (63 mg, 52%). 
1H NMR (400 MHz, CDCl3): δ = 7.29–7.49 (m, 7H), 7.17–7.21 (m, 1H), 7.13–7.16 (m, 1H), 
6.99 (s, 1H), 6.90 (ddd, J = 8.2, 2.6, 1.0 Hz, 1H), 4.71 (s, 2H), 3.87 (s, 3H), 1.62 ppm (br. s, 
1H); 13C NMR (101 MHz, CDCl3): δ = 159.9 (s), 142.1 (s), 140.0 (s), 136.8 (s), 131.4 (s), 
129.7 (s), 128.9 (s), 128.4 (s), 127.4 (s), 119.0 (s), 113.1 (s), 112.5 (s), 60.4 (s), 55.3 ppm (s); 
IR (ATR): ṽ = 3392, 3023, 2938, 2834, 1713, 1597, 1576, 1487, 1447, 1286, 1266, 1228, 
1169, 1033, 1010, 862, 777, 755, 694 cm-1; MS (EI, 70 eV) m/z (%): 241 (16), 240 (100) 
[M+], 223 (30), 135 (19), 121 (7); HRMS (EI–TOF) calcd. for C16H16O2: 240.1150; found 
240.1156. 
7.5.6.29. Synthesis of ethyl–(2E)–3–(3–methylphenyl)–3–phenylprop–2–enoate 
 
[CAS: 329968-28-7] 
The title compound was prepared following general procedure A, starting from 2–
methoxybenzoic acid (69 mg, 0.5 mmol) and ethyl–3–phenylpropiolate (133 mg, 127 µL, 
0.75 mmol). The title compound was isolated as colorless liquid (59 mg, 44%). 
1H NMR (400 MHz, CDCl3): δ = 7.34–7.43 (m, 4H), 7.28–7.34 (m, 4H), 7.18 (ddd, J = 4.6, 
3.5, 1.5 Hz, 1H), 7.05 (s, 1H), 4.30 (q, J = 7.0 Hz, 2H), 2.40 (s, 3H), 1.22 ppm (t, J = 7.2 Hz, 
3H); 13C NMR (101 MHz, CDCl3): δ = 169.7 (s), 138.3 (s), 136.8 (s), 135.8 (s), 135.4 (s), 
130.9 (s), 129.1 (s), 128.6 (s), 128.4 (s), 128.2 (s), 128.2 (s), 127.0 (s), 123.5 (s), 61.3 (s), 21.5 
(s), 13.9 ppm (s); IR (ATR): ṽ = 2981, 1717, 1602, 1495, 1446, 1371, 1286,, 1208, 1157, 
1094, 1029, 782, 752, 692 cm-1; MS (EI, 70 eV) m/z (%): 267 (19), 266 (100) [M+], 219 (11), 
193 (43), 178 (12), 135 (21), 107 (18); HRMS (EI–TOF) calcd. for C18H18O2: 266.1307; 
found 266.1294. 
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7.5.6.30. Synthesis of 1–((E)–3–hydroxy–1–phenylprop–1–en–2–yl)–3-methylbenzene 
 
[CAS: 335267-58-8] 
The title compound was prepared following general procedure A, starting from 2–
methylbenzoic acid (69 mg, 0.5 mmol) and 1–(3–hydroxyprop–1–ynyl)–benzene (105 mg, 
110 µL, 0.75 mmol). The title compound was isolated as colorless liquid (79 mg, 70%). 
1H NMR (400 MHz, CDCl3): δ = 7.37–7.47 (m, 6H), 7.29–7.36 (m, 2H), 7.17 (d, J = 7.5 Hz, 
1H), 6.97 (s, 1H), 4.72 (s, 2H), 2.42 (s, 3H), 1.63 ppm (s, 1H); 13C NMR (101 MHz, CDCl3): 
δ = 140.3 (s), 138.3 (s), 137.0 (s), 131.1 (s), 128.9 (s), 128.6 (s), 128.5 (s), 128.4 (s), 127.4 (s), 
127.3 (s), 123.7 (s), 120.0 (s), 60.4 (s), 21.6 ppm (s); IR (ATR): ṽ = 3360, 3052, 3021, 2921, 
1601, 1493, 1445, 1010, 999, 966, 782, 754, 692 cm-1; MS (EI, 70 eV) m/z (%): 225 (12), 224 
(100) [M+], 209 (15), 195 (13), 178 (11), 119 (70), 105 (40), 91 (36), 77 (20); HRMS (EI–
TOF) calcd. for C16H16O: 224.1201; found 224.1212. 
7.5.6.31. Synthesis of 1–methyl–3–((Z)–1–phenylbut–1–en–2–yl)–benzene 
 
[CAS: 2079114-98-8] 
The title compound was prepared following general procedure A, starting from 2–
methylbenzoic acid (69 mg, 0.5 mmol) and 1–(but–1–ynyl)–benzene (97 mg, 109 µL, 
0.75 mmol). The title compound was isolated as colorless solid (80 mg, 70%). 
1H NMR (400 MHz, CDCl3): δ = 7.32–7.41 (m, 4H), 7.29–7.31 (m, 1H), 7.25–7.29 (m, 3H), 
7.09–7.15 (m, 1H), 6.69 (s, 1H), 2.75 (q, J = 7.4 Hz, 2H), 2.40 (s, 3H), 1.07 ppm (t, J = 
7.5 Hz, 3H); 13C NMR (101 MHz, CDCl3): δ = 144.6 (s), 142.7 (s), 138.3 (s), 137.9 (s), 128.9 
(s), 128.7 (s), 128.2 (s), 127.9 (s), 127.8 (s), 127.4 (s), 126.5 (s), 123.7 (s), 23.3 (s), 21.6 (s), 
13.5 ppm (s); IR (ATR): ṽ = 3020, 2965, 1601, 1494, 1445, 1376, 864, 780, 753, 698 cm-1; 
MS (EI, 70 eV) m/z (%): 223 (21), 222 (100) [M+], 208 (9), 207 (44), 193 (14), 129 (10), 115 
(26); HRMS (EI–TOF) calcd. for C17H18: 222.1409; found 298.1401; m.p.: 46–47 °C. 
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7.5.6.32. Synthesis of 1–methyl–3–((Z)–1–phenylpent–1–en–2–yl)–benzene 
 
[CAS: 2079115-31-2] 
The title compound was prepared following general procedure A, starting from 2–
methylbenzoic acid (69 mg, 0.5 mmol) and 1–phenyl–1–pentyne (110 mg, 115 µL, 
0.75 mmol). The title compound was isolated as colorless liquid (95 mg, 80%). 
1H NMR (400 MHz, CDCl3): δ = 7.30–7.40 (m, 4H), 7.22–7.30 (m, 4H), 7.09–7.15 (m, 1H), 
6.69 (s, 1H), 2.63–2.72 (m, 2H), 2.40 (s, 3H), 1.40–1.52 (m, 2H), 0.91 ppm (t, J = 7.4 Hz, 
3H); 13C NMR (101 MHz, CDCl3): δ = 143.4 (s), 143.2 (s), 138.4 (s), 137.8 (s), 128.8 (s), 
128.2 (s), 128.2 (s), 128.1 (s), 127.9 (s), 127.4 (s), 126.4 (s), 123.7 (s), 77.3 (s), 76.7 (s), 32.2 
(s), 22.0 (s), 21.6 (s), 14.1 ppm (s); IR (ATR): ṽ = 3023, 2958, 2927, 1601, 1493, 1455, 1377, 
1088, 781, 698 cm-1; MS (EI, 70 eV) m/z (%): 237 (21), 236 (100) [M+], 208 (9), 207 (44), 
193 (14), 129 (10), 115 (26); HRMS (EI–TOF) calcd. for C18H20: 236.1565; found 236.1576. 
7.5.6.33. Synthesis of 1–((E)–3–methoxy–1–phenylprop–1–en–2–yl)–3-methylbenzene 
 
[CAS: 2079115-01-6] 
The title compound was prepared following general procedure A, starting from 2–
methylbenzoic acid (69 mg, 0.5 mmol) and 1–(3–methoxyprop–1–ynyl)–benzene (110 mg, 
115 µL, 0.75 mmol). The title compound was isolated as colorless liquid (66 mg, 56%). 
1H NMR (400 MHz, CDCl3): δ = 7.37–7.45 (m, 6H), 7.28–7.35 (m, 2H), 7.12–7.15 (m, 1H), 
7.05 (s, 1H), 4.39 (s, 2H), 3.40 (s, 3H), 2.41 ppm (s, 3H); 13C NMR (101 MHz, CDCl3): δ 
= 141.5 (s), 138.0 (s), 138.0 (s), 137.2 (s), 132.4 (s), 129.0 (s), 128.3 (s), 128.3 (s), 128.2 (s), 
127.2 (s), 127.1 (s), 123.4 (s), 70.1 (s), 58.1 (s), 21.6 ppm (s); IR (ATR): ṽ = 3022, 2922, 
1603, 1493, 1446, 1193, 1094, 952, 785, 692 cm-1; MS (EI, 70 eV) m/z (%): 238 (100) [M+], 
237 (59), 223 (75), 207 (21), 206 (21), 115 (34), 91 (22); HRMS (EI–TOF) calcd. for 
C17H18O: 238.1358; found 238.1363. 
Experimental Section 
 
 207 
7.5.6.34. Synthesis of (Z)–2–(3–fluorophenyl–3–phenylprop–1–en–1–ol) 
 
[CAS: 2079115-04-9] 
The title compound was prepared following general procedure A, starting from 4–
fluorobenzoic acid (71.5 mg, 0.5 mmol) and 1–(3–hydroxyprop–1–ynyl)–benzene (105 mg, 
110 µL, 0.75 mmol). The title compound was isolated as colorless liquid (83 mg, 73%). 
The title compound was prepared following general procedure B, starting from 4–
fluorobenzoic acid (143 mg, 1 mmol) and 1–(3–hydroxyprop–1–ynyl)–benzene (70 mg, 
73.3 µL, 0.5 mmol). The title compound was isolated as colorless liquid (75 mg, 66%). 
1H NMR (400 MHz, CDCl3): δ = 7.29–7.50 (m, 8H), 6.97–7.10 (m, 2H), 4.70 ppm (s, 2H); 
13C NMR (101 MHz, CDCl3): δ = 163.1 (d, J = 246.1 Hz), 143.0 (d, J = 7.3 Hz), 138.9 (d, J = 
2.7 Hz), 136.5 (s), 132.2 (s), 130.1 (d, J = 8.2 Hz), 128.9 (s), 128.5 (s), 127.7 (s), 122.2 (d, J = 
2.7 Hz), 114.5 (d, J = 21.8 Hz), 113.5 (d, J = 22.7 Hz), 60.3 ppm (s); 19F NMR (376 MHz, 
CDCl3): δ = -112.95 ppm; IR (ATR): ṽ = 3333, 3024, 2338, 1741, 1609, 1580, 1484, 1443, 
1263, 1229, 1174, 1158, 1011, 968, 902, 864, 780, 756, 694 cm-1; MS (EI, 70 eV) m/z (%): 
228 (15), 227 (100) [M+], 211 (32), 123 (10), 105 (33), 91 (13); HRMS (EI–TOF) calcd. for 
C15H13OF: 228.0950; found 228.0964. 
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